Prof. Dr. Roland Schmieder

Publikationsliste Prof. Dr. Roland Schmieder

Ortiz A, Ferro CJ, Balafa O, Burnier M, Ekart R, Halimi JM, Kreutz R, Mark PB, Persu A, Rossignol P, Ruilope LM, Schmieder RE, Valdivielso JM, Del Vecchio L, Zoccali C, Mallamaci F, Sarafidis P, European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association—European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and Kidney working group of the European Society of Hypertension (ESH): (2023) Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. Nephrol Dial Transplant. 2023;38(1): 10-25
Schmieder RE: (2023) Renal denervation in patients with chronic kidney disease: current evidence and future perspectives. Nephrol Dial Transplant. 2023;38(5): 1089-1096
Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, Bramlage P, Nöh L, Schiffer M, Uder M, Achenbach S, Schmieder RE: (2023) The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial. Clin Res Cardiol. 2023;112(1): 134-144
Pietschner R, Bosch A, Kannenkeril D, Striepe K, Schiffer M, Achenbach S, Schmieder RE, Kolwelter J: (2023) Is vascular remodelling in patients with chronic heart failure exaggerated? ESC Heart Fail. 2023;10(1): 245-254
Agarwal R, Ruilope LM, Ruiz-Hurtado G, Haller H, Schmieder RE, Anker SD, Filippatos G, Pitt B, Rossing P, Lambelet M, Nowack C, Kolkhof P, Joseph A, Bakris GL: (2023) Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes. J Hypertens. 2023;41(2): 295-302
Kario K, Mahfoud F, Kandzari DE, Townsend RR, Weber MA, Schmieder RE, Tsioufis K, Pocock S, Brar S, Hettrick DA, Fahy M, Böhm M: (2023) Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial. Hypertens Res. 2023;46(1): 280-288
Schmieder RE, Mahfoud F, Mancia G, Narkiewicz K, Ruilope L, Hutton D, Cao K, Hettrick DA, Fahy M, Schlaich MP, Böhm M, Pietzsch JB: (2023) Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry. Eur Heart J Qual Care Clin Outcomes. 2023;9(6): 575-582
Picone DS, Stoneman E, Cremer A, Schultz MG, Otahal P, Hughes AD, Black JA, Bos WJ, Chen CH, Cheng HM, Dwyer N, Lacy P, Laugesen E, Liang F, Kim HL, Ohte N, Okada S, Omboni S, Ott C, Pereira T, Pucci G, Rajani R, Schmieder R, Sinha MD, Stewart R, Stouffer GA, Takazawa K, Wang J, Weber T, Westerhof BE, Williams B, Yamada H, Sharman JE: (2023) Sex Differences in Blood Pressure and Potential Implications for Cardiovascular Risk Management. Hypertension. 2023;80(2): 316-324
Bosch A, Poglitsch M, Kannenkeril D, Kolwelter J, Striepe K, Ott C, Rauh M, Schiffer M, Achenbach S, Schmieder RE: (2023) Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure. ESC Heart Fail. 2023;10(3): 1635-1642
Barbato E, Azizi M, Schmieder RE, Lauder L, Böhm M, Brouwers S, Bruno RM, Dudek D, Kahan T, Kandzari DE, Lüscher TF, Parati G, Pathak A, Ribichini FL, Schlaich MP, Sharp ASP, Sudano I, Volpe M, Tsioufis C, Wijns W, Mahfoud F: (2023) Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2023;44(15): 1313-1330
Barbato E, Azizi M, Schmieder RE, Lauder L, Böhm M, Brouwers S, Bruno RM, Dudek D, Kahan T, Kandzari DE, Lüscher TF, Parati G, Pathak A, Ribichini FL, Schlaich MP, Sharp ASP, Sudano I, Volpe M, Tsioufis C, Wijns W, Mahfoud F: (2023) Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). EuroIntervention. 2023;18(15): 1227-1243
Stefański A, Wolf J, Harazny JM, Miszkowska-Nagórna E, Wolnik B, Murawska J, Narkiewicz K, Schmieder RE: (2023) Impact of type 1 diabetes and its duration on wall-to-lumen ratio and blood flow in retinal arterioles. Microvasc Res. 2023;147():
Ott C, Mahfoud F, Mancia G, Narkiewicz K, Ruilope LM, Fahy M, Schlaich MP, Böhm M, Schmieder RE: (2022) Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years. Nephrol Dial Transplant. 2022;37(2): 304-310
Ott C, Schmieder RE: (2022) Diagnosis and treatment of arterial hypertension 2021. Kidney Int. 2022;101(1): 36-46
Bosch A, Kannenkeril D, Jung S, Striepe K, Karg MV, Ott C, Schmieder RE: (2022) The influence of aircraft noise exposure on the systemic and renal haemodynamics. Eur J Prev Cardiol. 2022;29(1): 116-124
Striepe K, Schiffer M, Schmieder R: (2022) [Renal denervation : Really an alternative to reducing blood pressure?] Internist (Berl). 2022;63(3): 330-340
Fisher NDL, Kirtane AJ, Daemen J, Rader F, Lobo MD, Saxena M, Abraham J, Schmieder RE, Sharp ASP, Gosse P, Claude L, Song Y, Azizi M, RADIANCE-HTN Investigators: (2022) Plasma renin and aldosterone concentrations related to endovascular ultrasound renal denervation in the RADIANCE-HTN SOLO trial. J Hypertens. 2022;40(2): 221-228
Weber T, Wassertheurer S, Mayer CC, Hametner B, Danninger K, Townsend RR, Mahfoud F, Kario K, Fahy M, DeBruin V, Peterson N, Negoita M, Weber MA, Kandzari DE, Schmieder RE, Tsioufis KP, Binder RK, Böhm M: (2022) Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial. Hypertension. 2022;79(7): 1506-1514
Wilke T, Weisser B, Predel HG, Schmieder RE, Wassmann S, Gillessen A, Blettenberg J, Maywald U, Randerath O, Müller S, Böhm M: (2022) Effects of cardiovascular single pill combinations compared with identical multi-pill therapies on healthcare cost and utilization in Germany. J Comp Eff Res. 2022;11(6): 411-422
Silbernagel G, Duarte K, Sadiku S, Fauler G, März W, Schmieder RE, Jardine AG, Massy ZA, Girerd N, Fellström B, Rossignol P, Scharnagl H, Zannad F: (2022) High cholesterol absorption is associated with increased cardiovascular risk in haemodialysis patients: insights from the AURORA study. Eur J Prev Cardiol. 2022;29(13): 1731-1739
Wilke T, Weisser B, Predel HG, Schmieder R, Wassmann S, Gillessen A, Blettenberg J, Maywald U, Randerath O, Mueller S, Böhm M: (2022) Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-Study. Integr Blood Press Control. 2022;15(): 11-21
Kandzari DE, Mahfoud F, Weber MA, Townsend R, Parati G, Fisher NDL, Lobo MD, Bloch M, Böhm M, Sharp ASP, Schmieder RE, Azizi M, Schlaich MP, Papademetriou V, Kirtane AJ, Daemen J, Pathak A, Ukena C, Lurz P, Grassi G, Myers M, Finn AV, Morice MC, Mehran R, Jüni P, Stone GW, Krucoff MW, Whelton PK, Tsioufis K, Cutlip DE, Spitzer E: (2022) Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium. Circulation. 2022;145(11): 847-863
Böhm M, Schumacher H, Werner C, Teo KK, Lonn EM, Mahfoud F, Speer T, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Laufs U, Williams B, Yusuf S, Mann JFE: (2022) Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk. Cardiovasc Diabetol. 2022;21(1):
Ott C, Schmieder RE: (2022) Letter regarding "diagnosis and treatment of arterial hypertension 2021" reply Kidney Int. 2022;101(4): 830-832
Schmieder RE, Cao K, Esler M, Kandzari D, Lobo M, Sharp A, Mancia G, Boehm M, Pietzch J: (2022) 10-YEAR CLINICAL EVENTS AVOIDED IN DIABETIC AND CHRONIC KIDNEY DISEASE HYPERTENSION PATIENTS TREATED WITH RADIOFREQUENCY RENAL DENERVATION: PROJECTIONS BASED ON 3-YEAR DATA FROM THE GLOBAL SYMPLICITY REGISTRY Nephrol Dial Transplant. 2022;37 Suppl 3(): I54-I54
Schlaich M, Pietzsch JB, Mahfoud F, Wiliams B, Mancia G, Narkiewicz K, Ruilope L, Hettrick D, Bohm M, Schmieder RE: (2022) Reduction of Clinical Events in High-Risk Hypertension Patients Treated With Renal Denervation: A Modeled Estimate From 36-Month Global SYMPLICTY Registry Data J Am Coll Cardiol. 2022;79 Suppl S(15): S30-S31
Wang TD, Schmieder RE, Kandzari DE, Lee YH, Haro CF, Pathak A: (2022) Physician Preferences for Recommending Renal Denervation to Hypertensive Patients Is Influenced by Patients' Antihypertensive Medication Nonadherence Due to Medication Side Effects J Am Coll Cardiol. 2022;79 Suppl S(15): S30-S30
Mahfoud F, Kandzari DE, Kario K, Townsend RR, Weber MA, Schmieder RE, Tsioufis K, Pocock S, Dimitriadis K, Choi JW, East C, D'Souza R, Sharp ASP, Ewen S, Walton A, Hopper I, Brar S, McKenna P, Fahy M, Böhm M: (2022) Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial. Lancet. 2022;399(10333): 1401-1410
Kolwelter J, Striepe K, Bosch A, Kannenkeril D, Ott C, Schiffer M, Schmieder RE: (2022) Change of renal function after short-term use of cardioprotective agents in patients with type 2 diabetes is not accurately assessed by the change of estimated glomerular filtration rate: an observational study. Diabetol Metab Syndr. 2022;14(1):
Mahfoud F, Mancia G, Schmieder RE, Ruilope L, Narkiewicz K, Schlaich M, Williams B, Ribichini F, Weil J, Kao HL, Rodriguez-Leor O, Noory E, Ong TK, Unterseeh T, de Araújo Gonçalves P, Zirlik A, Almerri K, Sharif F, Lauder L, Wanten M, Fahy M, Böhm M: (2022) Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range. J Am Coll Cardiol. 2022;80(20): 1871-1880
Azizi M, Mahfoud F, Weber MA, Sharp ASP, Schmieder RE, Lurz P, Lobo MD, Fisher NDL, Daemen J, Bloch MJ, Basile J, Sanghvi K, Saxena M, Gosse P, Jenkins JS, Levy T, Persu A, Kably B, Claude L, Reeve-Stoffer H, McClure C, Kirtane AJ, RADIANCE-HTN Investigators , Mullin C, Thackeray L, Chertow G, Kahan T, Dauerman H, Ullery S, Abbott JD, Loening A, Zagoria R, Costello J, Krathan C, Lewis L, McElvarr A, Reilly J, Cash M, Williams S, Jarvis M, Fong P, Laffer C, Gainer J, Robbins M, Crook S, Maddel S, Hsi D, Martin S, Portnay E, Ducey M, Rose S, DelMastro E, Bangalore S, Williams S, Cabos S, Rodriguez Alvarez C, Todoran T, Powers E, Hodskins E, Paladugu V, Tecklenburg A, Devireddy C, Lea J, Wells B, Fiebach A, Merlin C, Rader F, Dohad S, Kim HM, Rashid M, Abraham J, Owan T, Abraham A, Lavasani I, Neilson H, Calhoun D, McElderry T, Maddox W, Oparil S, Kinder S, Radhakrishnan J, Batres C, Edwards S, Garasic J, Drachman D, Zusman R, Rosenfield K, Do D, Khuddus M, Zentko S, O'Meara J, Barb I, Foster A, Boyette A, Wang Y, Jay D, Skeik N, Schwartz R, Peterson R, Goldman JA, Goldman J, Ledley G, Katof N, Potluri S, Biedermann S, Ward J, White M, Mauri L, Sobieszczky P, Smith A, Aseltine L, Stouffer R, Hinderliter A, Pauley E, Wade T, Zidar D, Shishehbor M, Effron B, Costa M, Semenec T, Roongsritong C, Nelson P, Neumann B, Cohen D, Giri J, Neubauer R, Vo T, Chugh AR, Huang PH, Jose P, Flack J, Fishman R, Jones M, Adams T, Bajzer C, Mathur A, Jain A, Balawon A, Zongo O, Bent C, Beckett D, Lakeman N, Kennard S, D'Souza RJ, Statton S, Wilkes L, Anning C, Sayer J, Iyer SG, Robinson N, Sevillano A, Ocampo M, Gerber R, Faris M, Marshall AJ, Sinclair J, Pepper H, Davies J, Chapman N, Burak P, Carvelli P, Jadhav S, Quinn J, Rump LC, Stegbauer J, Schimmöller L, Potthoff S, Schmid C, Roeder S, Weil J, Hafer L, Agdirlioglu T, Köllner T, Böhm M, Ewen S, Kulenthiran S, Wachter A, Koch C, Fengler K, Rommel KP, Trautmann K, Petzold M, Ott C, Schmid A, Uder M, Heinritz U, Fröhlich-Endres K, Genth-Zotz S, Kämpfner D, Grawe A, Höhne J, Kaesberger B, von Zur Mühlen C, Wolf D, Welzel M, Heinrichs G, Trabitzsch B, Cremer A, Trillaud H, Papadopoulos P, Maire F, Gaudissard J, Sapoval M, Livrozet M, Lorthioir A, Amar L, Paquet V, Pathak A, Honton B, Cottin M, Petit F, Lantelme P, Berge C, Courand PY, Langevin F, Delsart P, Longere B, Ledieu G, Pontana F, Sommeville C, Bertrand F, Feyz L, Zeijen V, Ruiter A, Huysken E, Blankestijn P, Voskuil M, Rittersma Z, Dolmans H, Kroon AA, van Zwam WH, Vranken J, de Haan C, Renkin J, Maes F, Beauloye C, Lengelé JP, Huyberechts D, Bouvie A, Witkowski A, Januszewicz A, Kądziela J, Prejbisj A, Hering D, Ciecwierz D, Jaguszewski MJ, Owczuk R: (2022) Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial. JAMA Cardiol. 2022;7(12): 1244-1252
Ruilope LM, Agarwal R, Anker SD, Filippatos G, Pitt B, Rossing P, Sarafidis P, Schmieder RE, Joseph A, Rethemeier N, Nowack C, Bakris GL, FIDELIO-DKD Investigators: (2022) Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes. Hypertension. 2022;79(12): 2685-2695
Forst T, Mathieu C, Giorgino F, Wheeler DC, Papanas N, Schmieder RE, Halabi A, Schnell O, Streckbein M, Tuttle KR: (2022) New strategies to improve clinical outcomes for diabetic kidney disease. BMC Med. 2022;20(1):
Weber MA, Schmieder RE, Kandzari DE, Townsend RR, Mahfoud F, Tsioufis K, Kario K, Pocock S, Tatakis F, Ewen S, Choi JW, East C, Lee DP, Ma A, Cohen DL, Wilensky R, Devireddy CM, Lea JP, Schmid A, Fahy M, Böhm M: (2022) Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial. Clin Res Cardiol. 2022;111(11): 1269-1275
Rodionova K, Ditting T, Hilgers KF, Peter L, Schmieder RE, Ott C, Schiffer M, Amann K, Veelken R: (2022) Empagliflozin Improves Impaired Sensitivity Of Afferent Neurons With Renal Axons Hypertension. 2022;79 Suppl 1():
Rodionova K, Ditting T, Linz P, Hilgers KF, Ott C, Schmieder RE, Schiffer M, Amann K, Veelken R: (2022) High Sodium Intake Effects On Afferent Renal Nerve Activity Hypertension. 2022;79 Suppl 1():
Kannenkeril D, Bosch A, Striepe K, Berner L, Pietschner R, Kolwelter J, Ott C, Schiffer M, Achenbach S, Schmieder RE: (2022) Evolocumab Alters Vascular Function in Patients With Cardiovascular Disease Circulation. 2022;146 Suppl 1():
Bosch A, Poglitsch M, Kannenkeril D, Ott C, Pietschner R, Striepe K, Schiffer M, Schmieder RE: (2022) ANGIOTENSIN PROFILES IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES WITH COMBINATION THERAPY OF EMPAGLIFLOZIN AND LINAGLIPTIN VERSUS METFORMIN AND INSULIN GLARGINE J Hypertens. 2022;40 Suppl 1(SUPPL 1): E283-E284
Kannenkeril D, Ott C, Bosch A, Striepe K, Pietschner R, Schiffer M, Schmieder RE: (2022) IS BASAL NITRIC OXIDE ACTIVITY OF THE RENAL VASCULATURE ALTERED? ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL COMPARING TWO COMBINATION THERAPIES J Hypertens. 2022;40 Suppl 1(SUPPL): E59-E59
Kannenkeril D, Kolwelter J, Pietschner R, Striepe K, Bosch A, Achenbach S, Schmieder RE: (2022) SEMI-AUTOMATIC MEASUREMENT OF INTIMA-MEDIA THICKNESS OF BRACHIAL ARTERY IN PATIENTS WITH CONGESTIVE HEART FAILURE J Hypertens. 2022;40 Suppl 1(SUPPL): E239-E239
Kannenkeril D, Kolwelter J, Pietschner R, Striepe K, Bosch A, Achenbach S, Schmieder RE: (2022) SEMI-AUTOMATIC MEASUREMENT OF INTIMA-MEDIA THICKNESS OF BRACHIAL ARTERY IN PATIENTS WITH CONGESTIVE HEART FAILURE J Hypertens. 2022;40 Suppl 1(SUPPL): E239-E239
Kannenkeril D, Ott C, Bosch A, Striepe K, Pietschner R, Schiffer M, Schmieder RE: (2022) IS BASAL NITRIC OXIDE ACTIVITY OF THE RENAL VASCULATURE ALTERED? ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL COMPARING TWO COMBINATION THERAPIES J Hypertens. 2022;40 Suppl 1(SUPPL): E59-E59
Pietschner R, Kolwelter J, Bosch A, Striepe K, Kannenkeril D, Ott C, Schiffer M, Achenbach S, Schmieder RE: (2022) DETAILED ANALYSIS OF VASCULAR STIFFNESS IN PATIENTS WITH CHRONIC HEART FAILURE J Hypertens. 2022;40 Suppl 1(SUPPL 1): E129-E129
Pietschner R, Kolwelter J, Bosch A, Striepe K, Kannenkeril D, Ott C, Schiffer M, Achenbach S, Schmieder RE: (2022) DETAILED ANALYSIS OF VASCULAR STIFFNESS IN PATIENTS WITH CHRONIC HEART FAILURE J Hypertens. 2022;40 Suppl 1(SUPPL): E129-E129
Weil J, Mahfoud F, Schmieder R, Narkiewicz K, Williams B, Fahy M, Mancia G: (2022) Influence of Gender on Blood Pressure Reduction After Renal Denervation in GSR DEFINE J Am Coll Cardiol. 2022;80 Suppl S(12): B230-B230
Tsioufis K, Kandzari D, Kario K, Townsend R, Mahfoud F, Weber M, Schmieder R, Pocock S, Fahy M, Bohm M: (2022) LONG-TERM RESULTS FROM THE SPYRAL HTN-ON MED TRIAL: RENAL DENERVATION INCREASES TIME IN BLOOD PRESSURE TARGET RANGE OVER 36 MONTHS J Hypertens. 2022;40 Suppl 1(SUPPL): E10-E11
Tsioufis K, Kandzari D, Kario K, Townsend R, Mahfoud F, Weber M, Schmieder R, Pocock S, Fahy M, Bohm M: (2022) LONG-TERM RESULTS FROM THE SPYRAL HTN-ON MED TRIAL: RENAL DENERVATION INCREASES TIME IN BLOOD PRESSURE TARGET RANGE OVER 36 MONTHS J Hypertens. 2022;40 Suppl 1(SUPPL): E10-E11
Bloch M, Kirtane A, Mahfoud F, Azizi M, Basile J, Daemen J, Saxena M, Gosse P, Sanghvi K, Schmieder R: (2022) Twenty-Four Month Results in Patients With Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial J Am Coll Cardiol. 2022;80 Suppl S(12): B85-B86
Esler M, Cao K, Lobo M, Sharp ASP, Kandzari DE, Mancia G, Boehm M, Schmieder RE, Pietzch JB: (2022) CLINICAL EVENT REDUCTIONS IN HIGH-RISK HYPERTENSION PATIENTS TREATED WITH RENAL DENERVATION: 10-YEAR PROJECTIONS BASED ON 3-YEAR FOLLOW-UP FROM THE GLOBAL SYMPLICITY REGISTRY J Hypertens. 2022;40 Suppl 1(SUPPL): E55-E56
Esler M, Cao K, Lobo M, Sharp ASP, Kandzari DE, Mancia G, Bohm M, Schmieder RE, Pietzch JB: (2022) CLINICAL EVENT REDUCTIONS IN HIGH-RISK HYPERTENSION PATIENTS TREATED WITH RENAL DENERVATION: 10-YEAR PROJECTIONS BASED ON 3-YEAR FOLLOW-UP FROM THE GLOBAL SYMPLICITY REGISTRY J Hypertens. 2022;40 Suppl 1(SUPPL): E55-E56
Mahfoud F, Schmieder R, Schlaich M, Narkiewicz K, Ruilope L, Williams B, Fahy M, Mancia G, Bohm M: (2022) BLOOD PRESSURE REDUCTION AFTER CATHETER-BASED RENAL DENERVATION IN PATIENTS WITH CARDIOVASCULAR DISEASE IN THE GLOBAL SYMPLICITY REGISTRY J Hypertens. 2022;40 Suppl 1(SUPPL): E290-E290
Mahfoud F, Schmieder R, Schlaich M, Narkiewicz K, Ruilope L, Williams B, Fahy M, Mancia G, Bohm M: (2022) BLOOD PRESSURE REDUCTION AFTER CATHETER-BASED RENAL DENERVATION IN PATIENTS WITH CARDIOVASCULAR DISEASE IN THE GLOBAL SYMPLICITY REGISTRY J Hypertens. 2022;40 Suppl 1(SUPPL): E290-E290
Kandzari DE, Townsend RR, Kario K, Mahfoud F, Weber MA, Schmieder RE, Pocock S, Tsioufis K, Brar S, DeBruin V, Fahy M, Boehm M: (2022) Effect of Radiofrequency Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 6-Month Primary Results From the SPYRAL HTN-ON Med Expansion Randomized Trial Circulation. 2022;146(25): E584-E584
Rossignol P, Duarte K, Bresso E, A Å, Devignes MD, Eriksson N, Girerd N, Glerup R, Jardine AG, Holdaas H, Lamiral Z, Leroy C, Massy Z, März W, Krämer B, Wu PH, Schmieder R, Soveri I, Christensen JH, Svensson M, Zannad F, Fellström B: (2022) NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients. Eur Heart J Open. 2022;2(6):
Schmieder RE: (2022) Renal denervation: where do we stand and what is the relevance to the nephrologist? Nephrol Dial Transplant. 2022;37(4): 638-644
Salib M, Girerd S, Girerd N, März W, Scharnagl H, Massy ZA, Leroy C, Duarte K, Holdaas H, Jardine AG, Schmieder RE, Fellström B, López-Andrés N, Rossignol P, Zannad F: (2022) Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial. Clin Res Cardiol. 2022;111(6): 614-626
Saxena M, Schmieder RE, Kirtane AJ, Mahfoud F, Daemen J, Basile J, Lurz P, Gosse P, Sanghvi K, Fisher NDL, Rump LC, Pathak A, Blankestijn PJ, Mathur A, Wang Y, Weber MA, Sharp ASP, Bloch MJ, Barman NC, Claude L, Song Y, Azizi M, Lobo MD: (2022) Predictors of blood pressure response to ultrasound renal denervation in the RADIANCE-HTN SOLO study. J Hum Hypertens. 2022;36(7): 629-639
Gessner A, Gemeinhardt A, Bosch A, Kannenkeril D, Staerk C, Mayr A, Fromm MF, Schmieder RE, Maas R: (2022) Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers. Cardiovasc Diabetol. 2022;21(1):
Schmieder RE, Bosch A: (2022) Editorial comment: Renal denervation. Hypertens Res. 2022;45(2): 241-243
Bosch A, Schmieder RE: (2021) Novel approaches to management of hypertension. Curr Opin Nephrol Hypertens. 2021;30(1): 54-62
Szulc U, Dąbrowska E, Pieczyński J, Białkowski P, Narkiewicz K, Schmieder RE, Harazny J: (2021) How to measure retinal microperfusion in patients with arterial hypertension. Blood Press. 2021;30(1): 4-19
Manava P, Naraghi R, Schmieder R, Fahlbusch R, Doerfler A, Lell MM, Buchfelder M, Hastreiter P: (2021) 3D-Visualization of Neurovascular Compression at the Ventrolateral Medulla in Patients with Arterial Hypertension. Clin Neuroradiol. 2021;31(2): 335-345
Cífková R, Harazny JM, Bruthans J, Wohlfahrt P, Krajčoviechová A, Lánská V, Gelžinský J, Mateřánková M, Mareš Š, Filipovský J, Mayer O, Schmieder RE: (2021) Reference values of retinal microcirculation parameters derived from a population random sample. Microvasc Res. 2021;134():
Kario K, Weber MA, Böhm M, Townsend RR, Mahfoud F, Schmieder RE, Tsioufis K, Cohen SA, Fahy M, Kandzari DE: (2021) Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trial. Clin Res Cardiol. 2021;110(5): 725-731
Bertog S, Sharma A, Mahfoud F, Pathak A, Schmieder RE, Sievert K, Papademetriou V, Weber MA, Haratani N, Lobo MD, Saxena M, Kandzari DE, Fischell TA, Sievert H: (2021) Alcohol-Mediated Renal Sympathetic Neurolysis for the Treatment of Hypertension: The Peregrine™ Infusion Catheter. Cardiovasc Revasc Med. 2021;24(): 77-86
Picone DS, Schultz MG, Armstrong MK, Black JA, Bos WJW, Chen CH, Cheng HM, Cremer A, Dwyer N, Hughes AD, Kim HL, Lacy PS, Laugesen E, Liang F, Ohte N, Okada S, Omboni S, Ott C, Pereira T, Pucci G, Schmieder RE, Sinha MD, Stouffer GA, Takazawa K, Roberts-Thomson P, Wang JG, Weber T, Westerhof BE, Williams B, Sharman JE, Invasive Blood Pressure Consortium: (2021) Identifying Isolated Systolic Hypertension From Upper-Arm Cuff Blood Pressure Compared With Invasive Measurements. Hypertension. 2021;77(2): 632-639
Jung S, Bosch A, Kolwelter J, Striepe K, Kannenkeril D, Schuster T, Ott C, Achenbach S, Schmieder RE: (2021) Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction. ESC Heart Fail. 2021;8(2): 1562-1570
Otieno HA, Miezah C, Yonga G, Kueffer F, Guy M, Lang'At C, Hettrick DA, Schmieder R: (2021) Improved blood pressure control via a novel chronic disease management model of care in sub-Saharan Africa: Real-world program implementation results. J Clin Hypertens (Greenwich). 2021;23(4): 785-792
Schmieder RE, Kandzari DE, Wang TD, Lee YH, Lazarus G, Pathak A: (2021) Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension. J Hypertens. 2021;39(1): 162-168
Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Emrich I, Mancia G, Redon J, Schmieder RE, Sliwa K, Lehrke M, Marx N, Weber MA, Williams B, Yusuf S, Mann JFE: (2021) Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk. J Hypertens. 2021;39(4): 766-774
Ott C, Jung S, Korn M, Kannenkeril D, Bosch A, Kolwelter J, Striepe K, Bramlage P, Schiffer M, Schmieder RE: (2021) Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine. Cardiovasc Diabetol. 2021;20(1):
Kolwelter J, Bosch A, Jung S, Stabel L, Kannenkeril D, Ott C, Bramlage P, Schiffer M, Achenbach S, Schmieder RE: (2021) Effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failure. ESC Heart Fail. 2021;8(6): 5327-5337
Böhm M, Tsioufis K, Kandzari DE, Kario K, Weber MA, Schmieder RE, Townsend RR, Kulenthiran S, Ukena C, Pocock S, Ewen S, Weil J, Fahy M, Mahfoud F: (2021) Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension. J Am Coll Cardiol. 2021;78(10): 1028-1038
Rodionova K, Hindermann M, Hilgers K, Ott C, Schmieder RE, Schiffer M, Amann K, Veelken R, Ditting T: (2021) AT II Receptor Blockade and Renal Denervation: Different Interventions with Comparable Renal Effects? Kidney Blood Press Res. 2021;46(3): 331-341
Rodionova K, Hilgers KF, Rafii-Tabrizi S, Doellner J, Cordasic N, Linz P, Karl AL, Ott C, Schmieder RE, Schiffer M, Amann K, Veelken R, Ditting T: (2021) Responsiveness of afferent renal nerve units in renovascular hypertension in rats. Pflugers Arch. 2021;473(10): 1617-1629
Chatzikyrkou C, Schmieder RE, Schiffer M: (2021) Update on Treatment of Hypertension After Renal Transplantation. Curr Hypertens Rep. 2021;23(5):
Kannenkeril D, Jung S, Ott C, Striepe K, Kolwelter J, Schmieder RE, Bosch A: (2021) Association of Noise Annoyance with Measured Renal Hemodynamic Changes. Kidney Blood Press Res. 2021;46(3): 323-330
Otieno HA, Miezah C, Yonga G, Kueffer F, Guy M, Lang'at C, Hettrick DA, Schmieder R: (2021) Response to: Cavagna et al The importance of considering cultural and environmental elements in an interventional model of care to fight hypertension in Africa. J Clin Hypertens (Greenwich). 2021;23(6): 1271-1272
Böhm M, Schumacher H, Teo KK, Lonn EM, Lauder L, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Williams B, Yusuf S, Mann JFE, Mahfoud F: (2021) Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke. J Hypertens. 2021;39(8): 1602-1610
Engelbertz C, Pinnschmidt HO, Freisinger E, Reinecke H, Schmitz B, Fobker M, Schmieder RE, Wegscheider K, Breithardt G, Pavenstädt H, Brand E: (2021) Sex-specific differences and long-term outcome of patients with coronary artery disease and chronic kidney disease: the Coronary Artery Disease and Renal Failure (CAD-REF) Registry. Clin Res Cardiol. 2021;110(10): 1625-1636
Mahfoud F, Townsend RR, Kandzari DE, Kario K, Schmieder RE, Tsioufis K, Pocock S, David S, Patel K, Rao A, Walton A, Bloom JE, Weber T, Suppan M, Lauder L, Cohen SA, McKenna P, Fahy M, Böhm M, Weber MA: (2021) Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation. J Am Coll Cardiol. 2021;77(23): 2909-2919
Mahfoud F, Weber M, Schmieder RE, Lobo MD, Blankestijn PJ, Persu A, Fischell TA, Parise H, Pathak A, Kandzari DE: (2021) Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications. Am Heart J. 2021;239(): 90-99
Mahfoud F, Sievert H, Bertog S, Lauder L, Ewen S, Lengelé JP, Wojakowski W, Schmieder R, van der Giet M, Weber MA, Kandzari DE, Parise H, Fischell TA, Pathak A, Persu A: (2021) Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension. Circ Cardiovasc Interv. 2021;14(9):
Azizi M, Sanghvi K, Saxena M, Gosse P, Reilly JP, Levy T, Rump LC, Persu A, Basile J, Bloch MJ, Daemen J, Lobo MD, Mahfoud F, Schmieder RE, Sharp ASP, Weber MA, Sapoval M, Fong P, Pathak A, Lantelme P, Hsi D, Bangalore S, Witkowski A, Weil J, Kably B, Barman NC, Reeve-Stoffer H, Coleman L, McClure CK, Kirtane AJ, RADIANCE-HTN investigators , Sanghvi K, Costello J, Krathan C, Lewis L, McElvarr A, Reilly J, Jenkins S, Cash M, Williams S, Jarvis M, Fong P, Laffer C, Gainer J, Robbins M, Crook S, Maddel S, Hsi D, Martin S, Portnay E, Ducey M, Rose S, DelMastro E, Bangalore S, Williams S, Cabos S, Rodriguez Alvarez C, Todoran T, Basile J, Powers E, Hodskins E, Paladugu V, Tecklenburg A, Devireddy C, Lea J, Wells B, Fiebach A, Merlin C, Rader F, Dohad S, Kim HM, Rashid M, Abraham J, Owan T, Abraham A, Lavasani I, Neilson H, Calhoun D, McElderry T, Maddox W, Oparil S, Kinder S, Kirtane AJ, Radhakrishnan J, Batres C, Edwards S, Garasic J, Drachman D, Zusman R, Rosenfield K, Do D, Khuddus M, Zentko S, O'Meara J, Barb I, Foster A, Boyette A, Wang Y, Jay D, Skeik N, Schwartz R, Peterson R, Goldman JA, Goldman J, Ledley G, Katof N, Potluri S, Biedermann S, Ward J, White M, Fisher ND, Mauri L, Sobieszczky P, Smith A, Aseltine L, Stouffer R, Hinderliter A, Pauley E, Wade T, Zidar D, Shishehbor M, Effron B, Costa M, Semenec T, Bloch MJ, Roongsritong C, Nelson P, Neumann B, Cohen D, Giri J, Neubauer R, Vo T, Chugh AR, Huang PH, Jose P, Flack J, Fishman R, Jones M, Adams T, Bajzer C, Saxena M, Lobo MD, Mathur A, Jain A, Balawon A, Zongo O, Levy T, Bent C, Beckett D, Lakeman N, Kennard S, Sharp A, D'Souza RJ, Statton S, Wilkes L, Anning C, Sayer J, Iyer SG, Robinson N, Sevillano A, Ocampo M, Gerber R, Faris M, Marshall AJ, Sinclair J, Pepper H, Davies J, Chapman N, Burak P, Carvelli P, Jadhav S, Quinn J, Rump LC, Stegbauer J, Schimmöller L, Potthoff S, Schmid C, Roeder S, Weil J, Hafer L, Agdirlioglu T, Köllner T, Mahfoud F, Böhm M, Ewen S, Kulenthiran S, Wachter A, Koch C, Lurz P, Fengler K, Rommel KP, Trautmann K, Petzold M, Schmieder RE, Ott C, Schmid A, Uder M, Heinritz U, Fröhlich-Endres K, Genth-Zotz S, Kämpfner D, Grawe A, Höhne J, Kaesberger B, von Zur Mühlen C, Wolf D, Welzel M, Heinrichs G, Trabitzsch B, Gosse P, Cremer A, Trillaud H, Papadopoulos P, Maire F, Gaudissard J, Azizi M, Sapoval M, Cornu E, Fouassier D, Livrozet M, Lorthioir A, Paquet V, Pathak A, Honton B, Cottin M, Petit F, Lantelme P, Berge C, Courand PY, Langevin F, Delsart P, Longere B, Ledieu G, Pontana F, Sommeville C, Bertrand F, Daemen J, Feyz L, Zeijen V, Ruiter A, Huysken E, Blankestijn P, Voskuil M, Rittersma Z, Dolmans H, Kroon AA, van Zwam WH, Vranken J, de Haan C, Persu A, Renkin J, Maes F, Beauloye C, Lengelé JP, Huyberechts D, Bouvie A, Witkowski A, Januszewicz A, Kdziela J, Prejbisj A, Hering D, Ciecwierz D, Jaguszewski MJ, Owczuk R, Ciecwierz D, Jaguszewski MJ: (2021) Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial. Lancet. 2021;397(10293): 2476-2486
Schmieder RE, Mahfoud F, Mancia G, Azizi M, Böhm M, Dimitriadis K, Kario K, Kroon AA, D Lobo M, Ott C, Pathak A, Persu A, Scalise F, Schlaich M, Kreutz R, Tsioufis C, members of the ESH Working Group on Device-Based Treatment of Hypertension: (2021) European Society of Hypertension position paper on renal denervation 2021. J Hypertens. 2021;39(9): 1733-1741
Kannenkeril D, Jung S, Harazny J, Striepe K, Ott C, Dahlmann A, Kopp C, Schiffer M, Linz P, Nagel AM, Uder M, Schmieder RE: (2021) Tissue sodium content correlates with hypertrophic vascular remodeling in type 2 diabetes. J Diabetes Complications. 2021;35(12):
Pietschner R, Kolwelter J, Bosch A, Striepe K, Jung S, Kannenkeril D, Ott C, Schiffer M, Achenbach S, Schmieder RE: (2021) Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure. Cardiovasc Diabetol. 2021;20(1):
Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, Bramlage P, Uder M, Achenbach S, Schmieder RE: (2021) Reduced tissue sodium content is related to improvement of vascular function in patients with chronic heart failure treated with the SGLT2 inhibitor empagliflozin Eur Heart J. 2021;42 Suppl 1(): 795-795
Pietschner R, Kolwelter J, Bosch A, Kannenkeril D, Ott C, Schiffer M, Achenbach S, Schmieder RE: (2021) Effect of SGLT2 inhibition on ketone bodies in patients with stable chronic heart failure Diabetologia. 2021;64 Suppl 1(SUPPL 1): 107-107
Bosch A, Poglitsch M, Kannenkeril D, Ott C, Striepe K, Schmieder RE: (2021) Angiotensin profiles in patients with type 2 diabetes and combination therapy of empagliflozin and linagliptin versus metformin and insulin glargine Diabetologia. 2021;64 Suppl 1(SUPPL 1): 256-256
Mahfoud F, Bloch MJ, Azizi M, Wang Y, Schmieder RE, Lobo MD, Sharp ASP, Daemen J, Basile J, Weber MA, Scicli AP, McClure CK, Kirtane AJ: (2021) Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trial. EuroIntervention. 2021;17(12): e1024-e1032
Schmieder R, Delles C, Lauder L, Ott C, Boehm M, Mahfoud F: (2021) Predictors of blood pressure response after renal denervation beyond pretreatment blood pressure Eur Heart J. 2021;42 Suppl 1(): 2379-2379
Schmieder RE, Kandzari DE, Wang TD, Lee YH, Haro C, Pathak A: (2021) Reasons for antihypertensive medication nonadherence influence physician preferences for hypertension management Eur Heart J. 2021;42 Suppl 1(): 2375-2375
Mahfoud F, Mancia G, Ukena C, Schmieder R, Narkiewicz K, Ruilope L, Schlaich M, Williams B, Fahy M, Boehm M: (2021) Application of win ratio methodology in the Global SYMPLICITY Registry for patients with atrial fibrillation or obstructive sleep apnea Eur Heart J. 2021;42 Suppl 1(): 2376-2376
Kannenkeril D, Janka R, Bosch A, Jung S, Kolwelter J, Striepe K, Ott C, Martirosian P, Schiffer M, Uder M, Schmieder RE: (2021) Detection of Changes in Renal Blood Flow Using Arterial Spin Labeling MRI. Am J Nephrol. 2021;52(1): 69-75
Jung S, Kolwelter J, Bosch A, Cífková R, Harazny JM, Ott C, Achenbach S, Schmieder RE: (2021) Hypertrophic remodelling of retinal arterioles in patients with congestive heart failure. ESC Heart Fail. 2021;8(3): 1892-1900
Kannenkeril D, Bosch A, Kolwelter J, Jung S, Striepe K, Ott C, Delles C, Schmieder RE: (2021) Dependency of flow-mediated vasodilatation from basal nitric oxide activity. Clin Physiol Funct Imaging. 2021;41(4): 310-316
Bosch A, Kannenkeril D, Rauh M, Ott C, Striepe K, Jung S, Kolwelter J, Schmieder RE: (2021) RELATION BETWEEN NOISE ANNOYANCE, STRESS HORMONES AND THE RENAL HEMODYNAMIC J Hypertens. 2021;39 Suppl 1(): E178-E178
Bosch A, Kannenkeril D, Ott C, Harazny JM, Striepe K, Karg MV, Jung S, Kolwelter J, Schmieder RE: (2021) ANNOYANCE DUE TO NOISE TRIGGERS VASCULAR CHANGES IN THE RENAL HEMODYNAMIC J Hypertens. 2021;39 Suppl 1(): E169-E169
Kannenkeril D, Bosch A, Kolwelter J, Striepe K, Ott C, Schiffer M, Schmieder RE: (2021) LOW DOSE-EPLERENONE TREATMENT DECREASES AORTIC STIFFNESS IN PATIENTS WITH METABOLIC SYNDROME J Hypertens. 2021;39 Suppl 1(): E338-E338
Kannenkeril D, Janka R, Bosch A, Jung S, Kolwelter J, Striepe K, Ott C, Martirosian P, Schiffer M, Uder M, Schmieder RE: (2021) DETECTION OF CHANGES IN RENAL BLOOD FLOW USING ARTERIAL SPIN LABELING MRI J Hypertens. 2021;39 Suppl 1(): E307-E307
Kolwelter J, Striepe K, Kannenkeril D, Jung S, Bosch A, Ott C, Schmieder RE: (2021) CAN WE IDENTIFY GLOMERULAR HYPERFILTRATION IN PATIENTS WITH TYPE 2 DIABETES BY CLINICAL PARAMETERS? J Hypertens. 2021;39 Suppl 1(): E211-E211
Rodionova K, Hilgers KF, Linz P, Schätzl J, Raschke G, Ott C, Schmieder RE, Schiffer M, Amann K, Veelken R, Ditting T: (2021) Neurogenic substance P-influences on action potential production in afferent neurons of the kidney? Pflugers Arch. 2021;473(4): 633-646
Ditting T, Rodionova K, Reeh P, Schmieder R, Schiffer M, Amann K, Ott C, Veelken R: (2021) AFFERENT PEPTIDERGIC NERVE FIBERS - IMPORTANCE FOR THE SALT METABOLISM BEYOND THE KIDNEYS? J Hypertens. 2021;39 Suppl 1(): E15-E15
Rodionova K, Ditting T, Pickny L, Ott C, Schmieder R, Schiffer M, Amann K, Veelken R: (2021) DIFFERENT FORMS OF AFFERENT NERVE INPUT IN CARDIAC AND RENAL DISEASE IN RATS? J Hypertens. 2021;39 Suppl 1(): E249-E250
Rodionova K, Ditting T, Fahrmeier F, Ott C, Schmieder R, Schiffer M, Amann K, Veelken R: (2021) AFFERENT RENAL NERVE PATHWAYS IN RATS - RESPONSIVENESS TO HIGH SALT INTAKE J Hypertens. 2021;39 Suppl 1(): E250-E250
Ruilope L, Agarwal R, Anker SD, Filippatos G, Pitt B, Rossing P, Sarafidis P, Schmieder RE, Joseph A, Mentenich N, Nowack C, Bakris G: (2021) EFFECTS OF FINERENONE ON CARDIORENAL OUTCOMES IN BLOOD PRESSURE SUBGROUPS IN PATIENTS WITH CKD AND T2D Nephrol Dial Transplant. 2021;36 Suppl 1():
Predel HG, Weisser B, Wassmann S, Gillessen A, Blettenberg J, Fournier V, Noetel A, Randerath O, Boehm M, Schmieder RE: (2021) THE SINGLE PILL CONCEPT LEADS TO IMPROVED PERSISTENCE OF MEDICATION, CLINICAL OUTCOMES AND REDUCED ALL-CAUSE MORTALITY IN HYPERTENSIVE PATIENTS - RESULTS FROM THE START PROJECT J Hypertens. 2021;39 Suppl 1(): E378-E378
Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, Bramlage P, Uder M, Achenbach S, Schmieder R: (2021) THE SGLT2 INHIBITOR EMPAGLIFLOZIN REDUCES TISSUE SODIUM CONTENT IN PATIENTS WITH CHRONIC HEART FAILURE J Am Coll Cardiol. 2021;77 Suppl 1(18): 585-585
Kolwelter J, Bosch A, Jung S, Linz P, Kannenkeril D, Nagel AM, Ott C, Bramlage P, Uder M, Achenbach S, Schmieder R: (2021) EFFECTS OF THE SGLT2 INHIBITOR EMPAGLIFLOZIN ON VASCULAR FUNCTION IN PATIENTS WITH CHRONIC HEART FAILURE J Am Coll Cardiol. 2021;77 Suppl 1(18): 1806-1806
Rodionova K, Ditting T, Fahrmeier F, Ott C, Schmieder R, Schiffer M, Amann K, Veelken RA: (2020) High Sodium Diet - Role in Renal Sympathodepression FASEB J. 2020;34 Suppl 1():
Predel HG, Weisser B, Schmieder RE, Wassmann S, Blettenberg J, Gillessen A, Fournier V, Noetel A, Randerath O, Boehm M: (2020) Single pill regimen improves persistence and leads lo better clinical outcome compared to identical multi pill combination. Results of START, a German claims data analysis Eur Heart J. 2020;41 Suppl 2(): 2770-2770
Predel HG, Weisser B, Wassmann S, Schmieder RE, Blettenberg J, Gillessen A, Fournier V, Noetel A, Randerath O, Boehm M: (2020) Persistence and cardiovascular outcomes with ramipril, atorvastatin, ASA as a single pill compared to the multi pill combination. A subanalysis of the START study, a claims data analysis Eur Heart J. 2020;41 Suppl 2(): 2964-2964
Hrabak-Paar M, Kircher A, Al Sayari S, Kopp S, Santini F, Schmieder RE, Kachenoura N, Yates D, Langenickel T, Bremerich J, Heye T: (2020) Variability of MRI Aortic Stiffness Measurements in a Multicenter Clinical Trial Setting: Intraobserver, Interobserver, and Intracenter Variability of Pulse Wave Velocity and Aortic Strain Measurement. Radiol Cardiothorac Imaging. 2020;2(2):
Girerd S, Girerd N, Frimat L, Holdaas H, Jardine AG, Schmieder RE, Fellström B, Settembre N, Malikov S, Rossignol P, Zannad F: (2020) Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial. Clin Kidney J. 2020;13(1): 116-122
Jung S, Bosch A, Kannenkeril D, Karg MV, Striepe K, Bramlage P, Ott C, Schmieder RE: (2020) Combination of empagliflozin and linagliptin improves blood pressure and vascular function in type 2 diabetes. Eur Heart J Cardiovasc Pharmacother. 2020;6(6): 364-371
Rodionova K, Hilgers KF, Paulus EM, Tiegs G, Ott C, Schmieder R, Schiffer M, Amann K, Veelken R, Ditting T: (2020) Neurogenic tachykinin mechanisms in experimental nephritis of rats. Pflugers Arch. 2020;472(12): 1705-1717
Mancia G, Schumacher H, Böhm M, Mann JFE, Redon J, Facchetti R, Schmieder RE, Lonn EM, Teo KK, Yusuf S: (2020) Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials. J Hypertens. 2020;38(10): 2050-2058
Kolwelter J, Uder M, Schmieder RE: (2020) Tissue sodium content in hypertension and related organ damage. J Hypertens. 2020;38(12): 2363-2368
Mahfoud F, Townsend R, Kandzari D, Kario K, Schmieder R, Tsioufis K, Boehm M, Pocock S, Cohen S, Fahy M, Weber M: (2020) Impact of Renal Denervation on Plasma Renin Activity and Relationship of Baseline Plasma Renin Activity to Blood Pressure Lowering Response to Renal Denervation in the SPYRAL HTN-OFF MED Pivotal trial J Am Coll Cardiol. 2020;76 Suppl S(17): B179-B179
Schlaich M, Boehm M, Mancia G, Schmieder R, Narkiewicz K, Ruilope L, Williams B, Shen C, Mahfoud F: (2020) Patients With Resistant Hypertension in the Global SYMPLICITY Registry: Antihypertensive Medication Burden and Changes in Blood Pressure out to 3 Years J Am Coll Cardiol. 2020;76 Suppl S(17): B179-B180
Kandzari DE, Mahfoud F, Bhatt DL, Böhm M, Weber MA, Townsend RR, Hettrick DA, Schmieder RE, Tsioufis K, Kario K: (2020) Confounding Factors in Renal Denervation Trials: Revisiting Old and Identifying New Challenges in Trial Design of Device Therapies for Hypertension. Hypertension. 2020;76(5): 1410-1417
Rodionova K, Veelken R, Hilgers KF, Paulus EM, Linz P, Fischer MJM, Schenker M, Reeh P, Tiegs G, Ott C, Schmieder R, Schiffer M, Amann K, Ditting T: (2020) Afferent renal innervation in anti-Thy1.1 nephritis in rats. Am J Physiol Renal Physiol. 2020;319(5): F822-F832
Jóźwik-Plebanek K, Dobrowolski P, Lewandowski J, Narkiewicz K, Sikorska A, Siński M, Eisenhofer G, Schmieder RE, Januszewicz M, Windyga J, Prejbisz A, Januszewicz A: (2020) Blood pressure profile, sympathetic nervous system activity, and subclinical target organ damage in patients with polycythemia vera. Pol Arch Intern Med. 2020;130(7-8): 607-614
Gosk-Przybyłek M, Doroszko A, Dobrowolski P, Warchoł-Celińska E, Harazny J, Bińczyk E, Szymanek K, Pęczkowska M, Kabat M, Toutounchi S, Gałązka Z, Górnicka B, Szaflik J, Januszewicz M, Klisiewicz A, Hoffman P, Lenders JWM, Eisenhofer G, Szaflik JP, Schmieder RE, Prejbisz A, Januszewicz A: (2020) Retinal arterial remodeling in patients with pheochromocytoma or paraganglioma and its reversibility following surgical treatment. J Hypertens. 2020;38(8): 1551-1558
Dziamałek-Macioszczyk P, Harazny JM, Kwella N, Wojtacha P, Jung S, Dienemann T, Schmieder RE, Stompór T: (2020) Relationship Between Ubiquitin-Specific Peptidase 18 and Hypertension in Polish Adult Male Subjects: A Cross-Sectional Pilot Study. Med Sci Monit. 2020;26():
Dąbrowska E, Harazny JM, Miszkowska-Nagórna E, Stefański A, Graff B, Kunicka K, Świerblewska E, Rojek A, Szyndler A, Gąsecki D, Wolf J, Gruchała M, Laurent S, Schmieder RE, Narkiewicz K: (2020) Aortic stiffness is not only associated with structural but also functional parameters of retinal microcirculation. Microvasc Res. 2020;129():
Mahfoud F, Mancia G, Schmieder R, Narkiewicz K, Ruilope L, Schlaich M, Whitbourn R, Zirlik A, Zeller T, Stawowy P, Cohen SA, Fahy M, Böhm M: (2020) Renal Denervation in High-Risk Patients With Hypertension. J Am Coll Cardiol. 2020;75(23): 2879-2888
Williams B, Masi S, Wolf J, Schmieder RE: (2020) Facing the Challenge of Lowering Blood Pressure and Cholesterol in the Same Patient: Report of a Symposium at the European Society of Hypertension. Cardiol Ther. 2020;9(1): 19-34
Poulter NR, Borghi C, Parati G, Pathak A, Toli D, Williams B, Schmieder RE: (2020) Medication adherence in hypertension. J Hypertens. 2020;38(4): 579-587
Picone DS, Schultz MG, Otahal P, Black JA, Bos WJ, Chen CH, Cheng HM, Cremer A, Dwyer N, Fonseca R, Hughes AD, Kim HL, Lacy PS, Laugesen E, Ohte N, Omboni S, Ott C, Pereira T, Pucci G, Roberts-Thomson P, Rossen NB, Schmieder RE, Sueta D, Takazawa K, Wang J, Weber T, Westerhof BE, Williams B, Yamada H, Yamamoto E, Sharman JE, Invasive Blood Pressure Consortium: (2020) Influence of Age on Upper Arm Cuff Blood Pressure Measurement. Hypertension. 2020;75(3): 844-850
Böhm M, Brueckmann M, Eikelboom JW, Ezekowitz M, Fräßdorf M, Hijazi Z, Hohnloser SH, Mahfoud F, Schmieder RE, Schumacher H, Wallentin L, Yusuf S: (2020) Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial. Eur Heart J. 2020;41(30): 2848-2859
Jung S, Bosch A, Ott C, Kannenkeril D, Dienemann T, Harazny JM, Michelson G, Schmieder RE: (2020) Retinal neurodegeneration in patients with end-stage renal disease assessed by spectral-domain optical coherence tomography. Sci Rep. 2020;10(1):
Lurz P, Kresoja KP, Rommel KP, von Roeder M, Besler C, Lücke C, Gutberlet M, Schmieder RE, Mahfoud F, Thiele H, Desch S, Fengler K: (2020) Changes in Stroke Volume After Renal Denervation: Insight From Cardiac Magnetic Resonance Imaging. Hypertension. 2020;75(3): 707-713
Mahfoud F, Azizi M, Ewen S, Pathak A, Ukena C, Blankestijn PJ, Böhm M, Burnier M, Chatellier G, Durand Zaleski I, Grassi G, Joner M, Kandzari DE, Kirtane A, Kjeldsen SE, Lobo MD, Lüscher TF, McEvoy JW, Parati G, Rossignol P, Ruilope L, Schlaich MP, Shahzad A, Sharif F, Sharp ASP, Sievert H, Volpe M, Weber MA, Schmieder RE, Tsioufis C, Wijns W: (2020) Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies. Eur Heart J. 2020;41(16): 1588-1599
de Gonzalo-Calvo D, Martínez-Camblor P, Bär C, Duarte K, Girerd N, Fellström B, Schmieder RE, Jardine AG, Massy ZA, Holdaas H, Rossignol P, Zannad F, Thum T: (2020) Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids. Theranostics. 2020;10(19): 8665-8676
Bosch A, Schmid A, Ott C, Kannenkeril D, Karg M, Ditting T, Veelken R, Uder M, Schmieder RE: (2020) Copeptin Levels in Patients With Treatment-Resistant Hypertension Before and 6 Months After Renal Denervation. Am J Hypertens. 2020;33(2): 182-189
Azizi M, Daemen J, Lobo MD, Mahfoud F, Sharp ASP, Schmieder RE, Wang Y, Saxena M, Lurz P, Sayer J, Bloch MJ, Basile J, Weber MA, Rump LC, Levy T, Sapoval M, Sanghvi K, Rader F, Fisher NDL, Gosse P, Abraham J, Claude L, Barman NC, McClure CK, Liu Y, Kirtane AJ, RADIANCE-HTN Investigators: (2020) 12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation. JACC Cardiovasc Interv. 2020;13(24): 2922-2933
Böhm M, Townsend RR, Kario K, Kandzari D, Mahfoud F, Weber MA, Schmieder RE, Tsioufis K, Hickey GL, Fahy M, DeBruin V, Brar S, Pocock S: (2020) Correction to: Rationale and design of two randomized sham‑controlled of catheter‑based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN‑OFF MED Pivotal) and presence (SPYRAL HTN‑ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design. Clin Res Cardiol. 2020;109(5):
Böhm M, Townsend RR, Kario K, Kandzari D, Mahfoud F, Weber MA, Schmieder RE, Tsioufis K, Hickey GL, Fahy M, DeBruin V, Brar S, Pocock S: (2020) Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design. Clin Res Cardiol. 2020;109(3): 289-302
Mahfoud F, Renkin J, Sievert H, Bertog S, Ewen S, Böhm M, Lengelé JP, Wojakowski W, Schmieder R, van der Giet M, Parise H, Haratani N, Pathak A, Persu A: (2020) Alcohol-Mediated Renal Denervation Using the Peregrine System Infusion Catheter for Treatment of Hypertension. JACC Cardiovasc Interv. 2020;13(4): 471-484
Böhm M, Kario K, Kandzari DE, Mahfoud F, Weber MA, Schmieder RE, Tsioufis K, Pocock S, Konstantinidis D, Choi JW, East C, Lee DP, Ma A, Ewen S, Cohen DL, Wilensky R, Devireddy CM, Lea J, Schmid A, Weil J, Agdirlioglu T, Reedus D, Jefferson BK, Reyes D, D'Souza R, Sharp ASP, Sharif F, Fahy M, DeBruin V, Cohen SA, Brar S, Townsend RR, SPYRAL HTN-OFF MED Pivotal Investigators , Akarca E, Allaqaband S, Andrikou E, Aoki J, Arnold A, Aronow H, Asami M, Bachinsky W, Barton J, Bass K, Batson B, Bell C, Bertolet B, Bewarder Y, Bihlmaier K, Binner C, Bloom J, Blossom B, Brar S, Brown A, Burke R, Burke MN, Butler M, Calhoun W, Campbell J, Carroll S, Chapman N, Chasen C, Cheng SC, Chia B, Choksi N, Cohen J, Connolly N, Contreras J, Cusack R, Dangas G, David S, Davies J, Dederer J, Denker M, Desch U, Didangelos M, Dienemann T, Dimitriadis K, Dorval JF, Estess J, Fan S, Fengler K, Ferguson L, Fudim M, Fuster V, Garcia F, Garcia S, Garton A, Gessler C, Ghali M, Gummadi B, Gupta A, Gutierrez A, Hardesty P, Hartung P, Haught WH, Haun Y, Hays S, Helmreich W, Hill D, Hopper I, Horiuchi Y, Hoshide S, Howard J, Ikeda W, Jan F, Jauhar R, Jay D, Johnson J, Johnston T, Jones S, Jung S, Kalos T, Kanitkar M, Kannenkeril D, Kasiakogias A, Kazziha S, Keene D, Khitha J, Kikushima H, Kobayashi T, Komiyama K, Komori T, Kotter J, Kouparanis A, Krasnow J, Kulenthiran S, Kumar S, L'Allier P, Laney P, Lauder L, Lavoie MA, Lerche M, Linesky E, Little N, Lomboy C, Lucic J, Lurz P, Lynch S, Mansukhani P, McDuffie K, McGrath B, McLaurin B, Meade A, Meraj P, Millenaar D, Moore N, Mori F, Munch P, Murphy J, Murray J, Nanjundappa A, Ninomiya K, Oba Y, O'Connor T, Ogata Y, Ogoyama Y, Onsrud R, Ott C, Padaliya B, Pagidipati N, Patel M, Patel K, Petteinidou E, Porr W, Rao A, Razi R, Regan C, Remetz M, Rizik D, Robison M, Rommel KP, Rosseel L, Rothstein M, Rough R, Saavedra J, Saba S, Schwartz R, Selcer S, Sen S, Sennott J, Shadman R, Shah S, Shemin D, Shimizu H, Shimpo M, Shishehbor M, Shun-Shin M, Sierra F, Singh J, Singh A, Sirajeldin Y, Skeik N, Soliman G, Statton S, Stehli J, Steigerwalt S, Striepe K, Stuck J, Suppan M, Svetkey L, Takker G, Tanabe K, Tanaka T, Tomii D, Torre S, Traverse J, Tyson C, Vasquez A, Velasquez E, Vemulapalli S, Waki H, Walton T, Wang Y, Weber T, Wells B, Wilkins R, Wright T, Yahagi K, Yeung A, Zadegan R, Zeller T, Ziada K, Ziakas A, Zidar D: (2020) Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet. 2020;395(10234): 1444-1451
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G, FIDELIO-DKD Investigators , Bakris GL, Filippatos G, Agarwal R, Anker SD, Ruilope LM, Pitt B, Vallejos A, MacIsaac R, Schernthaner G, Gillard P, Canziani MEF, Temelkova-Kurktschiev T, Burgess E, Tobe S, González F, Liu ZH, Cadena Bonfanti AÁ, Jaramillo CF, Prazny M, Rossing P, Strand J, Marre M, Schmieder R, Wanner C, Sarafidis PA, Chan J, Rosivall L, Eustace J, Grossman E, Yagil Y, Remuzzi G, Koya D, Wada T, Madero Rovalo M, Gansevoort R, Kooy A, Finnes T, Leon F, Gumprecht J, Teixeira E Costa F, Dreval A, Vathsala A, Amod A, Kim SG, Lee BW, Santos JP, Tengmark BO, Burnier M, Lee CT, Yamwong S, Sari R, McCafferty K, Mankovsky B, Adler S, Fried L, Toto R, Williams M, Khanh TQ, Epstein M, Maggioni A, Chertow G, DiBona G, Friede T, Lopez-Sendon J, Rouleau J, Collamati S, West L, May A, Christopher L, King M, Beakhouse N, Lindroth A, Hussell M, Fedorov C, You G, Alta D, Schloemer P, Tasto C, Mentenich N, Gerstner J, Buytendach J, Gregory M, Hadisusanto Y, Klein C, Tuemer A, Zywno K, Roberts L, Lage A, Ferreira AC, Palombo G, Brinker M, Horvat-Broecker A, Joseph A, Nowack C, Aizenberg D, Bartolacci I, Besada D, Bittar J, Chahin M, Elbert A, Gelersztein E, Liberman A, Maffei L, Pérez Manghi F, Sanabria H, Viñes G, Wassermann A, Abhayaratna W, Acharya S, Ekinci E, Lee D, Mah PM, Nelson C, Packham D, Pape A, Roger S, Stephenson H, Suranyi M, Wittert G, Vale E, Clodi M, Ebenbichler C, Fliesser-Görzer E, Hanusch U, Krebs M, Lhotta K, Ludvik B, Mayer G, Neudorfer P, Paulweber B, Prager R, Preiß W, Prischl F, Schernthaner GH, Sourij H, Wiesholzer M, Doubel P, Engelen W, Hougardy JM, Krzesinski JM, Maes B, Speeckaert M, Stas K, van Gaal L, Vanbelleghem H, Antunes D, Botelho R, Brito C, Canani L, Canziani ME, Cerqueira M, de Paula R, Eliaschewitz F, Figueiredo CE, Forti A, Hissa M, Leite M, Lima E, Noronha I, Paolino B, Paschoalin N, Paschoalin R, Pecoits Filho R, Pereira M, Portes E, Precoma D, Rea R, Riella M, Salles JE, Vasconcellos E, Vencio S, Apostolova E, Boshnyashka R, Farah G, Georgiev D, Gushterova V, Klyuchkova N, Lucheva M, Manova P, Minkova D, Nonchev B, Pichmanova M, Prakova Z, Rangelov R, Rashkov R, Stanchev P, Stoyanovska-Elencheva B, Tagarev Z, Temelkova-Kurktschieva T, Vasileva S, Yoncheva-Mihaylova M, Barre P, Carlson B, Conway J, Cournoyer S, Dumas R, Fikry S, Goluch R, Hamet P, Hart R, Henein S, Liutkus J, Madore F, Martinho V, Mazza G, McFarlane P, O'Keefe D, Peterson S, Schwartz D, Shu D, Steele A, Tellier G, Tennankore K, Tsoukas G, Tytus R, Vitou L, Walsh M, Weisnagel S, Wilderman I, Yale JF, Cobos J, Godoy J, Lobos S, Palma JC, Prieto JC, Reyes E, Romero C, Saavedra V, Vega M, Bu R, Cai H, Chen N, Chen Q, Chen D, Cheng J, Dong Y, Dong J, Guan T, Hao C, Huang W, Jiang F, Lei M, Li L, Li Z, Li X, Li J, Li Y, Liang X, Liang B, Liu F, Liu Y, Liu Y, Liu Z, Long G, Lu G, Lu W, Lu Y, Luo P, Ma J, Mo Z, Niu J, Peng A, Shen J, Shen F, Shi B, Su Q, Sun Z, Tang S, Tong N, Wang H, Wang X, Wang L, Wang G, Wang J, Wang Y, Wang L, Wei J, Wu T, Wu C, Xing C, Xiong F, Xu X, Xu N, Yan T, Yang J, Yin A, Zeng L, Zhang H, Zhang Y, Zhang Y, Zhao W, Zhao Z, Zheng H, Zhong L, Zhu D, Zhuang Y, Arango C, Barrera S, Beltrán López N, Benitez D, Blanco G, Cadena A, Coronel J, Cure C, Durán C, González A, Guzmán G, Hernández E, Ibarra J, Jaramillo C, Jaramillo N, Kattah W, Molina D, Sánchez G, Terront M, Trujillo F, Urina M, Vargas R, Villegas I, Yupanqui H, Alferi D, Brada M, Brezina J, Bucek P, Edelsberger T, Gulakova D, Hasalova Zapletalova J, Hola O, Hornova L, Houdova J, Hrmova H, Karasek D, Kopecka S, Kovar R, Krcova E, Kuchar J, Kutejova V, Lubanda H, Matyasek I, Mokrejsova M, Okenka L, Pumprla J, Tomanek P, Bech J, Faber J, Gislason G, Hangaard J, Jaroslaw Pacyk G, Juhl C, Krarup T, Lindhardt M, Madsbad S, Nielsen J, Pedersen-Bjergaard U, Poulsen P, Rasmussen O, Schousboe K, Honkasalo M, Humaloja K, Kananen K, Kantola I, Koistinen A, Korsoff P, Lahtela J, Nieminen S, Nieminen T, Sadeharju K, Sulosaari S, Cariou B, Chantrel F, Clavel S, Combe C, Fauvel JP, Gallouj K, Gouet D, Guerci B, Guerrot D, Hourmant M, Klein A, Mariat C, Mesbah R, Le Meur Y, Monier A, Moranne O, Serusclat P, Vendrely B, Verges B, Zaoui P, Axthelm C, Bergmann A, Birkenfeld AL, Braun H, Busch K, Contzen C, Degenhardt S, Derwahl K, Giebel T, Hagenow A, Haller H, Hasslacher C, Horacek T, Jungmair W, Kloos C, Koch T, Krüger T, Mühlfeld A, Müller J, Pfützner A, Pistrosch F, Rose L, Rump L, Schettler V, Schiefke I, Schlichthaar H, Schröppel B, Schürholz T, Sigal H, Stemler L, Strack G, Täschner H, Toursarkissian N, Tschöpe D, Ulmer A, van der Giet M, Winkelmann BR, Boletis I, Hatziagelaki E, Ioannidis I, Kounadi T, Makriniotou I, Papadopoulou D, Papagianni A, Passadakis P, Stefanidis I, Ip TP, Lee P, Luk OYA, Wang A, Yeung V, Bajcsi D, Danos P, Harcsa E, Kazup S, Keltai K, Kirschner R, Kiss J, Kovacs L, Lamboy B, Literati-Nagy B, Mileder M, Nagy L, Noori E, Nyirati G, Petro G, Schneider K, Szocs A, Vasas S, Wudi K, Zilahi Z, Zsom M, Eustace J, Holian J, Reddan D, O'Meara Y, Abramof Ness R, Adawi F, Armaly Z, Atar S, Ben Chetrit S, Berar Yanay N, Chernin G, Darawsha M, Efrati S, Elias M, Farber E, Glandt M, Halabi M, Khazim K, Liberty I, Mosenzon O, Nimer A, Schwartz D, Wainstein J, Zukermann R, Avogaro A, Battaglia GG, Bonora E, Bossi CA, Calabrò P, Cavalot FL, Cimino R, Cozzolino MG, Fiaccadori E, Fiorina P, Giorda CB, Gregorini MC, La Manna G, Maggi DC, Pani A, Perico N, Piatti P, Pisani A, Ponzani P, Santorelli G, Santoro D, Tonolo G, Trevisan R, Veronelli AM, Araki H, Ebisui O, Fujita N, Furuya R, Hamamoto Y, Hatazaki M, Hayashi T, Higashi T, Hirohata Y, Horinouchi S, Inagaki M, Ishii M, Ishiko T, Jinnouchi H, Kanai H, Kanda D, Kanehara H, Kashima M, Kato K, Katsuki T, Kawamitsu K, Kawasaki S, Kikuchi F, Kikuchi H, Kobayashi K, Koide J, Kubota M, Kusano Y, Maeda H, Matsubayashi S, Matsumoto K, Matsuo Y, Matsuoka N, Miyaoka H, Murao S, Nakayama M, Nakazawa J, Nomiyama T, Noritake M, Ogiwara T, Ohashi H, Okamoto H, Osonoi T, Sasaki N, Sekigami T, Shibasaki T, Shibata H, Shinoda J, Sobajima H, Sugitatsu K, Sugiura T, Sugiyama T, Suzuki D, Suzuki H, Suzuki M, Takeda A, Tanaka A, Tanaka S, Tsunematsu I, Ujihara M, Yamada D, Yamada M, Yamagata K, Yamakawa K, Yamakawa F, Yamasaki Y, Yambe Y, Yanagida T, Yanai H, Yasuda T, Kriauciuniene D, Lasiene J, Navickas A, Radzeviciene L, Urbanaviciene E, Urbonas G, Velaviciene A, Abd Ghani R, Azizah Aziz N, Lee LY, Loh CL, Mohd Ali N, Mohd Noor N, Nik Ahmad NNF, Ratnasingam J, Wan Hasan WHHB, Wan Mohamed WMI, Avila Pardo S, Bastidas Adrian M, Chew Wong A, Escobedo de la Peña J, Fanghänel Salmón G, González Gálvez G, Gutiérrez Ochoa R, Irizar Santana S, Méndez Machado G, Nevarez Ruiz L, Ramos Ibarra D, Ramos López G, Sauque Reyna L, Solache Ortiz G, Valdez Ortiz R, Villagordoa Mesa J, Bakker RC, Barendregt JNM, Boonstra AH, Bos W, Brouwer CB, van Buren M, Krekels M, van Leendert RJM, Lieverse LAG, Luik PT, Lars Penne E, Smak Gregoor P, Vogt L, Baker J, Crawford V, Cutfield R, Dunn P, Krebs J, Nirmalaraj K, Scott R, Smuts N, Eriksen E, Høivik H, Karlsson T, Munk PS, Radtke M, Risberg K, Rocke J, Solnør L, Stenehjem AE, Tafjord AB, Pamugas G, Panelo A, Perez R, Tanque M, Tirador L, Villa M, Butrymowicz P, Ciechanowski K, Cieslik G, Franek E, Hoffmann M, Krzykowska J, Kurnatowska I, Landa K, Madrzejewski A, Madziarska K, Mazur S, Napora P, Nowicki M, Ocicka-Kozakiewicz A, Rewerska B, Rusicka T, Ruxer J, Skokowska E, Stankiewicz A, Stompor T, Tiuryn-Petrulewicz A, Wasilewska K, Wierusz-Wysocka B, Wnetrzak-Michalska R, Almeida E, Ballesteros R, Barreto C, Beirao I, Birne R, Esteves C, Guia J, Heitor S, Marques O, Melo P, Nolasco F, Pereira A, Roque C, Rosario F, Silva G, Silva A, Vila Lobos A, Cortes-Maisonet G, Roman-Miranda A, Albota A, Bala C, Barbonta H, Caceaune E, Catrinoui D, Constantin C, Dumitrescu A, Mindrescu N, Mistode C, Negrisanu G, Onaca A, Paveliu S, Pintilei E, Pop L, Popa A, Popescu A, Radulian G, Szilagyi I, Turcu L, Vacaru G, Vlad A, Antsiferov M, Arkhipov M, Babkin A, Barbarash O, Baranov V, Chernyavskaya E, Demko A, Edin A, Ermakova P, Fadeev V, Galyavich A, Gaysina L, Gordeev I, Ipatko I, Kalashnikova M, Khalimov Y, Klimontov V, Kobalava Z, Kosmacheva E, Koziolova N, Kvitkova L, Levashov S, Libis R, Marasaev V, Malykh N, Martynenko V, Malyutina S, Merai I, Mkrtumyan A, Nechaeva G, Petunina N, Palyutin S, Pimenov L, Rechkova E, Rodionova T, Rymar O, Sardinov R, Semenova O, Sherenkov A, Solovev O, Smolyarchuk E, Strongin L, Ukhanova O, Verlan N, Vorokhobina N, Yakhontov D, Yakushin S, Zakharova E, Zalevskaya A, Zanozina O, Zhdanova E, Zhukova L, Zykova T, Sum CF, Suhail SM, Tan RS, Wong E, Babikova J, Buganova I, Dzupina A, Ochodnicka Z, Dalibor D, Sosovec S, Spodniakova D, Ahmed F, Bhana S, Distiller L, Jansen van Rensburg D, Joshi M, Joshi S, Lakha D, Mitha E, Podgorski G, Ranjith N, Rayner B, Rheeder P, Sarvan M, Seeber M, Siebert H, Tayob M, Trokis J, Urbach D, Zyl LV, Choi BS, Choi MG, Chung C, Hwang Y, Kim C, Kim I, Kim J, Kim S, Kim S, Kim TH, Lee W, Lee B, Lee KW, Oh KH, Oh JE, Oh YK, Oh DJ, Park J, Shin SJ, Sung SA, Yu JM, Agraz I, Ampudia FJ, Bouarich H, Calero F, Castro C, Cigarrán Guldris S, Cruzado Garrit J, de Álvaro F, Galcerán J, González Albarrán O, Hernández Jaras J, Ibernón M, Martínez Deben F, Martínez Esteban MD, Pascual Izuel JM, Martins J, Mediavilla J, Michán A, Poch E, Polaina Rusillo M, Sánchez Juan C, Santamaría Olmo R, Segura de la Morena JJ, Soto A, Troya M, Bruchfeld A, Curiac D, Eliasson K, Frank M, Guron G, Hellberg O, Hellgren M, Larnefeldt H, Lindholm CJ, Löndahl M, Rein-Hedin E, Soveri I, Spaak J, Ackermann D, Bilz S, Forster C, Kalbermatter S, Kistler A, Pechère-Bertschi A, Schultes B, Chang CT, Hung CC, Jiang JY, Lin SL, Tarng DC, Tu ST, Wu MS, Wu MJ, Deerochanawong C, Kitiyakara C, Ophascharoensuk V, Pongchaiyakul C, Satirapoj B, Eren N, Gul I, Gulel O, Kocyigit I, Kumbasar A, Sahin I, Sayin B, Tavli T, Ustundag S, Yenicerioglu Y, Bondarets I, Botsyurko V, Chernikova V, Donets O, Fushtey I, Grachova M, Isayeva A, Kogut D, Komisarenko J, Kravchun N, Malyar K, Martynyuk L, Maslyanko V, Myshanych H, Pererva L, Pertseva N, Serhiyenko O, Smirnov I, Sokolova L, Stryzhak V, Vlasenko M, AbouSaleh A, Barratt J, Dang C, Kahal H, Kirk A, Kilvert A, Kon SP, Patel D, Rice S, Vijayaraman A, Wong YK, Gibson M, Wahba M, Zaidi R, Acosta I, Adams A, Ajani D, Ali S, Alicic R, Al-Karadsheh A, Alla S, Allison D, Andrawis N, Arif A, Awad A, Azizad M, Bahrami M, Bansal S, Barag S, Barakzoy A, Barney M, Barzilay J, Bashir K, Bautista J, Beddhu S, Belo D, Benjamin S, Berenji R, Bhargava A, Birriel J, Brietzke S, Brosius F, Brusco O, Burgner A, Busch R, Canadas R, Caramori M, Cardona J, Case C, Cruz H, Dandillaya R, Dawoud D, Din Z, Dixon B, Doshi A, Drakakis J, El Shahawy M, El-Meanawy A, El-Shahawy M, Evans J, Fadda G, Farooq U, Fernando R, Fink R, First B, Fitz-Patrick D, Flack J, Fluck P, Fogelfeld L, Fonseca V, Frias J, Galphin C, Garcia-Mayol L, Goldstein G, Gonzalez E, Gonzalez-Abreu F, Gore A, Grant D, Habwe V, Hamilton M, Hammoud J, Handelsman S, Hartman I, Heigerick G, Henry A, Hernandez G, Hernandez-Cassis C, Herrera C, Hertel J, Huang W, Iglesias R, Iranmanesh A, Jackson T, Jain M, Jamerson K, Johnson K, Judd E, Kaplan J, Kayali Z, Khan B, Khan M, Kharait S, Kirkman MS, Kopyt N, Kotzker W, Kovesdy C, Kreit C, Krishna A, Kronfli S, Lee K, LeJeune D, Lemus B, Leon-Forero C, Linfert D, Lora H, Lurie A, Maddukuri G, Magno A, Maletz L, Mandayam S, Markell M, Mayfield R, Mbogua C, McMullen D, Meisner C, Minton S, Mocherla B, Mohandas R, Montero M, Moustafa M, Nadkarni S, Nakhle S, Navarro J, Neyra N, Nica R, Nicol P, Norwood P, Numrungroad V, O'Donovan R, Odugbesan A, Paoli-Bruno J, Parikh S, Patel R, Peixoto A, Pergola P, Perlman A, Pettis K, Pisoni R, Ponduchi M, Posada J, Prabhakar S, Radhakrishnan J, Rahman M, Raina R, Rastogi A, Reisin E, Rendell M, Robertson D, Rocco M, Romeu H, Rosas S, Rosenfeld J, Ross D, Rothman J, Rudolph L, Ruhullah Y, Ruoff G, Ryu J, Sahani M, Sam R, Samuels G, Sanchez W, Santos V, Satko S, Saxena S, Scott D, Seco G, Seek M, Serota H, Shafi T, Shahid N, Shanik M, Sharma S, Sinha A, Smelser J, Smith M, Soe K, Solomon R, Soroka E, Soufer J, Spinowitz B, Spry L, Suarez R, Subramanian B, Szerlip H, Tamirisa A, Thomson S, Tran TH, Treger R, Trullenque G, Turk T, Umpierrez G, Urbach D, Valdes M, Valika S, Vega D, Weissman P, Whaley-Connell A, Winston J, Wise J, Wynne A, Zeig S, Chu P, Hoang LV, Khanh T, Nga NTP, Son PN, Tran LP: (2020) Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med. 2020;383(23): 2219-2229
Gallwitz B, Schmieder R: (2020) Metabolic effects and cardiovascular safety of an oral triple therapy of type 2 diabetes: the metformin, empagliflozin, linagliptin example Dibaetol Stoffwechs. 2020;15(04): 317-326
Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Ukena C, Mann JFE, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Williams B, Yusuf S: (2020) Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials. Eur Heart J. 2020;41(2): 231-238
Dąbrowska E, Harazny JM, Miszkowska-Nagórna E, Stefański A, Graff B, Kunicka K, Świerblewska E, Rojek A, Szyndler A, Wolf J, Gruchała M, Schmieder RE, Narkiewicz K: (2020) Lumen narrowing and increased wall to lumen ratio of retinal microcirculation are valuable biomarkers of hypertension-mediated cardiac damage. Blood Press. 2020;29(2): 70-79
Ott C, Bosch A, Winzer N, Friedrich S, Schinzel R, Tegtmeier F, Schmieder RE: (2019) Effects of the nitric oxide synthase inhibitor ronopterin (VAS203) on renal function in healthy volunteers. Br J Clin Pharmacol. 2019;85(5): 900-907
Ott C, Schmid A, Ditting T, Veelken R, Uder M, Schmieder RE: (2019) Effects of renal denervation on blood pressure in hypertensive patients with end-stage renal disease: a single centre experience. Clin Exp Nephrol. 2019;23(6): 749-755
Schneider MP, Scheppach JB, Raff U, Toncar S, Ritter C, Klink T, Störk S, Wanner C, Schlieper G, Saritas T, Reinartz SD, Floege J, Friedrich N, Janka R, Uder M, Schmieder RE, Eckardt KU: (2019) Left Ventricular Structure in Patients With Mild-to-Moderate CKD-a Magnetic Resonance Imaging Study. Kidney Int Rep. 2019;4(2): 267-274
Bosch A, Ott C, Jung S, Striepe K, Karg MV, Kannenkeril D, Dienemann T, Schmieder RE: (2019) How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial. Cardiovasc Diabetol. 2019;18(1):
Schmieder RE, Högerl K, Jung S, Bramlage P, Veelken R, Ott C: (2019) Patient preference for therapies in hypertension: a cross-sectional survey of German patients. Clin Res Cardiol. 2019;108(12): 1331-1342
Schmieder RE, Mahfoud F: (2019) Reply. J Hypertens. 2019;37(2):
Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JFE, Mancia G, Redon J, Schmieder RE, Marx N, Sliwa K, Weber MA, Williams B, Yusuf S: (2019) Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk. Eur Heart J. 2019;40(25): 2032-2043
Mahfoud F, Böhm M, Bongarth CM, Bosch R, Schmieder RE, Schunkert H, Stellbrink C, Trenkwalder P, Vonend O, Weil J, Kreutz R: (2019) [Comments on the guidelines (2018) of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) on the management of arterial hypertension]. Internist (Berl). 2019;60(4): 424-430
Jung S, Schmieder RE: (2019) [European guidelines for the management of arterial hypertension 2018-what has changed?] Internist (Berl). 2019;60(2): 202-208
Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Lobo MD, Sharp ASP, Bloch MJ, Basile J, Wang Y, Saxena M, Lurz P, Rader F, Sayer J, Fisher NDL, Fouassier D, Barman NC, Reeve-Stoffer H, McClure C, Kirtane AJ, RADIANCE-HTN Investigators: (2019) Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial. Circulation. 2019;139(22): 2542-2553
Kario K, Weber MA, Mahfoud F, Kandzari DE, Schmieder RE, Kirtane AJ, Böhm M, Hettrick DA, Townsend RR, Tsioufis KP: (2019) Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy. Hypertension. 2019;74(2): 244-249
Kannenkeril D, Karg MV, Bosch A, Ott C, Linz P, Nagel AM, Uder M, Schmieder RE: (2019) Tissue sodium content in patients with type 2 diabetes mellitus. J Diabetes Complications. 2019;33(7): 485-489
Weber MA, Mahfoud F, Schmieder RE, Kandzari DE, Tsioufis KP, Townsend RR, Kario K, Böhm M, Sharp ASP, Davies JE, Osborn JW, Fink GD, Euler DE, Cohen DL, Schlaich MP, Esler MD: (2019) Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence. JACC Cardiovasc Interv. 2019;12(12): 1095-1105
Kiuchi MG, Esler MD, Fink GD, Osborn JW, Banek CT, Böhm M, Denton KM, DiBona GF, Everett TH, Grassi G, Katholi RE, Knuepfer MM, Kopp UC, Lefer DJ, Lohmeier TE, May CN, Mahfoud F, Paton JFR, Schmieder RE, Pellegrino PR, Sharabi Y, Schlaich MP: (2019) Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019;73(23): 3006-3017
Jung S, Bosch A, Kohler N, Ott C, Kannenkeril D, Dienemann T, Harazny JM, Michelson G, Schmieder RE: (2019) Evidence of neurodegeneration in individuals with only mildly elevated blood pressure. J Hypertens. 2019;37(12): 2389-2397
Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I: (2019) [2018 ESC/ESH Guidelines for the management of arterial hypertension]. Kardiol Pol. 2019;77(2): 71-159
Azizi M, Schmieder R, Mahfoud F, Weber M, Daemen J, Lobo M, Sharp A, Basile J, Wang Y, Saxena M, Feyz L, Rader F, Lurz P, Sayer J, Kirtane A, RADIANCE-HTN Investigators: (2019) TREATMENT-BLINDED MEDICATION TITRATION FOR HYPERTENSION CONTROL FOLLOWING RANDOMIZATION TO ENDOVASCULAR ULTRASOUND RENAL DENERVATION OR A SHAM PROCEDURE J Am Coll Cardiol. 2019;73 Suppl 1(9): 1034-1034
Boehm M, Townsend R, Weber M, Kandzari D, Mahfoud F, Kario K, Schmieder R, Tsioufis K, DeBruin V, Hickey G, Fahy M, Pocock S: (2019) Implementation of Bayesian Study Design in the SPYRAL HTN-OFF MED Pivotal Trial J Am Coll Cardiol. 2019;74 Suppl B(13): B597-B597
Mahfoud F, Boehm M, Schmieder R, Narkiewicz K, Ewen S, Ruilope L, Schlaich M, Williams B, Fahy M, Mancia G: (2019) Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry Eur Heart J. 2019;40(42): 3474-+
Mahfoud F, Mancia G, Schmieder R, Narkiewicz K, Ruilope L, Schlaich M, Williams B, Whitbourn R, Zirlik A, Zeller T, Fahy M, Boehm M: (2019) SUBGROUP ANALYSIS OF LONG-TERM BLOOD PRESSURE REDUCTION IN THE GLOBAL SYMPLICITY REGISTRY J Am Coll Cardiol. 2019;73 Suppl 1(9): 1723-1723
Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchettit A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I: (2019) ESC/ESH 2018 Guide on the diagnosis and treatment of arterial hypertension Rev Esp Cardiol. 2019;72(2):
Hindermann M, Ditting T, Rodionova K, Loosen S, Ott C, Schmieder R, Amann K, Veelken R: (2019) Low doses of Intrarenal Bradykinin induce a Monophasic Sympathoinhibitory Response FASEB J. 2019;33 Suppl 1():
Rodionova K, Hindermann M, Ditting T, Pickny L, Loosen S, Ott C, Schmieder R, Amann K, Veelken R: (2019) Different forms of afferent nerve input in cardiac and renal disease in rats? FASEB J. 2019;33 Suppl 1():
Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, ESC Sci Document Grp: (2019) 2018 ESC/ESH Guidelines for the management of arterial hypertension (vol 39, pg 3021, 2018) Eur Heart J. 2019;40(5): 475-475
Papademetriou V, Stavropoulos K, Imprialos K, Doumas M, Schmieder RE, Pathak A, Tsioufis C: (2019) New data, new studies, new hopes for renal denervation in patients with uncontrolled hypertension. Int J Cardiol Hypertens. 2019;3():
Cholesterol Treatment Trialists' Collaboration , Armitage J, Baigent C, Barnes E, Betteridge DJ, Blackwell L, Blazing M, Bowman L, Braunwald E, Byington R, Cannon C, Clearfield M, Colhoun H, Collins R, Dahlöf B, Davies K, Davis B, de Lemos J, Downs JR, Durrington P, Emberson J, Fellström B, Flather M, Ford I, Franzosi MG, Fulcher J, Fuller J, Furberg C, Gordon D, Goto S, Gotto A, Halls H, Harper C, Hawkins CM, Herrington W, Hitman G, Holdaas H, Holland L, Jardine A, Jukema JW, Kastelein J, Kean S, Keech A, Kirby A, Kjekshus J, Knatterud Deceased G, Knopp Deceased R, Koenig W, Koren M, Krane V, Landray MJ, LaRosa J, Lonn E, MacFarlane P, MacMahon S, Maggioni A, Marchioli R, Marschner I, Mihaylova B, Moyé L, Murphy S, Nakamura H, Neil A, Newman C, O'Connell R, Packard C, Parish S, Pedersen T, Peto R, Pfeffer M, Poulter N, Preiss D, Reith C, Ridker P, Robertson M, Sacks F, Sattar N, Schmieder R, Serruys P, Sever P, Shaw J, Shear C, Simes J, Sleight P, Spata E, Tavazzi L, Tobert J, Tognoni G, Tonkin A, Trompet S, Varigos J, Wanner C, Wedel H, White H, Wikstrand J, Wilhelmsen L, Wilson K, Young R, Yusuf S, Zannad F: (2019) Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Lancet. 2019;393(10170): 407-415
Ott C, Franzen KF, Graf T, Weil J, Schmieder RE, Reppel M, Mortensen K: (2018) Renal denervation improves 24-hour central and peripheral blood pressures, arterial stiffness, and peripheral resistance. J Clin Hypertens (Greenwich). 2018;20(2): 366-372
Bosch A, Scheppach JB, Harazny JM, Raff U, Eckardt KU, Schmieder RE, Schneider MP: (2018) Retinal capillary and arteriolar changes in patients with chronic kidney disease. Microvasc Res. 2018;118(): 121-127
Bertog SC, Sobotka NA, Sobotka PA, Lobo MD, Sievert K, Vaskelyte L, Sievert H, Schmieder RE: (2018) Percutaneous Creation of a Central Iliac Arteriovenous Anastomosis for the Treatment of Arterial Hypertension. Curr Hypertens Rep. 2018;20(3):
Bertog SC, Sobotka NA, Sobotka PA, Lobo MD, Sievert K, Vaskelyte L, Sievert H, Schmieder RE: (2018) Correction to: Percutaneous Creation of a Central Iliac Arteriovenous Anastomosis for the Treatment of Arterial Hypertension. Curr Hypertens Rep. 2018;20(3):
Schmieder RE, Tschöpe D, Koch C, Ouarrak T, Gitt AK, DIALOGUE study group , Avsar S, Bramlage P, Duetting E, Gitt AK, Koch C, Müller A, Neumer A, Ouarrak T, Schmieder RE, Schneider S, Tschöpe D: (2018) Individualised treatment targets in patients with type-2 diabetes and hypertension. Cardiovasc Diabetol. 2018;17(1):
Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, Kirtane AJ, Wang Y, Lobo MD, Saxena M, Feyz L, Rader F, Lurz P, Sayer J, Sapoval M, Levy T, Sanghvi K, Abraham J, Sharp ASP, Fisher NDL, Bloch MJ, Reeve-Stoffer H, Coleman L, Mullin C, Mauri L, RADIANCE-HTN Investigators: (2018) Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet. 2018;391(10137): 2335-2345
Jung S, Ott C, Karg MV, Bosch A, Schmid M, Schlundt C, Achenbach S, Schmieder RE: (2018) Application of a central iliac arteriovenous coupler device in severe treatment-resistant hypertension: a 3.5-year follow-up. J Hypertens. 2018;36(12): 2471-2477
Böhm M, Schumacher H, Teo KK, Lonn E, Mahfoud F, Mann JFE, Mancia G, Redon J, Schmieder R, Weber M, Sliwa K, Williams B, Yusuf S: (2018) Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Eur Heart J. 2018;39(33): 3105-3114
Saxena M, Shour T, Shah M, Wolff CB, Julu POO, Kapil V, Collier DJ, Ng FL, Gupta A, Balawon A, Pheby J, Zak A, Rull G, O'Brien B, Schmieder RE, Lobo MD: (2018) Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success. J Am Heart Assoc. 2018;7(12):
Schmieder RE, Mahfoud F, Azizi M, Pathak A, Dimitriadis K, Kroon AA, Ott C, Scalise F, Mancia G, Tsioufis C, Members of the ESH Working Group on Interventional Treatment of Hypertension: (2018) European Society of Hypertension position paper on renal denervation 2018. J Hypertens. 2018;36(10): 2042-2048
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, ESC Scientific Document Group , De Backer G, Heagerty AM, Agewall S, Bochud M, Borghi C, Boutouyrie P, Brguljan J, Bueno H, Caiani EG, Carlberg B, Chapman N, Cifkova R, Cleland JGF, Collet JP, Coman IM, de Leeuw PW, Delgado V, Dendale P, Diener HC, Dorobantu M, Fagard R, Farsang C, Ferrini M, Graham IM, Grassi G, Haller H, Hobbs FDR, Jelakovic B, Jennings C, Katus HA, Kroon AA, Leclercq C, Lovic D, Lurbe E, Manolis AJ, McDonagh TA, Messerli F, Muiesan ML, Nixdorff U, Olsen MH, Parati G, Perk J, Piepoli MF, Polonia J, Ponikowski P, Richter DJ, Rimoldi SF, Roffi M, Sattar N, Seferovic PM, Simpson IA, Sousa-Uva M, Stanton AV, van de Borne P, Vardas P, Volpe M, Wassmann S, Windecker S, Zamorano JL, Windecker S, Aboyans V, Agewall S, Barbato E, Bueno H, Coca A, Collet JP, Coman IM, Dean V, Delgado V, Fitzsimons D, Gaemperli O, Hindricks G, Iung B, Jüni P, Katus HA, Knuuti J, Lancellotti P, Leclercq C, McDonagh TA, Piepoli MF, Ponikowski P, Richter DJ, Roffi M, Shlyakhto E, Simpson IA, Sousa-Uva M, Zamorano JL, Tsioufis C, Lurbe E, Kreutz R, Bochud M, Rosei EA, Jelakovic B, Azizi M, Januszewics A, Kahan T, Polonia J, van de Borne P, Williams B, Borghi C, Mancia G, Parati G, Clement DL, Coca A, Manolis A, Lovic D, Benkhedda S, Zelveian P, Siostrzonek P, Najafov R, Pavlova O, De Pauw M, Dizdarevic-Hudic L, Raev D, Karpettas N, Linhart A, Olsen MH, Shaker AF, Viigimaa M, Metsärinne K, Vavlukis M, Halimi JM, Pagava Z, Schunkert H, Thomopoulos C, Pall D, Andersen K, Shechter M, Mercuro G, Bajraktari G, Romanova T, Trušinskis K, Saade GA, Sakalyte G, Noppe S, DeMarco DC, Caraus A, Wittekoek J, Aksnes TA, Jankowski P, Polonia J, Vinereanu D, Baranova EI, Foscoli M, Dikic AD, Filipova S, Fras Z, Bertomeu-Martínez V, Carlberg B, Burkard T, Sdiri W, Aydogdu S, Sirenko Y, Brady A, Weber T, Lazareva I, Backer T, Sokolovic S, Jelakovic B, Widimsky J, Viigimaa M, Pörsti I, Denolle T, Krämer BK, Stergiou GS, Parati G, Trušinskis K, Miglinas M, Gerdts E, Tykarski A, de Carvalho Rodrigues M, Dorobantu M, Chazova I, Lovic D, Filipova S, Brguljan J, Segura J, Gottsäter A, Pechère-Bertschi A, Erdine S, Sirenko Y, Brady A: (2018) 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33): 3021-3104
Kandzari DE, Böhm M, Mahfoud F, Townsend RR, Weber MA, Pocock S, Tsioufis K, Tousoulis D, Choi JW, East C, Brar S, Cohen SA, Fahy M, Pilcher G, Kario K, SPYRAL HTN-ON MED Trial Investigators , Aoki J, Batson B, Böhm M, Choi JW, Cohen DL, Dangas G, David S, Davies J, Devireddy CM, Kandzari D, Kario K, Lee DP, Lurz PC, Papademetriou V, Patel M, Patel K, Schmieder RE, Sharp ASP, Singh J, Tsioufis K, Walton A, Weber T, Weil J, Zeller T, Ziada K, Tanabe K, Wilkins R, Mahfoud F, East C, Wilensky R, Contreras J, Steigerwalt S, Chapman N, Lea JP, Reedus D, Hoshide S, Ma A, Fengler K, Li P, Svetkey L, Rao A, Schmid A, Watkinson AF, Brown A, Tousoulis D, Hopper I, Suppan M, Agdirlioglu T, Noory E, Chasen C: (2018) Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet. 2018;391(10137): 2346-2355
Harazny JM, Schmieder RE: (2018) Interpretation of noninvasive retinal microvascular studies: the individual source of the automatic full field imaging analysis program has to be taken into account. J Hypertens. 2018;36(11):
Kannenkeril D, Bosch A, Harazny J, Karg M, Jung S, Ott C, Schmieder RE: (2018) Early vascular parameters in the micro- and macrocirculation in type 2 diabetes. Cardiovasc Diabetol. 2018;17(1):
Scheppach JB, Raff U, Toncar S, Ritter C, Klink T, Stoerk S, Wanner C, Schlieper G, Saritas T, Reinartz SD, Floege J, Janka R, Uder M, Schmieder RE, Eckardt KU, Schneider MP: (2018) Blood Pressure Pattern and Target Organ Damage in Patients With Chronic Kidney Disease Hypertension. 2018;72(4): 929-936
Ott C, Schmid A, Mahfoud F, Akarca E, Kistner I, Ditting T, Veelken R, Böhm M, Uder M, Schmieder RE: (2018) Secretory Capacity of Pancreatic Beta-Cells Is Enhanced 6 Months After Renal Denervation in Hypertensive Patients. J Am Coll Cardiol. 2018;72(25): 3372-3374
Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I: (2018) [2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]. G Ital Cardiol (Rome). 2018;19(11): 3-73
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, Authors/Task Force Members:: (2018) 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10): 1953-2041
Bosch A, Kannenkeril D, Ott C, Harazny JM, Striepe K, Karg M, Dienemann T, Jung S, Schmieder RE: (2018) THE INFLUENCE OF ANNOYANCE DUE TO NOISE ON RENAL HEMODYNAMIC J Hypertens. 2018;36(): E39-E39
Bosch A, Ott C, Kannenkeril D, Harazny JM, Striepe K, Karg M, Dienemann T, Jung S, Schmieder RE: (2018) DIFFERENT RESPONSE PATTERN TO AIRCRAFT NOISE EXPOSURE IN RENAL VERSUS SYSTEMIC HEMODYNAMIC J Hypertens. 2018;36(): E138-E138
Bosch A, Ott C, Schmid A, Kannenkeril D, Karg M, Ditting T, Veelken R, Uder M, Schmieder RE: (2018) COPEPTIN AS A RESEARCH MARKER IN CARDIOVASCULAR DISEASE J Hypertens. 2018;36(): E35-E35
Ott C, Schmid A, Ditting T, Veelken R, Uder M, Schmieder RE: (2018) EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE IN PATIENTS WITH END-STAGE RENAL DISEASE: A SINGLE CENTER EXPERIENCE J Hypertens. 2018;36(): E49-E49
Jung S, Ott C, Karg M, Bosch A, Schmid M, Schlundt C, Achenbach S, Schmieder RE: (2018) APPLICATION OF A CENTRAL ILIAC ARTERIOVENOUS COUPLER DEVICE IN SEVERE TREATMENT-RESISTANT ARTERIAL HYPERTENSION: A FOUR-YEAR FOLLOW-UP J Hypertens. 2018;36(): E104-E104
Schmieder RS, Schmid A, Janka R, Schmieder RE, Ott C, Uder M: (2018) Difference in renal parenchymal perfusion after renal denervation comparing treated vs. non-treated arteries Eur Heart J. 2018;39(): 663-663
Bosch A, Ott C, Jung S, Striepe K, Karg MV, Kannenkeril D, Dienemann T, Schmieder RE: (2018) How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Eur Heart J. 2018;39(): 869-869
Kannenkeril D, Karg M, Bosch A, Ott C, Harazny J, Schmieder RE: (2018) EARLY VASCULAR PARAMETERS IN THE MICRO- AND MACROCIRCULATION IN TYPE 2 DIABETES J Hypertens. 2018;36(): E9-E9
Azizi M, Schmieder RE, Mahfoud F, Weber M, Daemen J, Davies J, Basile J, Kirtane A, Wang Y, Mauri L: (2018) RADIANCE-HTN SOLO: A MULTICENTER, RANDOMIZED, SHAM-CONTROLLED STUDY OF RENAL DENERVATION IN PATIENTS WITH UNCONTROLLED HYPERTENSION IN THE ABSENCE OF ANTIHYPERTENSIVE MEDICATIONS J Hypertens. 2018;36(): E238-E238
Pietzsch JB, Geisler BP, Schmieder RE: (2018) COST-EFFECTIVENESS ANALYSIS OF NEXT GENERATION RENAL DENERVATION THERAPY DEVICES: THRESHOLD ANALYSIS AND PROJECTIONS OF THE SPYRAL HTN-ON MED TRIAL FOR GERMANY Value Health. 2018;21(): S261-S261
Solbu MD, Mark PB, Holdaas H, Schmieder RE, Zannad F, Herrington WG, Jardine AG: (2018) Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study. Nephrol Dial Transplant. 2018;33(1): 102-112
Ott C, Kopp C, Dahlmann A, Schmid A, Linz P, Cavallaro A, Hammon M, Ditting T, Veelken R, Uder M, Titze J, Schmieder RE: (2018) Impact of renal denervation on tissue Na+ content in treatment-resistant hypertension. Clin Res Cardiol. 2018;107(1): 42-48
Schmieder RE, Ott C, Toennes SW, Bramlage P, Gertner M, Dawood O, Baumgart P, O'Brien B, Dasgupta I, Nickenig G, Ormiston J, Saxena M, Sharp ASP, Sievert H, Spinar J, Starek Z, Weil J, Wenzel U, Witkowski A, Lobo MD: (2018) Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension - WAVE IV. J Hypertens. 2018;36(3): 680-689
Kannenkeril D, Harazny JM, Bosch A, Ott C, Michelson G, Schmieder RE, Friedrich S: (2018) Retinal vascular resistance in arterial hypertension. Blood Press. 2018;27(2): 82-87
Kapil V, Sobotka PA, Lobo MD, Schmieder RE: (2018) Central arteriovenous anastomosis to treat resistant hypertension. Curr Opin Nephrol Hypertens. 2018;27(1): 8-15
Mauri L, Kario K, Basile J, Daemen J, Davies J, Kirtane AJ, Mahfoud F, Schmieder RE, Weber M, Nanto S, Azizi M: (2018) A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs. Am Heart J. 2018;195(): 115-129
Karg MV, Bosch A, Kannenkeril D, Striepe K, Ott C, Schneider MP, Boemke-Zelch F, Linz P, Nagel AM, Titze J, Uder M, Schmieder RE: (2018) SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial. Cardiovasc Diabetol. 2018;17(1): 5
Clase CM, Barzilay J, Gao P, Smyth A, Schmieder RE, Tobe S, Teo KK, Yusuf S, Mann JF: (2017) Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes. Kidney Int. 2017;91(3): 683-690
Schneider MP, Raff U, Kopp C, Scheppach JB, Toncar S, Wanner C, Schlieper G, Saritas T, Floege J, Schmid M, Birukov A, Dahlmann A, Linz P, Janka R, Uder M, Schmieder RE, Titze JM, Eckardt KU: (2017) Skin Sodium Concentration Correlates with Left Ventricular Hypertrophy in CKD. J Am Soc Nephrol. 2017;28(6): 1867-1876
Linz D, Mancia G, Mahfoud F, Narkiewicz K, Ruilope L, Schlaich M, Kindermann I, Schmieder RE, Ewen S, Williams B, Böhm M, Global SYMPLICITY Registry Investigators: (2017) Renal artery denervation for treatment of patients with self-reported obstructive sleep apnea and resistant hypertension: results from the Global SYMPLICITY Registry. J Hypertens. 2017;35(1): 148-153
Reinold A, Schneider A, Kalizki T, Raff U, Schneider MP, Schmieder RE, Schmidt BM: (2017) Increased Aldosterone Release During Head-Up Tilt in Early Primary Hypertension. Am J Hypertens. 2017;30(5): 484-489
Ott C, Jumar A, Striepe K, Friedrich S, Karg MV, Bramlage P, Schmieder RE: (2017) A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation. Cardiovasc Diabetol. 2017;16(1): 26
Kalizki T, Schmidt BM, Raff U, Reinold A, Schwarz TK, Schneider MP, Schmieder RE, Schneider A: (2017) Low dose-eplerenone treatment decreases aortic stiffness in patients with resistant hypertension. J Clin Hypertens (Greenwich). 2017;19(7): 669-676
Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JF, Mancia G, Redon J, Schmieder RE, Sliwa K, Weber MA, Williams B, Yusuf S: (2017) Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017;389(10085): 2226-2237
Mahfoud F, Schmieder RE, Azizi M, Pathak A, Sievert H, Tsioufis C, Zeller T, Bertog S, Blankestijn PJ, Böhm M, Burnier M, Chatellier G, Durand Zaleski I, Ewen S, Grassi G, Joner M, Kjeldsen SE, Lobo MD, Lotan C, Felix Lüscher T, Parati G, Rossignol P, Ruilope L, Sharif F, van Leeuwen E, Volpe M, Windecker S, Witkowski A, Wijns W: (2017) Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future. Eur Heart J. 2017;38(44): 3272-3281
Engelbertz C, Reinecke H, Breithardt G, Schmieder RE, Fobker M, Fischer D, Schmitz B, Pinnschmidt HO, Wegscheider K, Pavenstädt H, Brand E: (2017) Two-year outcome and risk factors for mortality in patients with coronary artery disease and renal failure: The prospective, observational CAD-REF Registry. Int J Cardiol. 2017;243(): 65-72
Freudenmann RW, Freudenmann N, Zurowski B, Schönfeldt-Lecuona C, Maier L, Schmieder RE, Lange-Asschenfeldt C, Gahr M: (2017) [Arterial Hyper- and Hypotension associated with psychiatric medications: a risk assessment based on the summaries of product characteristics (SmPCs)]. Dtsch Med Wochenschr. 2017;142(16): e100-e107
Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B: (2017) Expertise: No Longer a Sine Qua Non for Guideline Authors? Hypertension. 2017;70(2): 235-237
Picone DS, Schultz MG, Otahal P, Aakhus S, Al-Jumaily AM, Black JA, Bos WJ, Chambers JB, Chen CH, Cheng HM, Cremer A, Davies JE, Dwyer N, Gould BA, Hughes AD, Lacy PS, Laugesen E, Liang F, Melamed R, Muecke S, Ohte N, Okada S, Omboni S, Ott C, Peng X, Pereira T, Pucci G, Rajani R, Roberts-Thomson P, Rossen NB, Sueta D, Sinha MD, Schmieder RE, Smulyan H, Srikanth VK, Stewart R, Stouffer GA, Takazawa K, Wang J, Westerhof BE, Weber F, Weber T, Williams B, Yamada H, Yamamoto E, Sharman JE: (2017) Accuracy of Cuff-Measured Blood Pressure: Systematic Reviews and Meta-Analyses. J Am Coll Cardiol. 2017;70(5): 572-586
Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B, de Leeuw PW: (2017) Expertise: no longer a sine qua non for guideline authors? J Hypertens. 2017;35(8): 1564-1566
Schneider A, Schwab J, Karg MV, Kalizki T, Reinold A, Schneider MP, Schmieder RE, Schmidt BM: (2017) Low-dose eplerenone decreases left ventricular mass in treatment-resistant hypertension. J Hypertens. 2017;35(5): 1086-1092
Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP, Watkinson AF, Schmieder RE, Schmid A, Choi JW, East C, Walton A, Hopper I, Cohen DL, Wilensky R, Lee DP, Ma A, Devireddy CM, Lea JP, Lurz PC, Fengler K, Davies J, Chapman N, Cohen SA, DeBruin V, Fahy M, Jones DE, Rothman M, Böhm M, SPYRAL HTN-OFF MED trial investigators* , Aoki J, Batson B, Böhm M, Choi JW, Cohen DL, Dangas G, David S, Davies J, Devireddy CM, Kandzari D, Kario K, Lee DP, Lurz PC, Patel M, Patel K, Schmieder RE, Sharp ASP, Singh J, Tsioufis K, Walton A, Weber T, Weil J, Zeller T, Ziada K, Tanabe K, Wilkins R, Mahfoud F, East C, Wilensky R, Contreras J, Steigerwalt S, Chapman N, Lea JP, Reedus D, Hoshide S, Ma A, Fengler K, Svetkey L, Rao A, Schmid A, Watkinson AF, Brown A, Tousoulis D, Hopper I, Suppan M, Agdirlioglu T, Noory E, Chasen C: (2017) Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017;390(10108): 2160-2170
Striepe K, Jumar A, Ott C, Karg MV, Schneider MP, Kannenkeril D, Schmieder RE: (2017) Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus. Circulation. 2017;136(12): 1167-1169
Schmieder RE, Wagner F, Mayr M, Delles C, Ott C, Keicher C, Hrabak-Paar M, Heye T, Aichner S, Khder Y, Yates D, Albrecht D, Langenickel T, Freyhardt P, Janka R, Bremerich J: (2017) The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study. Eur Heart J. 2017;38(44): 3308-3317
Bramlage P, Swift SL, Thoenes M, Minguet J, Ferrero C, Schmieder RE: (2017) Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease. Eur J Heart Fail. 2017;19(6): 811
Mancia G, Schumacher H, Böhm M, Redon J, Schmieder RE, Verdecchia P, Sleight P, Teo K, Yusuf S: (2017) Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND Patients. Hypertension. 2017;70(5): 938-948
Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, de Leeuw PW, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B: (2017) Reply. J Hypertens. 2017;35(11): 2327-2328
Lobo MD, Ott C, Sobotka PA, Saxena M, Stanton A, Cockcroft JR, Sulke N, Dolan E, van der Giet M, Hoyer J, Furniss SS, Foran JP, Witkowski A, Januszewicz A, Schoors D, Tsioufis K, Rensing BJ, Scott B, Ng GA, Schmieder RE: (2017) Central Iliac Arteriovenous Anastomosis for Uncontrolled Hypertension: One-Year Results From the ROX CONTROL HTN Trial. Hypertension. 2017;70(6): 1099-1105
Bosch AJ, Harazny JM, Kistner I, Friedrich S, Wojtkiewicz J, Schmieder RE: (2017) Retinal capillary rarefaction in patients with untreated mild-moderate hypertension. BMC Cardiovasc Disord. 2017;17(1): 300
Perrone-Filardi P, Coca A, Galderisi M, Paolillo S, Alpendurada F, de Simone G, Donal E, Kahan T, Mancia G, Redon J, Schmieder R, Williams B, Agabiti-Rosei E: (2017) Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and Eur Heart J Cardiovasc Imaging. 2017;18(9): 945-960
Wagner S, Apetrii M, Massy ZA, Kleber ME, Delgado GE, Scharnagel H, März W, Metzger M, Rossignol P, Jardine A, Holdaas H, Schmieder R, Stengel B, Zannad F, on behalf AURORA study group and F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) network: (2017) Oxidized LDL, statin use, morbidity, and mortality in patients receiving maintenance hemodialysis. Free Radic Res. 2017;51(1): 14-23
Perrone-Filardi P, Coca A, Galderisi M, Paolillo S, Alpendurada F, de Simone G, Donal E, Kahan T, Mancia G, Redon J, Schmieder R, Williams B, Agabiti-Rosei E: (2017) Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the Eur J Hypertens. 2017;35(9): 1727-1741
Schmieder RE, Kistner I, Schmid A, Mahfoud F, Friedrich S, Ditting T, Veelken R, Böhm M, Uder M, Ott C: (2017) Secretory Capacity of Pancreatic Beta Cells Is Enhanced 6 Months after Renal Denervation in Hypertensive Patients Diabetes. 2017;66 1(): A65-A65
Schmieder RE, Jumar A, Fronk EM, Alexandre AF, Bramlage P: (2017) Quality of life and emotional impact of a fixed-dose combination of antihypertensive drugs in patients with uncontrolled hypertension. J Clin Hypertens (Greenwich). 2017;19(2): 126-134
Schmid A, Schmieder R, Lell M, Janka R, Veelken R, Schmieder RE, Uder M, Ott C: (2016) Mid-Term Vascular Safety of Renal Denervation Assessed by Follow-up MR Imaging. Cardiovasc Intervent Radiol. 2016;39(3): 426-32
Jumar A, Schmieder RE: (2016) Cocoa Flavanol Cardiovascular Effects Beyond Blood Pressure Reduction. J Clin Hypertens (Greenwich). 2016;18(4): 352-8
Ditting T, Freisinger W, Rodionova K, Schatz J, Lale N, Heinlein S, Linz P, Ott C, Schmieder RE, Scrogin KE, Veelken R: (2016) Impaired excitability of renal afferent innervation after exposure to the inflammatory chemokine CXCL1. Am J Physiol Renal Physiol. 2016;310(5): F364-71
Bramlage P, Swift SL, Thoenes M, Minguet J, Ferrero C, Schmieder RE: (2016) Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease. Eur J Heart Fail. 2016;18(1): 28-37
Reinecke H, Breithardt G, Engelbertz C, Schmieder RE, Fobker M, Pinnschmidt HO, Schmitz B, Bruland P, Wegscheider K, Pavenstädt H, Brand E: (2016) Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry). PLoS ONE. 2016;11(2): e0148057
Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Guan TR, Zhang Y, Zhang X, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G, ESH-CHL-SHOT trial investigators: (2016) Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. J Hypertens. 2016;34(3): 393-6
Rodionova K, Fiedler C, Guenther F, Grouzmann E, Neuhuber W, Fischer MJ, Ott C, Linz P, Freisinger W, Heinlein S, Schmidt ST, Schmieder RE, Amann K, Scrogin KE, Veelken R, Ditting T: (2016) Complex reinnervation pattern after unilateral renal denervation in rats. Am J Physiol Regul Integr Comp Physiol. 2016;310(9): R806-18
Gitt AK, Bramlage P, Potthoff SA, Baumgart P, Mahfoud F, Buhck H, Ehmen M, Ouarrak T, Senges J, Schmieder RE, EARLY Registry Group: (2016) Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry. BMC Cardiovasc Disord. 2016;16(1): 56
Schmieder RE, Ott C, Schmid A, Friedrich S, Kistner I, Ditting T, Veelken R, Uder M, Toennes SW: (2016) Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation. J Am Heart Assoc. 2016;5(2):
Schmieder RE, Bramlage P, EARLY Registry Group: (2016) Is Azilsartan More Effective in Younger Than in Older Patients? An Explorative Analysis of the Prospective EARLY Registry. J Clin Hypertens (Greenwich). 2016;18(8): 826-7
De Jager RL, Sanders MF, Bots ML, Lobo MD, Ewen S, Beeftink MM, Böhm M, Daemen J, Dörr O, Hering D, Mahfoud F, Nef H, Ott C, Saxena M, Schmieder RE, Schlaich MP, Spiering W, Tonino PA, Verloop WL, Vink EE, Vonken EJ, Voskuil M, Worthley SG, Blankestijn PJ: (2016) Renal denervation in hypertensive patients not on blood pressure lowering drugs. Clin Res Cardiol. 2016;105(9): 755-62
Schmieder RE, Ott C, Bramlage P: (2016) Non-invasive Renal Denervation: Update on External Ultrasound Approaches. Curr Hypertens Rep. 2016;18(6): 48
Stumpf C, Raaz D, Klinghammer L, Schneider M, Schmieder RE, Garlichs CD, Achenbach S: (2016) Platelet CD40 contributes to enhanced monocyte chemoattractant protein 1 levels in patients with resistant hypertension. Eur J Clin Invest. 2016;46(6): 564-71
Kistner I, Zeymer U, Dechend R, Hagedorn I, Riemer T, Bramlage P, Pittrow D, Senges J, Schmieder RE: (2016) Benefits and Risks of Aliskiren Treatment in Patients With Type 2 Diabetes: Analyses of the 3A Registry. J Clin Hypertens (Greenwich). 2016;18(10): 1045-1053
Hammon M, Janka R, Siegl C, Seuss H, Grosso R, Martirosian P, Schmieder RE, Uder M, Kistner I: (2016) Reproducibility of Kidney Perfusion Measurements With Arterial Spin Labeling at 1.5 Tesla MRI Combined With Semiautomatic Segmentation for Differential Cortical and Medullary Assessment. Medicine (Baltimore). 2016;95(11): e3083
Schmieder RE, Bramlage P, Haller H, Ruilope LM, Böhm M, ROADMAP Investigators: (2016) The Effect of Resting Heart Rate on the New Onset of Microalbuminuria in Patients With Type 2 Diabetes: A Subanalysis of the ROADMAP Study. Medicine (Baltimore). 2016;95(15): e3122
Jumar A, Harazny JM, Ott C, Kistner I, Friedrich S, Schmieder RE: (2016) Improvement in Retinal Capillary Rarefaction After Valsartan Treatment in Hypertensive Patients. J Clin Hypertens (Greenwich). 2016;18(11): 1112-1118
Redon J, Pichler G, Missed Dose Study Group , Redon J, Pascual JM, Olivan-Martinez J, Martell N, Calvo-Gomez C, Lembo G, Benedetto FA, De Curtis G, Desideri G, Dognini GP, Ferri C, Fogari R, Ganau A, Gargiulo A, Gaudio G, Germanò G, Malatino L, Bucci M, Mos L, Novo S, Pedrinelli R, Perticone F, Portaluppi F, Mulé G, Sarzani R, Schillaci G, Spagnuolo V, Strazzullo P, Taddei S, Trimarco B, Veglio F, Verdecchia P, Volpe M, Tsioufis C, Zakopoulos N, Zamboulis C, Schmieder RE, Bönner G, Sehnert W, Haller H, Scholze J, Burnier M, Hayoz D, Asmar R, Blacher J, Benetos A, Gosse P, Mounier-Vehier C, Thuillez C: (2016) Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes. J Hypertens. 2016;34(2): 359-67
Neuzil P, Ormiston J, Brinton TJ, Starek Z, Esler M, Dawood O, Anderson TL, Gertner M, Whitbourne R, Schmieder RE: (2016) Externally Delivered Focused Ultrasound for Renal Denervation. JACC Cardiovasc Interv. 2016;9(12): 1292-9
Redon J, Mourad JJ, Schmieder RE, Volpe M, Weiss TW: (2016) Why in 2016 are patients with hypertension not 100% controlled? A call to action. J Hypertens. 2016;34(8): 1480-8
Jumar A, Ott C, Kistner I, Friedrich S, Michelson G, Harazny JM, Schmieder RE: (2016) Early Signs of End-Organ Damage in Retinal Arterioles in Patients with Type 2 Diabetes Compared to Hypertensive Patients. Microcirculation. 2016;23(6): 447-55
Zeymer U, Dechend R, Riemer T, Deeg E, Senges J, Pittrow D, Schmieder R, 3A Registry Investigators: (2016) Two-Year Outcomes of Patients Treated With Aliskiren Under Clinical Practice Conditions: Non-Interventional Prospective Study. J Clin Hypertens (Greenwich). 2016;18(7): 647-54
Ewen S, Lobo MD, Pathak A, Schmieder RE, Tsioufis C, Wijns W, Mahfoud F: (2016) Will SPRINT change my practice? SPRINT: a randomised trial of intensive versus standard blood-pressure control. EuroIntervention. 2016;12(6): 809-12
Moss JG, Belli AM, Coca A, Lee M, Mancia G, Peregrin JH, Redon J, Reekers JA, Tsioufis C, Vorwerk D, Schmieder RE: (2016) Executive Summary of the Joint Position Paper on Renal Denervation of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) and the European Society of Hypertension (ESH). Cardiovasc Intervent Radiol. 2016;39(12): 1681-1683
Ott C, Kistner I, Keller M, Friedrich S, Willam C, Bramlage P, Schmieder RE: (2016) Effects of linagliptin on renal endothelial function in patients with type 2 diabetes: a randomised clinical trial. Diabetologia. 2016;59(12): 2579-2587
Ott C, Mahfoud F, Schmid A, Ewen S, Toennes SW, Meyer MR, Helfer AG, Maurer HH, Ditting T, Veelken R, Zivanovic I, Uder M, Böhm M, Schmieder RE: (2016) The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence. J Hypertens. 2016;34(12): 2475-2479
Moss JG, Belli AM, Coca A, Lee M, Mancia G, Peregrin JH, Redon J, Reekers JA, Tsioufis C, Vorwerk D, Schmieder RE: (2016) Executive summary of the joint position paper on renal denervation of the Cardiovascular and Interventional Radiological Society of Europe and the European Society of Hypertension. J Hypertens. 2016;34(12): 2303-2304
Schmieder RE, Neuzil P: (2016) Scientific Data and Transparency of Conflict of Interest Are Important, Not Biased Editorial Without Facts. JACC Cardiovasc Interv. 2016;9(21): 2263
Jumar A, Harazny JM, Ott C, Friedrich S, Kistner I, Striepe K, Schmieder RE: (2016) Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus. PLoS ONE. 2016;11(12): e0162608
Ott C, Lobo MD, Sobotka PA, Mahfoud F, Stanton A, Cockcroft J, Sulke N, Dolan E, van der Giet M, Hoyer J, Furniss SS, Foran JP, Witkowski A, Januszewicz A, Schoors D, Tsioufis K, Rensing BJ, Saxena M, Scott B, Ng GA, Achenbach S, Schmieder RE: (2016) Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension. J Am Heart Assoc. 2016;5(12):
Schmieder RE, Wagner F, Mayr M, Delles C, Ott C, Keicher C, Aichner S, Khder Y, Yates D, Albrecht D, Langenickel T, Freyhardt P, Janka R, Bremerich J: (2016) The Effects of LCZ696 on Left Ventricular Remodeling in Hypertensive Patients - Results of a Double Blind, Randomized, Multicenter Trial Circulation. 2016;134 1(): -
Schmieder RE, Wagner F, Mayr M, Delles C, Ott C, Keicher C, Aichner S, Khder Y, Yates D, Albrecht D, Langenickel T, Freyhardt P, Janka R, Bremerich J: (2016) The effects of LCZ696 on left ventricular remodeling in hypertensive patients - Results of a double blind, randomized, multicenter trial Eur Heart J. 2016;37 1(): 621-621
Kistner I, Ott C, Jumar A, Friedrich S, Bramlage P, Schmieder RE: (2016) Effects of Dapagliflozin on Early Alterations of the Micro- and Macrocirculation in Patients with Type 2 Diabetes Diabetes. 2016;65(1): A115-A115
Schmieder RE, Ormiston JA, Neuzil P, Starek Z, Kay P, Dawood O, Anderson TL, Gertner M, White WB: (2015) Efficacy and Safety of Non-invasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension Circulation. 2015;132 3(): -
Gitt AK, Tschtope D, Bramlage P, Koch C, Ouarrak T, Schmieder RE: (2015) Individualized Treatment in Patients with Comorbid Type 2 Diabetes and Heart Failure: Insights from the DIALOGUE Registry Diabetes. 2015;64(1): A395-A395
Gitt AK, Tschöpe D, Bramlage P, Koch C, Ouarrak T, Schmieder RE: (2015) The Impact of Overt Vascular Disease in Patients with Comorbid Type 2 Diabetes and Hypertension: Data from the DIALOGUE Registry Diabetes. 2015;64(1): A680-A681
Schmieder RE, Ormiston JA, Neuzil P, Starek Z, Kay P, Dawood O, Anderson T, Gertner M, White WB: (2015) Non-invasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension: 1 Year Follow up Results J Am Coll Cardiol. 2015;66 S(15): B40-B40
Naess H, Zannad F, Jardine AG, Schmieder RE, Fellström B, Holdaas H, Mjoen G: (2015) NON-TRADITIONAL CARDIOVASCULAR RISK FACTORS PREDOMINATE IN HEMODIALYSIS PATIENTS WITH PRE-EXISTIN CARDIOVASCULAR DISEASE Nephrol Dial Transplant. 2015;30(3): -
Schmieder RE, Friedrich S, Kistner I, Ott C: (2015) EFFECTS OF LINAGLIPTIN ON EARLY ALTERATIONS OF RENAL ENDOTHELIAL FUNCTION IN PATIENTS WITH TYPE-2 DIABETES Nephrol Dial Transplant. 2015;30(3): -
Schmieder RE, Bretzel RG: (2015) Hypertension and Diabetes Der Diabetologe. 2015;11(5): 371-372
Tschoepe D, Schmieder RE, Bramlage P, Koch C, Ouarrak T, Gitt AK: (2015) Blood glucose and blood pressure related treatment target achievement: results of the prospective DIALOGUE registry Diabetologia. 2015;58 1(): S435-S436
Franzen KF, Mortensen K, Graf T, Weil J, Schmieder RM, Ott C, Reppel M: (2015) 24 months follow up of the Luebeck and Erlangen RDN registry: RDN improves 24 h peripheral and central blood pressure as well as 24h-arterial stiffness Eur Heart J. 2015;36 1(): 1055-1055
Gitt AK, Tschoepe D, Bramlage P, Koch C, Ouarrak T, Schmieder RE: (2015) The impact of overt vascular disease in patients with comorbid type-2 diabetes and hypertension: data from the Dialogue registry Eur Heart J. 2015;36 1(): 539-539
Schmieder RE, Tschoepe D, Koch C, Bramlage P, Ouarrak T, Gitt AK: (2015) Achievement of individualized blood pressure and HbA1c targets in patients with hypertension and type-2 diabetes Eur Heart J. 2015;36 1(): 539-539
Gitt AK, Tschoepe D, Bramlage P, Koch C, Ouarrak T, Schmieder R: (2015) Individualized treatment in patients with comorbid type-2 diabetes and heart failure: insights from the DIALOGUE registry Eur Heart J. 2015;36 1(): 667-667
Mennini FS, Marcellusi A, von der Schulenburg JM, Gray A, Levy P, Sciattella P, Soro M, Staffiero G, Zeidler J, Maggioni A, Schmieder RE: (2015) Cost of poor adherence to anti-hypertensive therapy in five European countries. Eur J Health Econ. 2015;16(1): 65-72
Schmidt ST, Ditting T, Deutsch B, Schutte R, Friedrich S, Kistner I, Ott C, Raff U, Veelken R, Schmieder RE: (2015) Circadian rhythm and day to day variability of serum potassium concentration: a pilot study. J Nephrol. 2015;28(2): 165-72
Ewen S, Ukena C, Linz D, Kindermann I, Cremers B, Laufs U, Wagenpfeil S, Schmieder RE, Böhm M, Mahfoud F: (2015) Reduced effect of percutaneous renal denervation on blood pressure in patients with isolated systolic hypertension. Hypertension. 2015;65(1): 193-9
Mahfoud F, Ruilope LM, Böhm M, Schmieder RE: (2015) Aldosterone antagonists and renal denervation: friends or foes? Hypertension. 2015;65(2): 280-2
Friedrich S, Zeymer U, Dechend R, Hagedorn I, Riemer T, Zemmrich C, Bramlage P, Pittrow D, Senges J, Schmieder RE: (2015) The impact of age on the benefits and risks of aliskiren treatment: analyses of the 3A registry. J Hum Hypertens. 2015;29(5): 316-23
Messerli FH, Bangalore S, Schmieder RE: (2015) Wilder's principle: pre-treatment value determines post-treatment response. Eur Heart J. 2015;36(9): 576-579
Raff U, Walker S, Ott C, Schneider MP, Schmieder RE: (2015) Olmesartan improves pulse wave velocity and lowers central systolic blood pressure and ambulatory blood pressure in patients with metabolic syndrome. J Clin Hypertens (Greenwich). 2015;17(2): 98-104
Böhm M, Schumacher H, Schmieder RE, Mann JF, Teo K, Lonn E, Sleight P, Mancia G, Linz D, Mahfoud F, Ukena C, Sliwa K, Bakris G, Yusuf S: (2015) Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies. J Intern Med. 2015;278(1): 38-49
Bramlage P, Fronk EM, Wolf WP, Smolnik R, Sutton G, Schmieder RE: (2015) Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice. Vasc Health Risk Manag. 2015;11(): 1-8
Schmieder RE, Gitt AK, Koch C, Bramlage P, Ouarrak T, Tschöpe D, DIALOGUE study group: (2015) Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry. BMC Endocr Disord. 2015;15(1): 23
Oparil S, Schmieder RE: (2015) New approaches in the treatment of hypertension. Circ Res. 2015;116(6): 1074-95
Pöss J, Ewen S, Schmieder RE, Muhler S, Vonend O, Ott C, Linz D, Geisel J, Rump LC, Schlaich M, Böhm M, Mahfoud F: (2015) Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension. Clin Res Cardiol. 2015;104(8): 672-8
Schmieder RE, Mitrovic V, Hengstenberg C: (2015) Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin. Clin Res Cardiol. 2015;104(8): 621-31
Ott C, Harazny JM, Schmid A, Ditting T, Veelken R, Bladowski M, Michelson G, Uder M, Schmieder RE: (2015) Retinal microperfusion after renal denervation in treatment-resistant hypertensive patients. Clin Res Cardiol. 2015;104(9): 782-9
Mahfoud F, Böhm M, Azizi M, Pathak A, Durand Zaleski I, Ewen S, Tsioufis K, Andersson B, Blankestijn PJ, Burnier M, Chatellier G, Gafoor S, Grassi G, Joner M, Kjeldsen SE, Lüscher TF, Lobo MD, Lotan C, Parati G, Redon J, Ruilope L, Sudano I, Ukena C, van Leeuwen E, Volpe M, Windecker S, Witkowski A, Wijns W, Zeller T, Schmieder RE: (2015) Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design. Eur Heart J. 2015;36(33): 2219-27
Ott C, Schmid A, Toennes SW, Ditting T, Veelken R, Uder M, Schmieder RE: (2015) Central pulse pressure predicts BP reduction after renal denervation in patients with treatment-resistant hypertension. EuroIntervention. 2015;11(1): 110-6
Böhm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, Ruilope L, Schlaich MP, Schmieder RE, Whitbourn R, Williams B, Zeymer U, Zirlik A, Mancia G, GSR Investigators , Aguirre L, Ahn TH, Al Habib K, Al Jarallah M, Alimbaev S, Ammerer M, Andersson B, Andersson J, Andresen D, Anné W, Baumgartner I, Bergmann M, Berland J, Bilger J, Blumenstein M, Böhm M, Brachmann J, Branny M, Brussee H, Clifford P, Cornelis K, Cunnington M, Cyrne de Carvalho H, Dandona S, Danilov N, Dasgupta I, Dong-Ju C, Dorsch M, Drieghe B, Ebrahim IO, Echeverri D, Eckert S, Fajadet J, Fichtlscherer S, Fleck E, Frey N, Gahnim D, Galyavich A, Giannattasio C, Göing O, Gomes M, Gonçalves P, Grossman E, Grund M, Gutierrez E, Gwon HC, Hausberg M, Hoffmann E, Ibrahim R, Jardine A, Jung W, Jung J, Katritsis D, Kerschbaum J, Kim CJ, Kim HS, Konradi A, Krasowski W, Kuznetsov V, Kwok OH, Kwon HM, Leong G, Lotan C, Lurz P, Luscher T, MacKinnon M, Malik FT, Mangos G, Martinez C, McCann A, Misonis N, Mölmann H, Mordovin V, Mortensen K, Mueller O, Muller O, Münzel T, Ntsekhe M, Oliveira E, Ong TK, Ong P, Ormiston J, Oswald H, Park SJ, Park CG, Plehn A, Pressley L, Reith S, Reuter H, Rosenschein U, Rottbauer W, Ruilope L, Rump LC, Scheinert D, Schillinger , Schlaich M, Schmieder R, Schultheiss HP, Sechtem U, Seung KB, Sharif F, Sharpe A, Shetty S, Sievert H, Soo JY, Teik LS, Stefanadis C, Stellbrink C, Sticherling C, Stoel M, Strasser R, Thambar S, Tonino P, Udayachalerm W, Unterseeh T, Vaclavik J, von Scheidt W, Voskuil M, Wan Ahmad WA, Weber T, Wedekind H, Weil J, Werner N, Whitbourn R, Winkens M, Winter KD, Witkowski A, Wyffels E, Yip T, Zambahari R, Zeller T, Zeymer U, Zirlik A, Zürn C: (2015) First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension. 2015;65(4): 766-74
Schmieder RE, Nitschmann S: (2015) [Cardiac effects of hypertension]. Internist (Berl). 2015;56(5): 583-5
Ott C, Mahfoud F, Schmid A, Toennes SW, Ewen S, Ditting T, Veelken R, Ukena C, Uder M, Böhm M, Schmieder RE: (2015) Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension. J Hypertens. 2015;33(6): 1261-6
Böhm M, Schumacher H, Linz D, Reil JC, Ukena C, Lonn E, Teo K, Sliwa K, Schmieder RE, Sleight P, Yusuf S: (2015) Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/TRANSCEND studies. J Intern Med. 2015;278(3): 303-12
Lobo MD, Sobotka PA, Stanton A, Cockcroft JR, Sulke N, Dolan E, van der Giet M, Hoyer J, Furniss SS, Foran JP, Witkowski A, Januszewicz A, Schoors D, Tsioufis K, Rensing BJ, Scott B, Ng GA, Ott C, Schmieder RE, ROX CONTROL HTN Investigators , Jain A, Knight C, Lobo MD, Mathur A, Saxena M, Stanton A, Cockcroft JR, Sulke N, Dolan E, van der Giet M, Hoyer J, Furniss SS, Foran JP, Mungur D, Witkowski A, Januszewicz A, Prejbisz A, Kadziela J, Florczak E, Galvin J, Schoors D, Dimitriadis K, Tsioufis K, Rensing BJ, Scott B, Ng GA, Ott C, Schmid M, Schmieder RE, Sobotka PA, Balmforth P, Luitjens SF, Sobotka PA, Smits G, Leiter J, Block C, Pinto D, Deaton DH: (2015) Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial. Lancet. 2015;385(9978): 1634-41
Vonend O, Böhm M, Eckert S, Hausberg M, Rittger H, Rump LC, Schmieder R, Schulte KL, Schunkert H, Uder M, Veelken R, Vorwerk D, Weil J, Wenzel U, Mahfoud F: (2015) [Renal denervation in refractory hypertension: joint statement of the German hypertension league DHL eV and the German societies of cardiology, angiology, nephrology and radiology]. Dtsch Med Wochenschr. 2015;140(5): 363
Böhm M, Schumacher H, Leong D, Mancia G, Unger T, Schmieder R, Custodis F, Diener HC, Laufs U, Lonn E, Sliwa K, Teo K, Fagard R, Redon J, Sleight P, Anderson C, O'Donnell M, Yusuf S: (2015) Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk. Hypertension. 2015;65(3): 651-61
Schmieder RE: (2015) Managing Treatment-Resistant Patients. High Blood Press Cardiovasc Prev. 2015;22 Suppl 1(): 11-3
Ott C, Schmieder RE: (2015) Renal Denervation for Resistant Hypertension: Past, Present, and Future. Curr Hypertens Rep. 2015;17(8): 65
Schmieder RE, Potthoff SA, Bramlage P, Baumgart P, Mahfoud F, Buhck H, Ouarrak T, Ehmen M, Senges J, Gitt AK, EARLY Registry Group: (2015) Patients With Newly Diagnosed Hypertension Treated With the Renin Angiotensin Receptor Blocker Azilsartan Medoxomil vs Angiotensin-Converting Enzyme Inhibitors: The Prospective EARLY Registry. J Clin Hypertens (Greenwich). 2015;17(12): 947-53
Bakris GL, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Kolkhof P, Joseph A, Pieper A, Kimmeskamp-Kirschbaum N, Ruilope LM, Mineralocorticoid Receptor Antagonist Tolerability Study-Diabetic Nephropathy (ARTS-DN) Study Group , Polkinghorne K, McMachon L, Packham D, Walker R, Pedagogos E, Isbel N, Pollock C, Sunder-Plassmann G, Schnack C, Prager R, Balcke P, Rosenkranz A, Paulweber B, Weitgasser R, Mayer G, Temelkova N, Nonchev B, Vasileva S, Prakova Z, Rashkov R, Hristozov K, Klyuchkova N, Slavyanov V, Chow S, Ting R, Pichette V, Elliott T, Steele A, Desmeules S, Tobe S, Jolly S, Tildesley H, Pelikanova T, Pelikanova M, Hradec J, Prazny M, Lacnak B, Dellanna F, Kasperk C, Behnke T, Reschke K, StemLer L, Haller H, Tschöpe D, Poulsen P, Pedersen E, Rasmussen O, Rossing P, Faber J, Berum K, Roseva-Nielsen N, Thosteinsson B, Strand J, Mäkelä S, Kantola I, Strandberg T, Koistinen A, Choukroun G, Fauvel JP, Thervet E, Zaoui P, Rieu P, Moulin B, Chow WS, Ozaki R, Fulop T, Harcsa E, Kerenyi Z, Kesmarki N, Kiss J, Tabak A, Mosenzon O, Yagil Y, Wainstein J, Minuchin O, Ben Chetrit S, Van Dijk DJ, Jaffe A, Levin-Iaina N, Wainstein J, Perico N, Trevisan R, Bevilacqua M, Teatini U, Pisani A, Avogaro A, De Cosmo S, Pani A, Del Prato S, Scanziani R, Bossi CA, Cha BS, Kim I, Yoon KH, Gansevoort R, Kooy A, Lieverse A, Schaper N, Alhakim M, Selsås H, Finnes T, Loba J, Napora P, Sciborski R, Polaszewska-Muszynska M, Górska M, Mosiewicz J, Jedynasty K, Bandurska-Stankiewicz E, Nolasco F, Carrilho F, Teixeira F, Lourenço A, Silva AP, Bayat J, Dulabh R, Ellis G, Engelbrecht J, Jurgens J, Lakha D, Mitha E, Nortje H, Omar M, RamLachan P, Ranjith N, Sarvan M, Trokis J, van Zyl L, Wing J, Fernández PG, Deben FM, Izuel JM, Albarrán OG, Calero F, Vallès i Prats M, de la Morena JJ, Oskarsson P, Tengmark BO, Beling E, Liu B, Wehlou M, Jasinska E, Jendle J, Ramsauer B, Torstensson I, Wu KD, Yang WC, Wu MS, Lee CT, Acosta I, Arif A, Belo D, Cherlin R, Coca S, El-Shahawy M, Fogelfeld L, Molitch M, Moustafa M, Nassar G, Raskin P, Solomon R, Spinowitz B, Warnock D, Zeig S, Tumlin J: (2015) Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial. JAMA. 2015;314(9): 884-94
Jumar A, Ott C, Kistner I, Friedrich S, Schmidt S, Harazny JM, Schmieder RE: (2015) Effect of aliskiren on vascular remodelling in small retinal circulation. J Hypertens. 2015;33(12): 2491-9
Schmieder RE, Fronk E, Alexandre AF, Bramlage P: (2015) Quality Of Life And Emotional Impact Of A Fixed Dose Combination Of Antihypertensive Drugs In Patients With Uncontrolled Hypertension. Value Health. 2015;18(7): A397
Schmieder RE, Ott C, Veelken R, Schmid A, Uder M, Toennes SW: (2015) 7B.01: FINAL ANALYSIS ON ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN TREATMENT RESISTANT HYPERTENSION (TRH) UNDERGOING RENAL DENERVATION (RDN). J Hypertens. 2015;33 Suppl 1(): e92
Bramlage P, Schmieder RE, Gitt AK, Baumgart P, Mahfoud F, Buhck H, Ouarrak T, Ehmen M, Potthoff SA, EARLY Registry Group: (2015) The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry. Trials. 2015;16(1): 581
Lobo MD, Sobotka PA, Dolan E, Witkowski A, Schmieder RE, ROX CONTROL HTN Investigators: (2015) Central arteriovenous anastomosis and hypertension - Authors' reply. Lancet. 2015;386(10006): 1821-2
Kistner I, Ott C, Jumar A, Friedrich S, Grosso R, Siegl C, Schmieder RE, Janka R: (2015) 1D.09: APPLICABILITY OF MEASUREMENT OF RENAL PERFUSION USING 1.5 TESLA MRI ARTERIAL SPIN LABELLING. J Hypertens. 2015;33 Suppl 1(): e17
Mennini FS, Marcellusi A, von der Schulenburg JM, Gray A, Levy P, Sciattella P, Soro M, Staffiero G, Zeidler J, Maggioni A, Schmieder RE: (2015) Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country. Eur J Health Econ. 2015;16(8): 909-11
Prejbisz A, Harazny J, Szymanek K, Binczyk E, Gosk-Przybylek M, Szaflik J, Kasperlik-Zaluska A, Peczkowska M, Otto M, Kabat M, Warchol-Celinska E, Eisenhofer G, Narkiewicz K, Szaflik J, Schmieder RE, Januszewicz A: (2015) 7D.07: RETINAL ARTERIOLAR STRUCTURE IN PATIENTS WITH PHEOCHROMOCYTOMA. J Hypertens. 2015;33 Suppl 1(): e102
Gosk-Przybylek M, Harazny J, Binczyk E, Szymanek K, Prejbisz A, Szaflik J, Kolodziejczyk-Kruk S, Pregowska-Chwala B, Makowiecka-Ciesla M, Janas J, Kadziela J, Warchol-Celinska E, Ambroziak U, Bednarczuk T, Toutounchi S, Narkiewicz K, Reincke M, Szaflik J, Schmieder RE, Januszewicz A: (2015) 7D.11: RETINAL ARTERIOLAR STRUCTURE IN PATIENTS WITH PRIMARY ALDOSTERONISM. J Hypertens. 2015;33 Suppl 1(): e103
Mahfoud F, Linz D, Mancia G, Narkiewicz K, Ruilope LM, Schlaich MP, Schmieder RE, Williams B, Böhm M: (2015) 8B.04: RENAL ARTERY DENERVATION FOR TREATMENT OF HYPERTENSIVE PATIENTS WITH OR WITHOUT OBSTRUCTIVE SLEEP APNEA AND RESISTANT HYPERTENSION: RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY. J Hypertens. 2015;33 Suppl 1(): e108
Mancia G, Mahfoud F, Narkiewicz K, Ruilope LM, Schlaich MP, Schmieder RE, Williams B, Böhm M: (2015) 4A.01: LONG-TERM EFFECTS OF RENAL ARTERY DENERVATION IN REAL WORLD PATIENTS WITH UNCONTROLLED HYPERTENSION FROM THE GLOBAL SYMPLICITY REGISTRY. J Hypertens. 2015;33 Suppl 1(): e49
Schmieder RE, Ott C, Lobo MD, Sobotka PA, Mahfoud F, Rox, Control Htn Investigators: (2015) LB02.02: EFFECT OF ARTERIOVENOUS ANASTOMOSIS ON BLOOD PRESSURE REDUCTION IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION COMPARED TO COMBINED HYPERTENSION. J Hypertens. 2015;33 Suppl 1(): e85
Ruilope LM, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Ferreira AC, Pieper A, Kimmeskamp-Kirschbaum N, Bakris GL: (2014) Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy. Am J Nephrol. 2014;40(6): 572-81
Schutte R, Schmieder RE, Huisman HW, Smith W, van Rooyen JM, Fourie CM, Kruger R, Uys L, Ware L, Mels CM, Greeff M, Kruger IM, Schutte AE: (2014) Urinary albumin excretion from spot urine samples predict all-cause and stroke mortality in africans. Am J Hypertens. 2014;27(6): 811-8
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F: (2014) 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press. 2014;23(1): 3-16
Ott C, Raff U, Schmidt S, Kistner I, Friedrich S, Bramlage P, Harazny JM, Schmieder RE: (2014) Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes. Cardiovasc Diabetol. 2014;13(): 19
Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M: (2014) Response to letter regarding article, "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension". Circulation. 2014;129(20): e500-1
Bramlage P, Ketelhut R, Fronk EM, Wolf WP, Smolnik R, Zemmrich C, Schmieder RE: (2014) Clinical impact of patient adherence to a fixed-dose combination of olmesartan, amlodipine and hydrochlorothiazide. Clin Drug Investig. 2014;34(6): 403-11
Schneider MP, Schneider A, Jumar A, Kistner I, Ott C, Schmieder RE: (2014) Effects of folic acid on renal endothelial function in patients with diabetic nephropathy: results from a randomized trial. Clin Sci (Lond). 2014;127(7): 499-505
Schmieder RE, Volpe M, Waeber B, Ruilope LM: (2014) A guide for easy- and difficult-to-treat hypertension. Int J Cardiol. 2014;172(1): 17-22
Ott C, Mahfoud F, Schmid A, Ditting T, Veelken R, Ewen S, Ukena C, Uder M, Böhm M, Schmieder RE: (2014) Improvement of albuminuria after renal denervation. Int J Cardiol. 2014;173(2): 311-5
Bramlage P, Zemmrich C, Gansz A, Sturm CD, Fimmers R, Nadal J, Schmieder RE, Schrader J, Lüders S: (2014) Daytime systolic ambulatory blood pressure with a two-step switch from candesartan to olmesartan monotherapy and the fixed-dose combination of olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-2). J Clin Hypertens (Greenwich). 2014;16(1): 41-6
Campbell NR, Lackland DT, Chockalingam A, Lisheng L, Harrap SB, Touyz RM, Burrell LM, Ramírez AJ, Schmieder RE, Schutte AE, Prabhakaran D, Schiffrin EL, Executive Board of the World Hypertension League: , Executive Committee of the International Society of Hypertension:: (2014) The International Society of Hypertension and World Hypertension League call on governments, nongovernmental organizations and the food industry to work to reduce dietary sodium. J Hypertens. 2014;32(2): 446-7
Schmieder RE: (2014) Hypertension: How should data from SYMPLICITY HTN-3 be interpreted? Nat Rev Cardiol. 2014;11(7): 375-6
Veelken R, Schmieder RE: (2014) Renal denervation-implications for chronic kidney disease. Nat Rev Nephrol. 2014;10(6): 305-13
Rothuizen TC, Ocak G, Verschuren JJ, Dekker FW, Rabelink TJ, Jukema JW, Rotmans JI, Silva V, Raimann JG, Grassmann A, Marcelli D, Usvyat L, Canaud B, Kotanko P, Pecoits-Filho R, Consortium M, ORAL-D Investigators , Strippoli GF, Sue YM, Tang CH, Chen TH, Hong CY, Ochi A, Ishimura E, Masuda M, Tsujimoto Y, Okuno S, Tabata T, Nishizawa Y, Inaba M, Moon Ki H, Do Hyoung K, Min Jee H, Hyun K, Wang Soo L, Su-Hyun K, Selim G, Stojceva-Taneva O, Tozija L, Dzekova-Vidimliski P, Trajceska L, Gelev S, Amitov V, Petronievic Z, Sikole A, Kee YK, Kim YL, Han JH, Oh HJ, Park JT, Han SH, Yoo TH, Kang SW, Okute Y, Shoji T, Sonoda M, Kuwamura Y, Tsujimoto Y, Tabata T, Shioi A, Tahara H, Emoto M, Inaba M, El Amrani M, Asserraji M, Benyahia M, Galloway PA, Yiu V, Hiemstra TF, Nilssen C, Zannad F, Jardine A, Schmieder R, Fellstrøm B, Holdaas H, Mjoen G, AURORA Study Group , Eftimovska-Otovic N, Babalj-Banskolieva E, Bogdanoska-Kostadinoska S, Grozdanovski R, Silva BC, Freitas GR, Silva VB, Abensur H, Luders C, Pereira BJ, Castro MC, Oliveira RB, Moyses RM, Elias RM, Pérez De José A, Abad S, Vega A, Reque J, Quiroga B, López-Gómez JM, Sasaki K, Yamguchi K, Hesaka A, Iwahashi E, Sakai S, Fujimoto T, Minami S, Fujita Y, Yokoyama K, Kidir V, Ersoy I, Altuntas A, Inal S, Do?an A, Sezer MT, Azar H, Chacra D, Dabar G, Chelala D, Zhao L, Huang S, Liang T, Tang H, Turkmen K, Demirtas L, Akbas EM, Buyuklu M, Bakirci E, Kocyigit I, Ozcelik O, Guney I, Mumajesi S, Velaj A, Idrizi A, Pasko N, Cadri V, Barbullushi M, Bolleku E, Strakosh A, Cenaj A, Kacori V, Zekollari E, Rista E, Dusha D, Belba A, Thereska N, Gelev S, Toshev S, Trajceska L, Pavleska S, Selim G, Dzekova P, Shikole A, Næss H, Fellstrøm B, Jardine AG, Schmieder RE, Zannad F, Holdaas H, AURORA Study Group , Sasaki K, Yamguchi S, Hesaka A, Iwahashi E, Sakai S, Fujimoto T, Minami S, Fujita Y, Yokoyama K, Bilevich O, Bunova S, Semchenko S, Schwermer K, Hoppe K, Klysz P, Baum E, Sikorska D, Radziszewska D, Sawatiuk P, Olejniczak P, Pawlaczyk K, Lindholm B, Oko A, El Amrani M, Asserraji M, Rbaibi A, El Kharass A, Benyahia M, Rroji Molla M, Seferi S, Cafka M, Spahia N, Likaj E, Thereska N, Barbullushi M, Pelletier CC, Jolivot A, Kalbacher E, Panaye M, Bureau Du Colombier P, Juillard L, Burmeister JE, Mosmann CB, Bastos JP, Burmeister BO, Munaro G, Pereira JD, Youssef DW, Rosito GA: (2014) Dialysis cardiovascular complications 2. Nephrol Dial Transplant. 2014;29 Suppl 3(): iii481-iii490
Hoye NA, Baldi JC, Jardine DL, Wilkins GT, Wilson LC, Walker RJ, Dores H, Branco P, Silva Sousa H, Carvalho MS, Gonçalves P, Almeida M, Andrade MJ, Gaspar MA, Pereira M, Barata JD, Mendes M, Ott C, Mahfoud F, Schmid A, Ditting T, Veelken R, Ewen S, Ukena C, Uder M, Böhm M, Schmieder RE, Schmieder RE, Mahfoud F, Schmid A, Ditting T, Veelken R, Uder M, Böhm M, Ott C, Vink EE, Verloop WL, Spiering W, Vonken EJ, Leiner T, Bots ML, Voskuil M, Blankestijn PJ: (2014) Renal denervation. Nephrol Dial Transplant. 2014;29 Suppl 3(): iii9-iii10
Esler MD, Böhm M, Sievert H, Rump CL, Schmieder RE, Krum H, Mahfoud F, Schlaich MP: (2014) Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial. Eur Heart J. 2014;35(26): 1752-9
Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Wang H, Zhang Y, Zhang X, Guan TR, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Erdine S, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G: (2014) Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence. J Hypertens. 2014;32(9): 1741-50
Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Wang H, Zhang Y, Zhang X, Guan TR, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Erdine S, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G: (2014) Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomize J Hypertens. 2014;32(9): 1888-97
Schwenger V, Remppis BA, Westenfeld R, Weinreich T, Brunkhorst R, Schieren G, Krumme B, Haller H, Schmieder R, Schlieper G, Frye B, Hoppe UC, Hoyer J, Keller T, Blumenstein M, Schunkert H, Mahfoud F, Rump LC: (2014) [Dialysis and ultrafiltration therapy in patients with cardio-renal syndrome: recommendations of the working group "heart-kidney" of the German Cardiac Society and the German Society of Nephrology]. Dtsch Med Wochenschr. 2014;139(7): e1-8
Pathak A, Ewen S, Fajadet J, Honton B, Mahfoud F, Marco J, Schlaich M, Schmieder R, Tsioufis K, Ukena C, Zeller T: (2014) From SYMPLICITY HTN-3 to the Renal Denervation Global Registry: where do we stand and where should we go? EuroIntervention. 2014;10(1): 21-3
Campbell N, Lackland D, Chockalingam A, Lisheng L, Schiffrin EL, Harrap S, Touyz RM, Burrell L, Ramírez A, Schmieder R, Aletta S, Prabhakaran D: (2014) The World Hypertension League and International Society of Hypertension call on governments, nongovernmental organizations, and the food industry to work to reduce dietary sodium. J Clin Hypertens (Greenwich). 2014;16(2): 99-100
Foulquier S, Böhm M, Schmieder R, Sleight P, Teo K, Yusuf S, Schumacher H, Unger T: (2014) Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: a Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysis. J Hypertens. 2014;32(6): 1334-41
Harazny JM, Ott C, Raff U, Welzenbach J, Kwella N, Michelson G, Schmieder RE: (2014) First experience in analysing pulsatile retinal capillary flow and arteriolar structural parameters measured noninvasively in hypertensive patients. J Hypertens. 2014;32(11): 2246-52; discussion 2252
Ott C, Schmieder RE: (2014) Invasive treatment of resistant hypertension: present and future. Curr Hypertens Rep. 2014;16(11): 488
Schmieder RE, Schmidt ST, Riemer T, Dechend R, Hagedorn I, Senges J, Messerli FH, Zeymer U: (2014) Disproportional decrease in office blood pressure compared with 24-hour ambulatory blood pressure with antihypertensive treatment: dependency on pretreatment blood pressure levels. Hypertension. 2014;64(5): 1067-72
Zeymer U, Dechend R, Riemer T, Kaiser E, Senges J, Pittrow D, Schmieder RE, 3A Registry Investigators: (2014) 1-Year outcomes of hypertension management in 13,000 outpatients under practice conditions: Prospective 3A registry. Int J Cardiol. 2014;176(3): 589-94
Raff U, Ott C, Ruilope LM, Menne J, Haller H, Schmieder RE: (2014) Prevention of electrocardiographic left ventricular remodeling by the angiotensin receptor blocker olmesartan in patients with type 2 diabetes. J Hypertens. 2014;32(11): 2267-76; discussion 2276
Schmieder RE: (2014) Renal denervation-a valid treatment option despite SYMPLICITY HTN-3. Nat Rev Cardiol. 2014;11(11): 638
Schmieder RE, Schutte R, Schumacher H, Böhm M, Mancia G, Weber MA, McQueen M, Teo K, Yusuf S, ONTARGET/TRANSCEND Investigators: (2014) Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studies. Diabetologia. 2014;57(10): 2019-29
Laurent S, Boutouyrie P, Vascular Mechanism Collaboration , Van Bortel L, Boutouyrie P, Laurent S, Pannier B, Zannad F, Schmieder R, Agabiti-Rosei E, Giannattasio C, Mancia G, Stehouwer C, Cockcroft J, Wilkinson I: (2014) Dose-dependent arterial destiffening and inward remodeling after olmesartan in hypertensives with metabolic syndrome. Hypertension. 2014;64(4): 709-16
Tschöpe D, Schmieder RE, Koch C, Bramlage P, Ouarrak T, Gitt AK: (2014) Achievement of individualised HbA(1c) treatment targets in patients with type 2 diabetes and comorbid hypertension in a real world setting: results of the DIALOGUE registry Diabetologia. 2014;57(1): S133-S133
Schmieder RE, Tschöpe D, Koch C, Bramlage P, Oarrak T, Gitt AK: (2014) Achievement of individualised blood pressure targets in patients with hypertension and comorbid type 2 diabetes in a real world setting: results of the DIALOGUE registry Diabetologia. 2014;57(1): S94-S95
Naess H, Fellström B, Jardine AG, Schmieder RE, Zannad F, Holdaas H, Mjoen G, Aurora Study Grp: (2014) RISK FACTORS FOR CARDIOVASCULAR EVENTS AND ALL-CAUSE MORTALITY IN DIABETIC HEMODIALYSIS PATIENTS Nephrol Dial Transplant. 2014;29 3(): 487-487
Waeber B, Volpe M, Ruilope LM, Schmieder RE: (2014) Diagnosis and treatment of resistant hypertension. Blood Press. 2014;23(4): 193-9
Kratz MT, Schumacher H, Sliwa K, Schmieder R, Pöss J, Mahfoud F, Unger T, Lonn E, Koon T, Mancia G, Sleight P, Yusuf S, Böhm M: (2014) Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients. Eur J Prev Cardiol. 2014;21(3): 272-80
Tsioufis Costas, Mahfoud Felix, Mancia Giuseppe, Redon Josep, Damascelli Bruno, Zeller Thomas, Schmieder RolandE: (2014) What the interventionalist should know about renal denervation in hypertensive patients: a position paper by the ESH WG on the interventional treatment of hypertension EuroIntervention. 2014;9(9): 27-35
Ott C, Mahfoud F, Schmid A, Ditting T, Veelken R, Ewen S, Ukena C, Uder M, Böhm M, Schmieder RE: (2014) IMPROVEMENT OF ALBUMINURIA AFTER RENAL DENERVATION Nephrol Dial Transplant. 2014;29 3(): 9-9
Hartner Andrea, Cordasic Nada, Klanke Bernd, Menendez-Castro Carlos, Veelken Roland, Schmieder RolandE, Hilgers KarlF: (2014) Renal protection by low dose irbesartan in diabetic nephropathy is paralleled by a reduction of inflammation, not of endoplasmic reticulum stress Biochim Biophys Acta Mol Basis Dis. 2014;1842(4): 558-565
Schmieder RE, Mahfoud F, Schmid A, Ditting T, Veelken R, Ewen S, Ukena C, Uder M, Boehm M, Ott C: (2014) IMPROVEMENT OF ALBUMINURIA AFTER RENAL DENERVATION J Am Coll Cardiol. 2014;63 S(12): A2055-A2055
Schmieder RE, Mahfoud F, Schmid A, Ditting T, Veelken R, Uder M, Böhm M, Ott C: (2014) RENAL DENERVATION STOPS THE DECLINE OF RENAL FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND RESISTANT HYPERTENSION Nephrol Dial Transplant. 2014;29 3(): 10-10
Esler M, Krum H, Schlaich M, Böhm M, Schmieder RE: (2013) Renal Denervation via Catheter-Based Delivery of Radiofrequency Energy Significantly Reduces Blood Pressure in Subjects With Severe Treatment-Resistant Hypertension: Long-Term Results From the Symplicity HTN Clinical Trials Circulation. 2013;128 S(22): -
Schmieder RE, Ruilope LM, Haller H, Ott C, Ott C, Raff U, ROADMAP Trial Investigators: (2013) LV remodelling in patients with type 2 diabetes: determinants of the beneficial effect of olmesartan Diabetologia. 2013;56(1): S38-S38
Schneider MP, Ott C, Schmidt S, Kistner I, Friedrich S, Schmieder RE: (2013) Poor glycaemic control is related with increased nitric oxide activity within the renal circulation of patients with type 2 diabetes mellitus Diabetologia. 2013;56(1): S473-S473
Schmidt S, Schmieder RE, Dechend R, Riemer T, Hagedorn I, Zeymer U: (2013) Prognostic impact of treatment resistant hypertension on clinical events during 2-year follow-up in outpatients with diabetes and hypertension: results of the 3A Registry Diabetologia. 2013;56(1): S99-S99
Mahfoud F, Ukena C, Schmieder RE, Rump LC, Weil J, Schmidt M, Zeller T, Schlaich M, Esler M, Boehm M: (2013) Ambulatory blood pressure changes and predictors of response in patients undergoing renal sympathetic denervation Eur Heart J. 2013;34(1): 495-495
Ditting T, Rodionova K, Heinlein S, Fischer M, Reeh P, Tiegs G, Ott C, Schmieder RE, Freisinger W, Veelken R: (2013) Increased Intrarenal CGRP Release From Afferent Renal Nerves Is Accompanied By Decreased Afferent Electric Activity Hypertension. 2013;62 S(3): -
Freisinger W, Karl A, Ditting T, Heinlein S, Ott C, Hilgers KF, Schmieder RE, Linz P, Schatz J, Veelken R: (2013) Reduced Firing Activity of Afferent Renal Innervation in the 2kidney/1clip Model of Hypertension Hypertension. 2013;62 S(3): -
Esler MD, Krum H, Schlaich MP, Schmieder RE, Böhm M: (2013) Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial J Am Coll Cardiol. 2013;62 1(18): B19-B19
Mahfoud F, Mancia G, Schlaich MP, Narkiewicz K, Ruilope L, Williams B, Schmieder RE, Böhm M: (2013) Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry J Am Coll Cardiol. 2013;62 1(18): B19-B20
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F: (2013) The guidelines of ESH/ESC Guidelines for hypertension in 2013 Kardiol Pol. 2013;71 3(): S27-S116
Ritt M, Schwarz C, Bollheimer LC, Schmieder RE, Gassmann KG, Sieber CC: (2013) Frailty as clinically relevant Parameters in elderly Patients with arterial Hypertension - the FOHYP Study: Rationale and Study Design Z Gerontol Geriatr. 2013;46(1): 31-31
Schmieder RE: (2013) Update hypertension Der Diabetologe. 2013;9(5): 373-379
Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R, ONTARGET investigators , Yusuf S, Sleight P, Anderson C, Teo K, Copland I, Ramos B, Richardson L, Murphy J, Haehl M, Hilbrich L, Svaerd R, Martin K, Murwin D, Meinicke T, Schlosser A, Schmidt G, Creek R, Schumacher H, Distel M, Aubert B, Pogue J, Dyal L, Schmieder R, Unger T, Asmar R, Mancia G, Diaz R, Paolasso E, Piegas L, Avezum A, Dagenais G, Munoz E, Probstfield J, Weber M, Young J, Fagard R, Jansky P, Mallion J, Mann J, Böhm M, Eber B, Karatzas NB, Keltai M, Trimarco B, Verdecchia P, Maggioni A, Verheugt FW, Holwerda NJ, Ceremuzynski L, Budaj A, Ferreira R, Chazova I, Rydén L, Svendsen TL, Metsärinne K, Dickstein K, Fodor G, Commerford P, Redon J, Luescher TR, Oto A, Binbrek A, Parkhomenko A, Jennings G, Liu LS, Yu CM, Dans AL, Shah R, Kim JH, Chen JH, Chaithiraphan S, Cairns J, Wilhelmsen L, Chalmers J, Wittes J, Gent M, Hennekens CH, Dagenais G, Anderson N, Avezum A, Budaj A, Fodor G, Keltai M, Maggioni A, Mann J, Parkhomenko A, Yusoff K, Auger P, Bernstein V, Lonn E, Panju A, Anand I, Bigger JT, Linz P, Healey J, Held C, McGorrian C, Rokoss M, Villar J, Sleight P, Anderson C, Creek R, Dans A, Diaz R, Fagard R, Probstfield J, Svaerd R, Teo K, Unger T, Yusuf S, Teo K, Copland I, Ramos B, McDonald A, Pogue J, Dyal L, Afzal R, Zhao F, Yusuf S, Sleight P, Richardson L, Anderson C, Murphy J, Diaz R, Paolasso E, Ahuad Guerrero RA, Amuchastegui M, Baglivo HP, Bendersky M, Bono J, Bustos B, Caccavo A, Cartasegna LR, Castellanos CR, Cipullo MA, Crunger P, Cuneo CA, Focaccia M, Fuselli JJ, Hasbani E, Hominal MA, Humphreys J, Inserra F, Killinger CR, Kuschnir E, Majul CR, Manuale OD, Martinez G, Marzetti EM, Nordaby R, Orlandini AD, Pomposiello JC, Rodríguez GM, Salas J, Salomone OA, Sanchez RA, Serra C, Vico ML, Jennings GL, Amerena JV, Arnolda LF, Aroney GM, Aylward PE, Bladin CF, Bridgeman JC, Chambers BR, Corbett AJ, Crimmins DS, Cross DB, Davies L, Davis SM, Donnan GA, Eccleston DS, Frayne JH, Hendriks R, Herkes GK, Hill AT, Jeffery IM, Karrasch JA, Koshy G, Marwick TH, Owensby DA, Parsons MW, Rees DM, Russell A, Schwartz R, Singh B, Thompson PL, Waites JH, Walsh WF, Walters DL, Watts RW, Whelan AP, Böhm M, Eber BE, Bonelli JB, Dolliner P, Hohenecker JH, Steurer GS, Weihs WW, Fagard R, Bekaert I, Brohet C, Chaumont P, Cheron P, Crasset V, Degaute JP, Dendale P, Dujardin K, Elshot S, Hellemans S, Herssens M, Heyndrickx G, Laloux P, Lesseliers H, Noyens P, Quinonez M, Stammen F, Striekwold H, Thoeng J, Van Mieghem W, Vanhooren G, Vervoort G, Vrolix M, Wollaert B, Piegas L, Avezum A, Abrantes JA, Armaganijan D, Ayoub JC, Bodanese LC, Carvalho AC, Coutinho M, Esteves JP, Franco RJ, Jardim PC, Kerr Saraiva JF, Leães PE, Maia LN, Marin-Neto JA, Marino RL, Mion D, Moreira JR, Oigman W, Pedrosa RC, Pelloso EA, Plavnik FL, Polanczyk CA, Rabelo Á, Rassi S, Reis G, Ribeiro AB, Ribeiro JM, Rocha JC, Rossi PR, Santos RD, Tarastchuk JC, Villalón MN, Teo K, Dagenais G, Abramson B, Arnold M, Ashton T, Auger P, Bata I, Bayly K, Beauchef J, Bélanger A, Bernstein V, Bhargava R, Booth AW, Bose S, Boulianne M, Cameron M, Chan YK, Constance C, Costi P, Dion D, Douketis J, Fell D, Giannoccaro JP, Glanz A, Gosselin G, Gould D, Goulet S, Grondin F, Gupta M, Gyenes G, Heath JW, Heath VA, Hess A, Hiscock JG, Hoag G, Honos G, Imrie J, Kuritzky R, Lai C, Lalani A, Lamy A, LeBouthillier P, Lochnan H, Lonn E, Lubelsky B, Mackey A, Meunier M, Milot A, Mitchell LB, Nawaz S, Omichinski M, Panju A, Pilon C, Pilon D, Polasek P, Proulx G, Rebane T, Ricci AJ, Rupka DW, Sabbah É, Savard D, Sharma NK, Shu D, St Hilaire R, St Maurice F, Starra R, Sussex B, Szaky T, Talbot P, Tan KW, To TB, Tobe S, Tytus R, Vexler R, Whitsitt P, Woo V, Liu L, Bai X, Chen X, Feng J, Fu S, Ge Y, Gong L, He Z, Huang J, Jiang Y, Li L, Li QH, Liao Y, Lu Z, Lu F, Ma S, Niu F, Pan C, Qian F, Shi X, Sun N, Sun M, Sun G, Wang J, Wang S, Wang Y, Wu Z, Yan X, Yang X, Yang H, Ye X, Yuan S, Zhang T, Zhang C, Zhang F, Zhang S, Zhao D, Zheng B, Zhou HY, Zhou S, Zhu J, Jansky P, Dedek V, Dvorák J, Holaj R, Kotou? J, Pederzoliová E, Polak M, Povolný J, Smetana K, ?pác J, Svendsen TL, Götzsche L, Juhl HF, Koelendorf K, Lund P, Pedersen F, Perdersen OL, Pindborg T, Rasmussen LH, Rasmussen SL, Thygesen K, Tuxen C, Metsärinne K, Antikainen R, Jääskivi M, Kantola I, Kastarinen M, Kohonen-Jalonen P, Koistinen A, Lehmus E, Nuuttila R, Tuominen ML, Ylihärsilä H, Mallion J, Abenhaim N, Allix J, Boucher L, Bourgoin M, Boye A, Breton N, Cadinot D, Campagne A, Churet J, Constantin G, de Sainte Lorette E, El Sawy A, Etchegarray G, Farhat S, Lacoin F, Latte T, Magnani C, Pineau-Valenciennes D, Pithon M, Quéguiner A, Sicard J, Sorbe G, Taminau D, Vilarem H, Vogel JY, Ebert HH, Genth-Zotz S, Hermanns N, Holzer C, Minnich J, Schimkus D, Boehm M, Mann J, Brado B, Claus G, Dietz U, Griebenow R, Haak T, Hahn K, Hampel R, Heitzer H, Holle G, Horacek T, Jordan J, Klein C, Kolloch R, Ludewig S, Motz W, Muenzel T, Nast HP, Nauck M, Nebelsieck H, Rybak K, Samer H, Schaefer T, Scholze J, Schulze B, Schleppinghoff , Schmieder R, Schwaab B, Sechtem U, Sehnert W, Steinhagen-Thiessen E, Stenzel G, Trenkwalder P, Wedler B, Zippel J, Karatzas N, Achimastos A, Diamantopoulos E, Efstratopoulos A, Elisaf M, Karvounis H, Mentzikof D, Mytas D, Papadogiannis D, Pyrgakis V, Stefanadis C, Symeonidis D, Tsoukas A, Vogiatzis I, Voyaki S, Zamboulis C, Yu CM, Chan CK, Lam L, Lau YK, Sanderson J, Wong J, Wu EB, Yue CS, Keltai M, Czuriga I, Édes I, Farsang CS, Kalina Á, Karlócai K, Keltai K, Kozma M, László Z, Nagy V, Papp A, Polák GY, Préda I, Rónaszéki A, Sereg M, Simon K, Sonkodi S, Szegedi J, Timár S, Tóth K, Vándorfi GY, Vértes A, Feely J, Maher VM, Stanton AV, Sullivan P, Trimarco B, Verdecchia P, Maggioni A, Agabiti Rosei E, Ambrosio GB, Bentivoglio M, Branzi A, Cavallo Perin P, Chiariello M, Cirrincione V, Ferrari R, Gattobigio R, Giovannini E, Giugliano D, Lacchè A, Lauro R, Lembo G, Marchetti G, Moretti L, Pancaldi L, Partemi L, Pede S, Pettinati G, Reboldi G, Ricci R, Rosiello G, Rozza F, Sardone MG, Scabbia EV, Selvetella G, Tavazzi L, Terrosu P, Venco A, Vetrano A, Volpe M, Zilio G, Ismail T, Shah RP, Singaraveloo M, Wan Ahmad WA, Yusof Z, Yusoff K, Zainal Abidin I, Zambahari R, Munoz E, Diaz L, Pascoe-Gonzalez S, Arriaga Nava R, De La Peña Topete G, Elizondo Sifuentes LA, Hernández García HR, Illescas-Diaz J, Macías Islas MA, Noriega Arellano JA, Olvera Ruiz R, Parra Carrillo JZ, Velasco Sánchez G, Vidrio Velásquez M, Verheugt FW, Holwerda NJ, Basart DC, Boermans AJ, Bosker HA, Bouter KP, Buiks CP, de Backer WA, de Graaf J, Deppenbroek JH, Eefting FD, Gunneweg FC, Michels HR, Poldermans D, Schrijver G, Sedney MI, Slagboom T, Smilde JG, Storms GE, Tjon RM, van Bergen PF, van Doesburg GJ, van Kempen LH, van Mierlo HF, Veerman A, Vermetten FA, Wester A, Bagg W, Benatar J, Coxon RJ, Doughty RN, Friedlander DH, Luke RA, Nairn PL, Ratnasabapathy Y, Richards AM, Singh GP, Stewart RA, Troughton RW, White HD, Williams M, Wong SP, Dickstein K, Bogale N, Lier JO, Otterstad JE, Rønnevik PK, Skeie S, Walle PO, Dans AL, Abola MT, Añonuevo JC, Jaro JM, Marañon DR, Mendoza VL, Morales DR, Pacheco EP, Reyes EB, Roxas AA, Sedurante MB, Ceremuzynski L, Budaj A, Binio Z, Bronisz M, Buszman P, Czerski T, Dalkowski M, Gessek J, Gieroba A, Janik K, Janion M, Kawka-Urbanek T, Klabisz R, Krauze-Wielicka M, Malinowski S, Miekus P, Mormul J, Ogorek M, Opolski G, Skura M, Szpajer M, Tendera M, Waszyrowski T, Wierzchowiecki M, Zalska B, Ferreira R, Capucho R, Correia C, Cunha L, Ferro JM, Gama Ribeiro V, Gil V, Marques da Silva P, Oliveira Carrageta M, Sebra Gomes R, Veloso Gomes M, Chazova I, Ageev F, Belenkov Y, Ivleva A, Karpov Y, Shestakova M, Shlyakhto E, Shustov S, Sidorenko B, Chang HM, Kwok B, Fodor G, Dukát A, Gonsorcík J, Hranai M, Lietava J, Pella D, Rybar R, Ruffini L, Commerford P, Bonnici F, Brown B, Dalby AJ, Gibson GJ, Herbst L, King J, Klug E, Middle M, Naidoo D, Pretorius M, Podgorski G, Ranjith N, Silwa-Hahnle K, Theron H, Kim JH, Chae SC, Chung NS, Hong KP, Jeong MH, Kang HJ, Kim JJ, Kim MH, Seo HS, Shin EK, Redon J, Abellán J, Aranda P, Barrios V, Calvo C, De La Figuera M, De Teresa E, Durá R, Escobar F, Fernandez-Cruz F, Galve E, Garcia-Puig J, Gil-Extremera B, Gomis R, Gonzalez-Albarran O, González-Juanatey JR, Llacer A, López-Bescós L, Oliván J, Picó A, Pose A, Roca-Cusachs A, Ruilope LM, Rydén L, Alvång A, Boström PÅ, Dellborg M, Ericsson UB, Herlitz J, Juhlin T, Pedersen K, Sträng B, Sundqvist B, Tengmark BO, Ulvenstam G, Westerdahl B, Winberg L, Luescher TR, Baumgartner I, Dubach P, Gallino A, Moccetti T, Noll G, Nordmann A, Rickli H, Schläpfer H, Weber K, Chen JH, Chao TH, Chen CY, Cheng JJ, Chiou HC, Fu CC, Fu M, Lai WT, Li YH, Lien LM, Tsai CD, Wang JH, Yeh PS, Chaithiraphan S, Chantadansuwan T, Jirasirirojanakorn K, Krittayaphong R, Laothavorn P, Mahanonda N, Sitthisook S, Tanomsup S, Tansuphaswadikul S, Tatsanavivat P, Yamwong S, Oto A, Akin M, Caglar NT, Ergin A, Müderrisoglu H, Oguz A, Ongen Z, Sansoy V, Tetiker T, Uysal A, Parkhomenko A, Amosova E, Cherkasova O, Dykun Y, Dzyak G, Galystska A, Grishyna O, Jaremenko O, Kononenko L, Koval E, Kovalenko V, Netyazhenko V, Pertseva T, Prokhorov A, Radchenko G, Rudyk YU, Sirenko Y, Skarzhevsky A, Binbrek AS, Al Hajiri AA, Al Hatou E, Al-Sousi AA, Alomairi M, Wajib I, Sleight P, Adgey AA, Andrews R, Ball SG, Barer DH, Barnett AH, Bridges AB, Bryson V, Cowie AS, De Belder AJ, Donnelly R, Francis CM, Furnace J, Glen SK, Gough N, Heagerty AM, Jackson PR, Jackson SH, Joyce E, McEneaney DJ, Moriarty AJ, Murdoch DL, O'Hare JP, Penny WJ, Reid CJ, Tilley J, Vora JP, Webster J, Williams B, Probstfield J, Weber M, Young J, Ahmed I, Anand IS, Anderson JL, Aponte Pagán JS, Barzilay J, Basile JN, Bass PF, Blumenthal SS, Bommer WJ, Brautigam DF, Brown CD, Brown N, Byrum JD, Carr AA, Chinn J, Chiu D, Cho NR, Ciocon JO, Colón-Ortíz PJ, Cruz JB, Dachman WD, Dolson GM, Dorfman SG, Drummond W, East C, Eelani F, Ellison HS, Felicetta JV, Fishbach MH, Force RW, Giddings SJ, Goldberg MC, Goldman S, Gomez Adrover R, Goss SL, Graham SP, Granger CB, Greenspan MM, Grimm RH, Habib GB, Hagen MR, Hart PD, Hartney TJ, Henriquez MA, Holland JJ, Hoogwerf BJ, Hossfeld M, Jacobson AK, Jelley MJ, Jones TV, Kaplan RA, Karalis DG, Katz LA, Kereiakes DJ, Khan M, Kipperman RM, Kozinn MJ, Kozlowski JG, Lader EW, Landau C, Landzberg JS, Laughrun D, Lewis SJ, Liang CS, Limacher MC, Linz PE, Lo TS, Lopez-Arostegui F, Maddox RR, Mahrer PR, Maurer MS, McGuire DK, Mercando AD, Mersey JH, Meyer M, Mooss AN, Narayan P, Oparil S, Padhiar DN, Phillips AL, Prisant M, Qureshi N, Raghuwanshi MP, Randall RR, Retta TM, Ringrose RE, Rizvi AA, Rizvi MD, Saklayen MG, Sastrasinh S, Savani IK, Schlau A, Schultz HS, Schweiger MJ, Smith RD, Sosa-Padilla M, Streja D, Stuver TP, Subich DC, Sulak FC, Swagler WA, Taitano M, Tavarez-Valle JA, Taylor EM, Tuck ML, White WB, Wickemeyer WJ, Wiegmann TB, Zee PA, Zhao XQ: (2013) Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus. JAMA Intern Med. 2013;173(18): 1682-92
Erdine S, Redon J, Böhm M, Ferri C, Kolloch R, Kreutz R, Laurent S, Persu A, Schmieder RE: (2013) Are physicians underestimating the challenges of hypertension management? Results from the Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey. Eur J Prev Cardiol. 2013;20(5): 786-92
Schmieder RE, Lehmann MV, Schmidt S: (2013) Optimizing blood pressure control in hypertension: The need to use ABPM. Blood Press. 2013;22(2): 65-72
Ott C, Raff U, Schneider MP, Titze SI, Schmieder RE: (2013) 25-Hydroxyvitamin D insufficiency is associated with impaired renal endothelial function and both are improved with rosuvastatin treatment. Clin Res Cardiol. 2013;102(4): 299-304
Mahfoud F, Böhm M, Rump LC, Vonend O, Schmieder RE, Kintscher U: (2013) Catheter-Based Renal Nerve Ablation and Centrally Generated Sympathetic Activity in Difficult-to-Control Hypertensive Patients: Prospective Case Series. Hypertension. 2013;61(2): e17
Kopp C, Linz P, Dahlmann A, Hammon M, Jantsch J, Muller DN, Schmieder RE, Cavallaro A, Eckardt KU, Uder M, Luft FC, Titze J: (2013) 23Na Magnetic Resonance Imaging-Determined Tissue Sodium in Healthy Subjects and Hypertensive Patients. Hypertension. 2013;61(3): 635-40
Schneider A, Jardine AG, Schneider MP, Holdaas H, Holme I, Fellstroem BC, Zannad F, Schmieder RE: (2013) Determinants of Cardiovascular Risk in Haemodialysis Patients: Post hoc Analyses of the AURORA Study. Am J Nephrol. 2013;37(2): 144-51
Ott C, Schneider MP, Raff U, Ritt M, Striepe K, Alberici M, Schmieder RE: (2013) Effects of manidipine vs. amlodipine on intrarenal haemodynamics in patients with arterial hypertension. Br J Clin Pharmacol. 2013;75(1): 129-35
Ott C, Janka R, Schmid A, Titze S, Ditting T, Sobotka PA, Veelken R, Uder M, Schmieder RE: (2013) Vascular and renal hemodynamic changes after renal denervation. Clin J Am Soc Nephrol. 2013;8(7): 1195-201
Ott C, Raff U, Harazny JM, Michelson G, Schmieder RE: (2013) Central pulse pressure is an independent determinant of vascular remodeling in the retinal circulation. Hypertension. 2013;61(6): 1340-5
Schlaich MP, Bart B, Hering D, Walton A, Marusic P, Mahfoud F, Böhm M, Lambert EA, Krum H, Sobotka PA, Schmieder RE, Ika-Sari C, Eikelis N, Straznicky N, Lambert GW, Esler MD: (2013) Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. Int J Cardiol. 2013;168(3): 2214-20
Lehmann MV, Zeymer U, Dechend R, Kaiser E, Hagedorn I, Deeg E, Senges J, Schmieder RE: (2013) Ambulatory blood pressure monitoring: Is it mandatory for blood pressure control in treated hypertensive patients?: Prospective observational study. Int J Cardiol. 2013;168(3): 2255-63
Schmieder RE, Grassi G, Kjeldsen SE: (2013) Patients with treatment-resistant hypertension report increased stress and anxiety: a worldwide study. J Hypertens. 2013;31(3): 610-5; discussion 615
Ritt M, Harazny JM, Schmidt S, Raff U, Ott C, Michelson G, Schmieder RE: (2013) Haemoglobin and vascular function in the human retinal vascular bed. J Hypertens. 2013;31(4): 775-81
Oliveras A, Schmieder RE: (2013) Clinical situations associated with difficult-to-control hypertension. J Hypertens. 2013;31 Suppl 1(): S3-8
Blessing E, Esler MD, Francis DP, Schmieder RE: (2013) Cardiac ablation and renal denervation systems have distinct purposes and different technical requirements. JACC Cardiovasc Interv. 2013;6(3): 314
Freisinger W, Schatz J, Ditting T, Lampert A, Heinlein S, Lale N, Schmieder R, Veelken R: (2013) Sensory renal innervation: a kidney-specific firing activity due to a unique expression pattern of voltage-gated sodium channels? Am J Physiol Renal Physiol. 2013;304(5): F491-7
Harazny JM, Schmieder RE, Welzenbach J, Michelson G: (2013) Local application of tropicamide 0.5% reduces retinal capillary blood flow. Blood Press. 2013;22(6): 371-6
Ott C, Schneider MP, Schmieder RE: (2013) Ruling out secondary causes of hypertension. EuroIntervention. 2013;9 Suppl R(): R21-8
Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Ruilope L, van de Borne P, Tsioufis C: (2013) Updated ESH position paper on interventional therapy of resistant hypertension. EuroIntervention. 2013;9 Suppl R(): R58-66
Gitt AK, Baumgart P, Bramlage P, Mahfoud F, Potthoff SA, Senges J, Schneider S, Buhck H, Schmieder RE, EARLY Registry Group: (2013) EARLY Treatment with azilsartan compared to ACE-inhibitors in anti-hypertensive therapy - rationale and design of the EARLY hypertension registry. BMC Cardiovasc Disord. 2013;13(1): 46
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F: (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension. Blood Press. 2013;22(4): 193-278
Schmid A, Ditting T, Sobotka PA, Veelken R, Schmieder RE, Uder M, Ott C: (2013) Does renal artery supply indicate treatment success of renal denervation? Cardiovasc Intervent Radiol. 2013;36(4): 987-91
Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M: (2013) Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation. 2013;128(2): 132-40
Ewen S, Ukena C, Linz D, Schmieder RE, Böhm M, Mahfoud F: (2013) The sympathetic nervous system in chronic kidney disease. Curr Hypertens Rep. 2013;15(4): 370-6
Authors/Task Force Members , Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, ESH Scientific Council , Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, ESC Committee for Practice Guidelines (CPG) , Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Document Reviewers , Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Rydén L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de Borne P, Vlachopoulos C, Volpe M, Wood DA: (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28): 2159-219
Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE: (2013) Renal denervation in moderate treatment-resistant hypertension. J Am Coll Cardiol. 2013;62(20): 1880-6
Schmieder RE, Ruilope LM, Ott C, Mahfoud F, Böhm M: (2013) Interpreting treatment-induced blood pressure reductions measured by ambulatory blood pressure monitoring. J Hum Hypertens. 2013;27(12): 715-20
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, List of authorsTask Force Members:: (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7): 1281-357
Friedrich S, Schmieder RE: (2013) Review of direct renin inhibition by aliskiren. J Renin Angiotensin Aldosterone Syst. 2013;14(3): 193-6
Bramlage P, Zemmrich C, Ketelhut R, Wolf WP, Fronk EM, Schmieder RE: (2013) Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice. Vasc Health Risk Manag. 2013;9(): 475-83
Brand E, Pavenstädt H, Schmieder RE, Engelbertz C, Fobker M, Pinnschmidt HO, Wegscheider K, Breithardt G, Reinecke H: (2013) The Coronary Artery Disease and Renal Failure (CAD-REF) registry: trial design, methods, and aims. Am Heart J. 2013;166(3): 449-56
Schneider MP, Ott C, Schmidt S, Kistner I, Friedrich S, Schmieder RE: (2013) Poor glycemic control is related to increased nitric oxide activity within the renal circulation of patients with type 2 diabetes. Diabetes Care. 2013;36(12): 4071-5
Schmieder RE: (2013) RELAX-AHF: consistency across subgroups and new hypotheses generated. Eur Heart J. 2013;34(40): 3100-1
Schlaich MP, Schmieder RE, Bakris G, Blankestijn PJ, Böhm M, Campese VM, Francis DP, Grassi G, Hering D, Katholi R, Kjeldsen S, Krum H, Mahfoud F, Mancia G, Messerli FH, Narkiewicz K, Parati G, Rocha-Singh KJ, Ruilope LM, Rump LC, Sica DA, Sobotka PA, Tsioufis C, Vonend O, Weber MA, Williams B, Zeller T, Esler MD: (2013) International expert consensus statement: percutaneous transluminal renal denervation for the treatment of resistant hypertension. J Am Coll Cardiol. 2013;62(22): 2031-45
Ott C, Schmieder RE: (2013) Blood pressure and retinal small arteries. J Hypertens. 2013;31(10): 1946-7
Böhm M, Schumacher H, Laufs U, Sleight P, Schmieder R, Unger T, Teo K, Yusuf S: (2013) Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease. Am Heart J. 2013;166(2): 306-314.e7
Böhm M, Mahfoud F, Ukena C, Bauer A, Fleck E, Hoppe UC, Kintscher U, Narkiewicz K, Negoita M, Ruilope L, Rump LC, Schlaich M, Schmieder R, Sievert H, Weil J, Williams B, Zeymer U, Mancia G: (2013) Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry. EuroIntervention. 2013;9(4): 484-92
Kjeldsen S, Mancia G, Schmieder R, Mattheus M, Unger T: (2013) An update on telmisartan/hydrochlorothiazide combinations for the management of hypertensive patients with additional cardiovascular risk factors. Expert Rev Cardiovasc Ther. 2013;11(6): 673-82
Zemmrich C, Lüders S, Gansz A, Sturm CD, Fimmers R, Nadal J, Schmieder RE, Schrader J, Bramlage P: (2013) Daytime Systolic Ambulatory Blood Pressure With a Direct Switch Between Candesartan Monotherapy and the Fixed-Dose Combination Olmesartan/Amlodipine in Patients With Uncontrolled Essential Hypertension (SEVICONTROL-1) J Clin Hypertens. 2013;15(11): 815-819
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F: (2013) 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) J Hypertens. 2013;31(10): 1925-1938
Schmieder RE, Mahfoud F, Schmid A, Ditting T, Sobotka P, Veelken R, Ukena C, Laufs U, Uder M, Böhm M, Ott C: (2013) HOW EFFECTIVE IS RENAL DENERVATION IN LESS SEVERE TREATMENT RESISTANT HYPERTENSION? J Am Coll Cardiol. 2013;61 S(10): E1385-E1385
Schmieder RE, Raff U: (2012) [Hypertensive crisis]. MMW Fortschr Med. 2012;154(8): 56-7
Schmieder RE, Bramlage P: (2012) [Diagnosis, implication, prevention and treatment of microalbuminuria]. Dtsch Med Wochenschr. 2012;137(27): 1409-16; quiz 1417-8
Ritt M, Harazny JM, Ott C, Raff U, Bauernschubert P, Lehmann M, Michelson G, Schmieder RE: (2012) Impaired increase of retinal capillary blood flow to flicker light exposure in arterial hypertension. Hypertension. 2012;60(3): 871-6
Dechend R, Kaiser E, Derer W, Deeg E, Busjahn A, Schmieder RE, Zeymer U: (2012) Guideline Adherence in Cardiovascular Risk Assessment and Analysis in 15,000 Hypertensive German Patients in Real Life: Results of the Prospective 3A Registry. J Clin Hypertens (Greenwich). 2012;14(8): 496-501
de Boer RA, Azizi M, Danser AJ, Nguyen G, Nussberger J, Ruilope LM, Schmieder RE, Volpe M: (2012) Dual RAAS suppression: recent developments and implications in light of the ALTITUDE study. J Renin Angiotensin Aldosterone Syst. 2012;13(3): 409-12
Ott C, Haetinger S, Schneider MP, Pauschinger M, Schmieder RE: (2012) Comparison of two noninvasive devices for measurement of central systolic blood pressure with invasive measurement during cardiac catheterization. J Clin Hypertens (Greenwich). 2012;14(9): 575-9
Schneider MP, Schmieder RE: (2012) Role of neuroendocrine activation for left ventricular hypertrophy in hypertension. J Hypertens. 2012;30(10): 1917-9
Ott C, Schmid A, Ditting T, Sobotka PA, Veelken R, Uder M, Schmieder RE: (2012) Renal denervation in a hypertensive patient with end-stage renal disease and small arteries: a direction for future research. J Clin Hypertens (Greenwich). 2012;14(11): 799-801
Gitt AK, Schmieder RE, Duetting E, Bramlage P, Schneider S, Tschöpe D, DIALOGUE Study Group*: (2012) Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice - study rationale and protocol of DIALOGUE. Cardiovasc Diabetol. 2012;11(): 148
Esler MD, Krum H, Schlaich M, Schmieder RE, Böhm M, Sobotka PA, for the Symplicity HTN-2 Investigators: (2012) Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension: One-Year Results From the Symplicity HTN-2 Randomized, Controlled Trial. Circulation. 2012;126(25): 2976-2982
Baumann M, Schmieder RE: (2012) [The role of retinal microcirculation in hypertension]. Dtsch Med Wochenschr. 2012;137(48): 2500-4
Kappert K, Böhm M, Schmieder R, Schumacher H, Teo K, Yusuf S, Sleight P, Unger T, ONTARGET/TRANSCEND Investigators: (2012) Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combinatio Circulation. 2012;126(8): 934-41
Mahfoud F, Cremers B, Janker J, Link B, Vonend O, Ukena C, Linz D, Schmieder R, Rump LC, Kindermann I, Sobotka PA, Krum H, Scheller B, Schlaich M, Laufs U, Böhm M: (2012) Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension. 2012;60(2): 419-24
Ruilope LM, Schmieder R: (2012) Current status of renal denervation in resistant hypertension. J Am Soc Hypertens. 2012;6(6): 414-6
Cholesterol Treatment Trialists' (CTT) Collaborators , Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R, Baigent C, de Lemos J, Braunwald E, Blazing M, Murphy S, Downs JR, Gotto A, Clearfield M, Holdaas H, Gordon D, Davis B, Koren M, Dahlof B, Poulter N, Sever P, Knopp RH, Fellström B, Holdaas H, Jardine A, Schmieder R, Zannad F, Goldbourt U, Kaplinsky E, Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Fuller J, Neil A, Wanner C, Krane V, Sacks F, Moyé L, Pfeffer M, Hawkins CM, Braunwald E, Kjekshus J, Wedel H, Wikstrand J, Barter P, Keech A, Tavazzi L, Maggioni A, Marchioli R, Tognoni G, Franzosi MG, Maggioni A, Bloomfield H, Robins S, Collins R, Armitage J, Keech A, Parish S, Peto R, Sleight P, Pedersen TR, Ridker PM, Holman R, Meade T, Simes J, Keech A, MacMahon S, Marschner I, Tonkin A, Shaw J, Serruys PW, Nakamura H, Knatterud G, Furberg C, Byington R, Macfarlane P, Cobbe S, Ford I, Murphy M, Blauw GJ, Packard C, Shepherd J, Kjekshus J, Pedersen T, Wilhelmsen L, Braunwald E, Cannon C, Murphy S, Collins R, Armitage J, Bowman L, Parish S, Peto R, Sleight P, Baigent C, Landray M, Collins R, La Rosa J, Rossouw J, Probstfield J, Shepherd J, Cobbe S, Macfarlane P, Ford I, Flather M, Kastelein J, Newman C, Shear C, Tobert J, Varigos J, White H, Yusuf S, Mellies M, McGovern M, Barclay J, Belder R, Mitchel Y, Musliner T, Ansquer JC, Llewellyn M, Bortolini M, Brandrup-Wognsen G, Bryzinski B, Olsson G, Pears J, DeMicco D, Baigent C, Barnes EH, Baxter A, Bhala N, Blackwell L, Buck G, Collins R, Emberson J, Herrington WG, Holland LE, Kearney PM, Keech A, Kirby A, Lewis DA, Marschner I, Pollicino C, Reith C, Simes J, Sourjina T: (2012) The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380(9841): 581-90
Cholesterol Treatment Trialists' (CTT) Collaboration , Emberson JR, Kearney PM, Blackwell L, Newman C, Reith C, Bhala N, Holland L, Peto R, Keech A, Collins R, Simes J, Baigent C, de Lemos J, Braunwald E, Blazing M, Murphy S, Downs JR, Gotto A, Clearfield M, Holdaas H, Gordon D, Davis B, Koren M, Dahlof B, Poulter N, Sever P, Knopp RH, Fellström B, Holdaas H, Jardine A, Schmieder R, Zannad F, Goldbourt U, Kaplinsky E, Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Fuller J, Neil A, Wanner C, Krane V, Sacks F, Moyé L, Pfeffer M, Hawkins CM, Braunwald E, Kjekshus J, Wedel H, Wikstrand J, Tavazzi L, Maggioni A, Marchioli R, Tognoni G, Franzosi MG, Maggioni A, Collins R, Armitage J, Keech A, Parish S, Peto R, Sleight P, Pedersen TR, Ridker PM, Simes J, Keech A, MacMahon S, Marschner I, Tonkin A, Shaw J, Serruys PW, Nakamura H, Knatterud G, Furberg C, Byington R, Macfarlane P, Cobbe S, Ford I, Murphy M, Blauw GJ, Packard C, Shepherd J, Kjekshus J, Pedersen T, Wilhelmsen L, Braunwald E, Cannon C, Murphy S, Collins R, Armitage J, Bowman L, Parish S, Peto R, Sleight P, La Rosa J, Shepherd J, Cobbe S, Macfarlane P, Ford I, Flather M, Kastelein J, Newman C, Shear C, Tobert J, Varigos J, White H, Yusuf S, Baxter A, Baigent C, Barnes EH, Bhala N, Blackwell L, Buck G, Collins R, Emberson J, Herrington WG, Holland LE, Kearney PM, Keech A, Kirby A, Lewis DA, Marschner I, Reith C, Simes J, Mellies M, McGovern M, Barclay J, Belder R, Mitchell Y, Musliner T, Ansquer JC, Llewellyn M, Bortolini M, Bryzinski B, Olsson G, Pears J, DeMicco D: (2012) Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS ONE. 2012;7(1): e29849
Holme I, Fellström BC, Jardin AG, Schmieder RE, Zannad F, Holdaas H: (2012) Prognostic model for total mortality in patients with haemodialysis from the Assessments of Survival and Cardiovascular Events (AURORA) study. J Intern Med. 2012;271(5): 463-71
Schneider MP, Janka R, Ziegler T, Raff U, Ritt M, Ott C, Veelken R, Uder M, Schmieder RE: (2012) Reversibility of the effects of aliskiren in the renal versus systemic circulation. Clin J Am Soc Nephrol. 2012;7(2): 258-64
Kopp C, Linz P, Wachsmuth L, Dahlmann A, Horbach T, Schöfl C, Renz W, Santoro D, Niendorf T, Muller DN, Neininger M, Cavallaro A, Eckardt KU, Schmieder RE, Luft FC, Uder M, Titze J: (2012) (23)Na magnetic resonance imaging of tissue sodium. Hypertension. 2012;59(1): 167-72
Ditting T, Freisinger W, Siegel K, Fiedler C, Small L, Neuhuber W, Heinlein S, Reeh PW, Schmieder RE, Veelken R: (2012) Tonic postganglionic sympathetic inhibition induced by afferent renal nerves? Hypertension. 2012;59(2): 467-76
Schneider MP, Ott C, Ritt M, Raff U, Schlaich MP, Schmieder RE: (2012) Postchallenge hyperglycemia is closely related with early vascular damage in overweight and obese patients. J Hypertens. 2012;30(1): 147-52
Breitscheidel L, Ehlken B, Kostev K, Oberdiek MS, Sandberg A, Schmieder RE: (2012) Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany. J Med Econ. 2012;15(1): 155-65
Ritt M, Harazny JM, Ott C, Raff U, Lehmann M, Michelson G, Schmieder RE: (2012) Influence of blood flow on arteriolar wall-to-lumen ratio in the human retinal circulation in vivo. Microvasc Res. 2012;83(2): 111-7
Manolis AJ, Rosei EA, Coca A, Cifkova R, Erdine SE, Kjeldsen S, Lip GY, Narkiewicz K, Parati G, Redon J, Schmieder R, Tsioufis C, Mancia G: (2012) Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension. J Hypertens. 2012;30(2): 239-252
Schmieder RE, Bramlage P, Schunkert H: (2012) [Chronobiology of blood pressure and chronopharmacotherapy of arterial hypertension]. Dtsch Med Wochenschr. 2012;137(7): 317-21
Raff U, Harazny JM, Titze SI, Schmidt BM, Michelson G, Schmieder RE: (2012) Salt intake determines retinal arteriolar structure in treatment resistant hypertension independent of blood pressure. Atherosclerosis. 2012;222(1): 235-40
Zolk O, Ott C, Fromm MF, Schmieder RE: (2012) Effect of the rs168924 Single-Nucleotide Polymorphism in the SLC6A2 Catecholamine Transporter Gene on Blood Pressure in Caucasians. J Clin Hypertens (Greenwich). 2012;14(5): 293-8
Frisoli TM, Schmieder RE, Grodzicki T, Messerli FH: (2012) Salt and hypertension: is salt dietary reduction worth the effort? Am J Med. 2012;125(5): 433-9
Mahfoud F, Ukena C, Pöss J, Bramlage P, Volpe M, Thoenes M, Schmieder R, Böhm M: (2012) Microalbuminuria independently correlates to cardiovascular comorbidity burden in patients with hypertension. Clin Res Cardiol. 2012;101(9): 761-6
Zeymer U, Dechend R, Deeg E, Kaiser E, Senges J, Pittrow D, Schmieder R, 3A Registry Investigators: (2012) Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry. Int J Clin Pract. 2012;66(3): 251-61
Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Ruilope L, van de Borne P, Tsioufis C: (2012) ESH position paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens. 2012;30(5): 837-41
Jordan J, Yumuk V, Schlaich M, Nilsson PM, Zahorska-Markiewicz B, Grassi G, Schmieder RE, Engeli S, Finer N: (2012) Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J Hypertens. 2012;30(6): 1047-1055
Schmieder RE, Ritt M: (2012) Wall-to-lumen ratio of retinal arterioles: a reproducible, valid and noninvasive approach for evaluation of early arteriolar changes in arterial hypertension in vivo. J Hypertens. 2012;30(6): 1108-10
Harazny J, Schmieder RE: (2012) Reliability of retinal microcirculation measurements by scanning laser Doppler flowmetry in humans. J Hypertens. 2012;30(6): 1266
Ott C, Schneider MP, Schlaich MP, Schmieder RE: (2012) Rosuvastatin improves pulse wave reflection by restoring endothelial function. Microvasc Res. 2012;84(1): 60-4
Schmieder RE, Goebel M, Bramlage P: (2012) Barriers to cardiovascular risk prevention and management in Germany - an analysis of the EURIKA study. Vasc Health Risk Manag. 2012;8(): 177-86
Schmieder RE, Böhm M: (2011) Efficacy and safety of olmesartan medoxomil plus amlodipine in age, gender and hypertension severity defined subgroups of hypertensive patients. J Hum Hypertens. 2011;25(6): 354-63
Schneider MP, Schlaich MP, Harazny JM, Raff U, Ritt M, Ott C, Schmieder RE: (2011) Folic Acid Treatment Normalizes NOS-Dependence of Vascular Tone in the Metabolic Syndrome. Obesity (Silver Spring). 2011;19(5): 960-7
Ritt M, Harazny JM, Ott C, Raff U, Schneider MP, Michelson G, Schmieder RE: (2011) Basal nitric oxide activity is an independent determinant of arteriolar structure in the human retinal circulation. J Hypertens. 2011;29(1): 123-9
Ott C, Schneider MP, Delles C, Schlaich MP, Schmieder RE: (2011) Reduction in Basal nitric oxide activity causes albuminuria. Diabetes. 2011;60(2): 572-6
Stumpf C, Auer C, Yilmaz A, Lewczuk P, Klinghammer L, Schneider M, Daniel WG, Schmieder RE, Garlichs CD: (2011) Serum levels of the Th1 chemoattractant interferon-gamma-inducible protein (IP) 10 are elevated in patients with essential hypertension. Hypertens Res. 2011;34(4): 484-8
Harazny JM, Raff U, Welzenbach J, Ott C, Ritt M, Lehmann M, Michelson G, Schmieder RE: (2011) New software analyses increase the reliability of measurements of retinal arterioles morphology by scanning laser Doppler flowmetry in humans. J Hypertens. 2011;29(4): 777-82
Uder M, Schmid A, Titze S, Schmieder RE: (2011) Renal artery denervation for the treatment of hypertension: opening up new horizons. Cardiovasc Intervent Radiol. 2011;34(3): 442-4
Schmieder RE, Bakris G, Weir MR: (2011) Telmisartan in incipient and overt diabetic renal disease. J Nephrol. 2011;24(3): 263-73
Ott C, Schneider MP, Delles C, Schlaich MP, Hilgers KF, Schmieder RE: (2011) Association of (pro)renin receptor gene polymorphism with blood pressure in Caucasian men. Pharmacogenet Genomics. 2011;21(6): 347-9
Schmieder RE, Ruilope LM, Barnett AH: (2011) Renal protection with angiotensin receptor blockers: where do we stand. J Nephrol. 2011;24(5): 569-80
Haller H, Ito S, Izzo JL, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G, ROADMAP Trial Investigators , Haller H, Viberti GC, Ito S, Izzo JL, Januszewicz A, Katayama S, Mimran A, Rabelink TJ, Remuzzi G, Ritz E, Ruilope LM, Rump LC, Staessen JA, Hedner T, Kuznetsova T, Narkiewicz K, Lange S, Clarke R, Thijs L, Heagerty AM, Petrie JE, Cifkova R, Toplak H, Prager R, Schernthaner G, van Gaal L, Giri M, Taelman P, Scheen A, Lamberigts G, Persu A, Tits J, Coucke F, Engelen W, Keymeulen B, Verhaegen WA, Goldstein M, Chachati A, Protich M, Christov V, Tankova T, Zacharieva S, Veleva N, Gotchev D, Dobreva D, Tsanova V, Donova T, Goudev A, Petkova M, Tisheva S, Dimitrova A, Slavcheva A, Vuchkova E, Mihov A, Hristozov K, Astl D, Bro? J, Drobník T, Jirka T, Galský J, Hausdorf P, Jansa P, Je?ábek O, Karen I, Krupicka J, Novák P, Pivar?iová V, Podzimek J, Pospí?il R, Psottová J, Siuda J, Urbanová R, Vondra K, Vo?enílková N, Zeman M, Zemanová V, Wernerová J, Linková H, Romanova H, Pomahacova H, Podar T, Lember M, Taim K, Lanno R, Kunder M, Marre M, Fauvel JP, Penfornis A, Zannad F, Ribstein J, Zaoui P, Halimi S, Marechaud R, Courreges JP, Geffray L, Halimi JM, Galland E, Bonnet AJ, Fajolles JF, Estour B, Gouet D, Pathak A, Lecomte P, Giacomino A, Humez D, Haller H, Schirmer M, Weber J, Ruhhammer L, Doumit A, Neumann E, Schmieder R, Strotmann HJ, Böhmer M, Becker B, Klausmann G, Eissfeller EF, Bögel M, Schöll N, Wagner W, Zimmermann A, Grosskopf W, Brillinger H, Reymann J, Simon-Wagner I, Wenzl-Bauer V, Faludi P, Takács J, Gurzó M, Oroszlán T, Fövényi J, Lippai J, Karadi L, Kovalok D, Szilagyi R, Genovese S, Cucinotta D, Cordera R, Pozzilli P, Squatrito S, Rosei EA, Pontiroli A, Ghigo E, Rasa I, Sokolova J, Stelmane I, Teterovska D, Pirags V, Storms GE, Verhoeven RP, Geelhoed-Duijvestijn PH, Lieverse AG, Smilde JG, van den Bergh JP, Feis WL, Boermans AJ, Mevissen HG, Fransen HJ, Costongs RJ, Oldenburg PC, Bierens IG, van Soest AJ, Ponikowski P, Januszewicz A, Pogorzelska H, Korzeniak R, Czech A, Pasierski T, Bandurska-Stankiewicz E, Gessek J, Kwiatkowska B, Deregowska PB, Kubalski , Doboszynska H, Sowinski D, Zytkiewicz-Jaruga D, Mazurek W, Loboz-Grudzien K, Niedzialek D, Kawecka-Jaszcz K, Ruzyllo W, Gniot A, Regulski M, Zgliczynski S, Grochowski J, Wojciechowski D, Mardarowicz G, Lewandowska-Stanek H, Helon H, Liszewska-Pfejfer D, Switalski M, Grzybowski J, Stepka M, Jeka S, Boavida JM, Constantin D, Mota M, Paveliu FS, Ranetti A, Ionescu-Tirgoviste C, Mindrescu N, Gorohovskaya G, Zadionchenko V, Ametov A, Nebieridze D, Kobalava Z, Gratsiansky N, Stryuk R, Volkova E, Kuzin A, Shoustov S, Shestakova M, Demidova I, Dvornikov V, Karpov Y, Chermysheva G, Glezer M, Bart B, Shih E, Konrady A, Krasilnikova E, Fedorova T, Chazova I, Konyakhin A, Zalevskaya A, Vertkin Vyortkin A, Jona? P, Sirotiakova J, Kmet M, Vargova A, ?omlo P, Tomasova L, Korecova M, Kuderova D, Teplanova M, Sisolakova O, Navratova D, Ruilope LM, Fernández-Cruz , Gil-Extremera B, Calvo C, González-Juanatey JR, Sobrino J, Divisón JA, Llisterri JL, Laporta F, García Nadal I, Aranda P, Sirenko Y, Amasova K, Bodnar P, Botsurko V, Dzjak G, Yena L, Korkushko O, Korpachev V, Rudyk Y, Kovalenko V, Lutaj M, Mankovsky B, Mitchenko E, Mostovoy Y, Nazar P, Pavlyk S, Pertseva T, Polivoda S, Yurievna VI, Samoylov A, Seredjuk N, Serhiyenko O, Stadnjuk L, Tseluyko V, Volkov V, Viberti G, Bladgen M, Tindall H, Bundy C, Wijnberg A, Chapman J, Idris I, Wyatt N, Rehman T, Page M, Cooper A, Cummings , Chattington P, Wyatt N, Khong T, Gallen , Rehman T, Wijenaike , Dayan , Page M, Cooper A: (2011) Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med. 2011;364(10): 907-17
Huchzermeyer C, Schaller B, Schmid K, Schmieder RE, Michelson G: (2011) [Comparison of Early Retinal Microvascular Changes and Microalbuminuria as Indicators for Increased Cardioascular Risk]. Klin Monatsbl Augenheilkd. 2011;228(11): 1003-8
Bramlage P, Wolf WP, Fronk EM, Stuhr T, Erdlenbruch W, Wasem J, Ketelhut R, Schmieder RE: (2011) [Fixed dose combination of an ARB calcium antagonist lowers blood pressure effectively and improves quality of life]. MMW Fortschr Med. 2011;153 Suppl (): 33-40
Holdaas H, Holme I, Schmieder RE, Jardine AG, Zannad F, Norby GE, Fellström BC, on behalf of the AURORA study group: (2011) Rosuvastatin in Diabetic Hemodialysis Patients. J Am Soc Nephrol. 2011;22(7): 1335-1341
Schneider MP, Leusen JH, Herrmann M, Garlichs CD, Amann K, John S, Schmieder RE: (2011) The Fc? receptor IIA R131H gene polymorphism is associated with endothelial function in patients with hypercholesterolaemia. Atherosclerosis. 2011;218(2): 411-5
Ott C, Schneider MP, Schmieder RE: (2011) Response to Comment on: Ott et al. Reduction in Basal Nitric Oxide Activity Causes Albuminuria. Diabetes 2011;60:572-576. Diabetes. 2011;60(8): e22
Schmieder RE, Mann JF, Schumacher H, Gao P, Mancia G, Weber MA, McQueen M, Koon T, Yusuf S, on behalf of the ONTARGET Investigators: (2011) Changes in Albuminuria Predict Mortality and Morbidity in Patients with Vascular Disease. J Am Soc Nephrol. 2011;22(7): 1353-1364
Schmieder RE, Schmidt BM, Raff U, Bramlage P, Dorfler A, Achenbach S, Schwab J, Kolominsky-Rabas P: (2011) Cerebral Microangiopathy in Treatment-Resistant Hypertension. J Clin Hypertens (Greenwich). 2011;13(8): 582-587
Grassi G, Schmieder RE: (2011) The renaissance of the retinal microvascular network assessment in hypertension: new challenges. J Hypertens. 2011;29(7): 1289-91
Redon J, Erdine S, Böhm M, Ferri C, Kolloch R, Kreutz R, Laurent S, Persu A, Schmieder RE, on behalf of the SHARE Steering Committee: (2011) Physician attitudes to blood pressure control: findings from the Supporting Hypertension Awareness and Research Europe-wide survey. J Hypertens. 2011;29(8): 1633-1640
Schneider MP, Schmidt BM, John S, Schmieder RE: (2011) Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels. J Hypertens. 2011;29(9): 1757-64
Schmieder RolandE, Schmidt BernhardMW, Raff Ulrike, Bramlage Peter, Doerfler Arnd, Achenbach Stephan, Schwab Johannes, Kolominsky-Rabas Peter: (2011) Cerebral Microangiopathy in Treatment-Resistant Hypertension J Clin Hypertens. 2011;13(8): 582-587
Lehmann MV, Schmieder RE: (2011) Remodeling of retinal small arteries in hypertension. Am J Hypertens. 2011;24(12): 1267-73
Frisoli TM, Schmieder RE, Grodzicki T, Messerli FH: (2011) Beyond salt: lifestyle modifications and blood pressure. Eur Heart J. 2011;32(24): 3081-7
Segura J, Cerezo C, Garcia-Donaire JA, Schmieder RE, Praga M, de la Sierra A, Ruilope LM: (2011) Validation of a therapeutic scheme for the treatment of resistant hypertension. J Am Soc Hypertens. 2011;5(6): 498-504
O'Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, Teo K, McQueen M, Sleight P, Sharma AM, Dans A, Probstfield J, Schmieder RE: (2011) Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA. 2011;306(20): 2229-38
Ukena C, Mahfoud F, Kindermann M, Gräber S, Kindermann I, Schneider M, Schmieder R, Bramlage P, Volpe M, Thoenes M, Böhm M: (2010) Smoking is associated with a high prevalence of microalbuminuria in hypertensive high-risk patients: data from I-SEARCH. Clin Res Cardiol. 2010;99(12): 825-32
Lüders S, Schrader J, Schmieder RE, Smolka W, Wegscheider K, Bestehorn K: (2010) Improvement of hypertension management by structured physician education and feedback system: cluster randomized trial. Eur J Cardiovasc Prev Rehabil. 2010;17(3): 271-9
Philipp T, Martinez F, Geiger H, Moulin B, Mourad G, Schmieder R, Lièvre M, Heemann U, Legendre C: (2010) Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. Nephrol Dial Transplant. 2010;25(3): 967-76
Ritt M, Janka R, Schneider MP, Martirosian P, Hornegger J, Bautz W, Uder M, Schmieder RE: (2010) Measurement of kidney perfusion by magnetic resonance imaging: comparison of MRI with arterial spin labeling to para-aminohippuric acid plasma clearance in male subjects with metabolic syndrome. Nephrol Dial Transplant. 2010;25(4): 1126-33
Stanton AV, Gradman AH, Schmieder RE, Nussberger J, Sarangapani R, Prescott MF: (2010) Aliskiren monotherapy does not cause paradoxical blood pressure rises: meta-analysis of data from 8 clinical trials. Hypertension. 2010;55(1): 54-60
Raff U, Schmidt BM, Schwab J, Schwarz TK, Achenbach S, Bar I, Schmieder RE: (2010) Renal resistive index in addition to low-grade albuminuria complements screening for target organ damage in therapy-resistant hypertension. J Hypertens. 2010;28(3): 608-14
Raff U, Schwarz TK, Schmidt BM, Schneider MP, Schmieder RE: (2010) Renal resistive index--a valid tool to assess renal endothelial function in humans? Nephrol Dial Transplant. 2010;25(6): 1869-74
Schmieder RE: (2010) The Role of Fixed-Dose Combination Therapy with Drugs that Target the Renin-Angiotensin System in the Hypertension Paradigm. Clin Exp Hypertens. 2010;32(1): 35-42
Kjeldsen SE, Schmieder RE, Unger T, Mancia G: (2010) Telmisartan and hydrochlorothiazide combination therapy for the treatment of hypertension. Curr Med Res Opin. 2010;26(4): 879-87
Schmieder RE: (2010) Angiotensin II-type 2 receptor: emerging target for cardiovascular protection. Am J Hypertens. 2010;23(3): 220
Mathes J, Kostev K, Gabriel A, Pirk O, Schmieder RE: (2010) Relation of the first hypertension-associated event with medication, compliance and persistence in naïve hypertensive patients after initiating monotherapy. Int J Clin Pharmacol Ther. 2010;48(3): 173-83
Baulmann J, Nürnberger J, Slany J, Schmieder R, Schmidt-Trucksäss A, Baumgart D, Cremerius P, Hess O, Mortensen K, Weber T: (2010) [Arterial stiffness and pulse wave analysis] Dtsch Med Wochenschr. 2010;135 Suppl (): S4-14
Raff U, Ott C, John S, Schmidt BM, Fleischmann EH, Schmieder RE: (2010) Nitric oxide and reactive hyperemia: role of location and duration of ischemia. Am J Hypertens. 2010;23(8): 865-9
Hummel D, Raff U, Schwarz TK, Schneider MP, Schmieder RE, Schmidt BM: (2010) Dihydropyridine calcium antagonists are associated with increased albuminuria in treatment-resistant hypertensives. J Nephrol. 2010;23(5): 563-8
Huber M, Völler H, Jakob S, Reibis R, Do V, Bolbrinker J, Zergibel I, Schmieder RE, Treszl A, Wegscheider K, Kreutz R: (2010) Role of the angiotensin II type 2 receptor gene (+1675G/A) polymorphism on left ventricular hypertrophy and geometry in treated hypertensive patients. J Hypertens. 2010;28(6): 1221-9
Schneider MP, Hua TA, Böhm M, Wachtell K, Kjeldsen SE, Schmieder RE: (2010) Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis. J Am Coll Cardiol. 2010;55(21): 2299-307
Olsen MH, Mallion JM, Rahn KH, Erdine S, Viigimaa M, Laurent S, Agabiti-Rosei E, Mancia G, Schmieder RE, Cifkova R, Dominiczak A, Kjeldsen SE, Redon J, Zanchetti A, Nilsson P, Narkiewicz K, ESH Council: (2010) Agreement within Europe about antihypertensive treatment and education - results from the European Society of Hypertension questionnaire. J Hypertens. 2010;28(7): 1593-4
Delles C, Schiffer E, von Zur Muhlen C, Peter K, Rossing P, Parving HH, Dymott JA, Neisius U, Zimmerli LU, Snell-Bergeon JK, Maahs DM, Schmieder RE, Mischak H, Dominiczak AF: (2010) Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals. J Hypertens. 2010;28(11): 2316-2322
Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F: (2010) Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis (vol 360, pg 1395, 2009) N Engl J Med. 2010;362(15): 1450-1450
Bramlage P, Wolf WP, Stuhr T, Fronk EM, Erdlenbruch W, Ketelhut R, Schmieder RE: (2010) Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice. Vasc Health Risk Manag. 2010;6(): 803-11
Schneider MP, Ott C, Raff U, Ritt M, Schmieder RE: (2010) Change in Augmentation Index during NOS Inhibition, an Index of Basal NO Production, Is an Independent Determinant of Large-Artery Function. Kidney Blood Press Res. 2010;33(5): 343-51
Bramlage P, Wolf WP, Fronk EM, Stuhr T, Erdlenbruch W, Wasem JX, Ketelhut R, Schmieder RE: (2010) Improving quality of life in hypertension management using a fixed-dose combination of olmesartan and amlodipine in primary care. Expert Opin Pharmacother. 2010;11(17): 2779-90
Maahs DM, Siwy J, Argilés A, Cerna M, Delles C, Dominiczak AF, Gayrard N, Iphöfer A, Jänsch L, Jerums G, Medek K, Mischak H, Navis GJ, Roob JM, Rossing K, Rossing P, Rychlík I, Schiffer E, Schmieder RE, Wascher TC, Winklhofer-Roob BM, Zimmerli LU, Zürbig P, Snell-Bergeon JK: (2010) Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology. PLoS ONE. 2010;5(9):
Bernhardt WM, Wiesener MS, Scigalla P, Chou J, Schmieder RE, Günzler V, Eckardt KU: (2010) Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J Am Soc Nephrol. 2010;21(12): 2151-6
Ritz E, Schmieder RE, Pollock CA: (2010) Renal protection in diabetes: lessons from ONTARGET. Cardiovasc Diabetol. 2010;9(): 60
Symplicity HTN-2 Investigators , Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M: (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376(9756): 1903-9
Schmieder RE: (2010) End organ damage in hypertension. Dtsch Arztebl Int. 2010;107(49): 866-73
Stumpf C, Jukic J, Yilmaz A, Raaz D, Schmieder RE, Daniel WG, Garlichs CD: (2009) Elevated VEGF-plasma levels in young patients with mild essential hypertension. Eur J Clin Invest. 2009;39(1): 31-6
Ritt M, Ott C, Raff U, Schneider MP, Schuster I, Hilgers KF, Schlaich MP, Schmieder RE: (2009) Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus. Am J Kidney Dis. 2009;53(2): 281-9
Schmieder RE, Philipp T, Guerediaga J, Gorostidi M, Smith B, Weissbach N, Maboudian M, Botha J, van Ingen H: (2009) Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide. Circulation. 2009;119(3): 417-25
Fellström B, Holdaas H, Jardine AG, Svensson MK, Gottlow M, Schmieder RE, Zannad F, AURORA Study Group: (2009) Cardiovascular disease in patients with renal disease: the role of statins. Curr Med Res Opin. 2009;25(1): 271-85
Hartner A, Klanke B, Cordasic N, Amann K, Schmieder RE, Veelken R, Hilgers KF: (2009) Statin treatment reduces glomerular inflammation and podocyte damage in rat deoxycorticosterone-acetate-salt hypertension. J Hypertens. 2009;27(2): 376-85
Ott C, Schmieder RE: (2009) The role of statins in the treatment of the metabolic syndrome. Curr Hypertens Rep. 2009;11(2): 143-9
Kohlmann O, Roca-Cusachs A, Laurent S, Schmieder RE, Wenzel RR, Fogari R: (2009) Fixed-dose manidipine/delapril versus losartan/hydrochlorothiazide in hypertensive patients with type 2 diabetes and microalbuminuria. Adv Ther. 2009;26(3): 313-24
Baleanu D, Ritt M, Harazny J, Heckmann J, Schmieder RE, Michelson G: (2009) Wall-to-lumen ratio of retinal arterioles and arteriole-to-venule ratio of retinal vessels in patients with cerebrovascular damage. Invest Ophthalmol Vis Sci. 2009;50(9): 4351-9
Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jennings GL: (2009) The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics. Clin Res Cardiol. 2009;98(7): 421-33
Schmieder RE, Nitschmann S: (2009) [Optimal therapy of diabetic nephropathy: AVOID Study (Aliskiren in the evaluation of proteinuria in diabetes)] Internist (Berl). 2009;50(7): 895-6
Schneider MP, Schmieder RE: (2009) Risk prediction in subjects with high-normal blood pressure. J Hypertens. 2009;27(6): 1126-8
Ritt M, Schmieder RE: (2009) Wall-to-lumen ratio of retinal arterioles as a tool to assess vascular changes. Hypertension. 2009;54(2): 384-7
Schmieder RE, Philipp T, Guerediaga J, Gorostidi M, Bush C, Keefe DL: (2009) Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial. J Hypertens. 2009;27(7): 1493-501
Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F, AURORA Study Group: (2009) Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360(14): 1395-407
Zanchetti A, Mancia G, Black HR, Oparil S, Waeber B, Schmieder RE, Bakris GL, Messerli FH, Kjeldsen SE, Ruilope LM: (2009) Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension. J Hypertens. 2009;27(4): 673-9
Schmieder RE, Veelken R: (2009) [Antihypertensive therapy] MMW Fortschr Med. 2009;151(14): 95-8; quiz 99
Deinzer A, Veelken R, Kohnen R, Schmieder RE: (2009) Is a shared decision-making approach effective in improving hypertension management? J Clin Hypertens (Greenwich). 2009;11(5): 266-70
Schneider MP, Ritt M, Raff U, Ott C, Schmieder RE: (2009) Gender is related to alterations of renal endothelial function in type 2 diabetes. Nephrol Dial Transplant. 2009;24(11): 3354-9
Schwab J, Schneider MP, Pauschinger M, Schmieder RE: (2009) [Hypertension and diastolic dysfunction] MMW Fortschr Med. 2009;151(23): 41-3
Mann JF, Schmieder RE, Dyal L, McQueen MJ, Schumacher H, Pogue J, Wang X, Probstfield JL, Avezum A, Cardona-Munoz E, Dagenais GR, Diaz R, Fodor G, Maillon JM, Rydén L, Yu CM, Teo KK, Yusuf S, TRANSCEND (Telmisartan Randomised Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease) Investigators: (2009) Effect of telmisartan on renal outcomes: a randomized trial. Ann Intern Med. 2009;151(1): 1-10, W1-2
Aksnes TA, Kjeldsen SE, Schmieder RE: (2009) Hypertension and atrial fibrillation with emphasis on prevention Blood Press. 2009;18(3): 94-98
Ritt M, Harazny JM, Ott C, Schneider MP, Schlaich MP, Michelson G, Schmieder RE: (2009) Wall-to-lumen ratio of retinal arterioles is related with urinary albumin excretion and altered vascular reactivity to infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine. J Hypertens. 2009;27(11): 2201-8
Verdecchia P, Sleight P, Mancia G, Fagard R, Trimarco B, Schmieder RE, Kim JH, Jennings G, Jansky P, Chen JH, Liu L, Gao P, Probstfield J, Teo K, Yusuf S, ONTARGET/TRANSCEND Investigators: (2009) Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Circulation. 2009;120(14): 1380-9
Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A: (2009) Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27(11): 2121-2158
Ott C, Ritt M, Titze SI, Schäufele T, Schmieder RE: (2009) Rosuvastatin does not affect intrarenal hemodynamics in patients with hypercholesterolemia. J Nephrol. 2009;22(5): 675-81
Schmieder RE, Martin S, Lang GE, Bramlage P, Böhm M: (2009) Angiotensin blockade to reduce microvascular damage in diabetes mellitus. Dtsch Arztebl Int. 2009;106(34-35): 556-62
Schmieder RE: (2009) Hypertension and Diabetes: what are the pros to treating early surrogates? Diabetes Care. 2009;32 Suppl 2(): S294-7
Schmieder RE, Schwertfeger M, Bramlage P: (2009) Significance of initial blood pressure and comorbidity for the efficacy of a fixed combination of an angiotensin receptor blocker and hydrochlorothiazide in clinical practice. Vasc Health Risk Manag. 2009;5(): 991-1000
Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A: (2009) Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press. 2009;18(6): 308-47
Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jennings GL, ONTARGET investigators: (2009) Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]). Am J Cardiol. 2009;104(11): 1484-9
Titze S, Uder M, Schmieder R: (2009) [Renal nerve ablation: innovative therapy for treatment of resistant hypertension] MMW Fortschr Med. 2009;151(42): 52-3
Muller DN, Klanke B, Feldt S, Cordasic N, Hartner A, Schmieder RE, Luft FC, Hilgers KF: (2008) (Pro)renin receptor peptide inhibitor "handle-region" peptide does not affect hypertensive nephrosclerosis in goldblatt rats. Hypertension. 2008;51(3): 676-81
Schlaich MP, Schmitt D, Ott C, Schmidt BM, Schmieder RE: (2008) Basal nitric oxide synthase activity is a major determinant of glomerular haemodynamics in humans. J Hypertens. 2008;26(1): 110-6
Zeltner R, Hilgers KF, Schmieder RE, Porst M, Schulze BD, Hartner A: (2008) A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease. Nephron Clin Pract. 2008;108(3): c169-75
Aksnes TA, Schmieder RE, Kjeldsen SE, Ghani S, Hua TA, Julius S: (2008) Impact of New-Onset Diabetes Mellitus on Development of Atrial Fibrillation and Heart Failure in High-Risk Hypertension (from the VALUE Trial). Am J Cardiol. 2008;101(5): 634-8
Schmieder RE, Kjeldsen SE, Julius S, McInnes GT, Zanchetti A, Hua TA, VALUE Trial Group: (2008) Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial. J Hypertens. 2008;26(3): 403-11
Ott C, Schlaich MP, Harazny J, Schmidt BM, Michelson G, Schmieder RE: (2008) Effects of angiotensin II type 1-receptor blockade on retinal endothelial function. J Hypertens. 2008;26(3): 516-22
Michelson G, Harazny J, Schmieder RE, Berendes R, Fiermann T, Wärntges S: (2008) Response to analysis of carotid and ophthalmic flow velocity waveforms Hypertension. 2008;51(3): E19-E19
Roca-Cusachs A, Schmieder RE, Triposkiadis F, Wenzel RR, Laurent S, Kohlmann O, Fogari R, MORE Study Group: (2008) Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes. J Hypertens. 2008;26(4): 813-8
Schneider MP, Delles C, Klingbeil AU, Ludwig M, Kolloch RE, Krekler M, Stumpe KO, Schmieder RE: (2008) Effect of angiotensin receptor blockade on central haemodynamics in essential hypertension: results of a randomised trial. J Renin Angiotensin Aldosterone Syst. 2008;9(1): 49-56
Ruilope LM, Schmieder RE: (2008) Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens. 2008;21(5): 500-8
Klanke B, Cordasic N, Hartner A, Schmieder RE, Veelken R, Hilgers KF: (2008) Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension. Nephrol Dial Transplant. 2008;23(11): 3456-63
Westermann D, Schmieder R, Schultheiss HP, Tschöpe C: (2008) Renin inhibitors, clinical experience. J Mol Med. 2008;86(6): 691-5
Werner C, Baumhäkel M, Teo KK, Schmieder R, Mann J, Unger T, Yusuf S, Böhm M: (2008) RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection. Clin Res Cardiol. 2008;97(7): 418-31
Leidig M, Bambauer R, Kirchertz EJ, Szabã T, Handrock R, Leinung D, Baier M, Schmieder RE: (2008) Efficacy, safety and tolerability of valsartan 80 mg compared to irbesartan 150 mg in hypertensive patients on long-term hemodialysis (VALID study). Clin Nephrol. 2008;Volume 69(June): 425-432
Delles C, Padmanabhan S, Lee WK, Miller WH, McBride MW, McClure JD, Brain NJ, Wallace C, Marçano AC, Schmieder RE, Brown MJ, Caulfield MJ, Munroe PB, Farrall M, Webster J, Connell JM, Dominiczak AF: (2008) Glutathione S-transferase variants and hypertension. J Hypertens. 2008;26(7): 1343-1352
Ritt M, Harazny JM, Ott C, Schlaich MP, Schneider MP, Michelson G, Schmieder RE: (2008) Analysis of retinal arteriolar structure in never-treated patients with essential hypertension. J Hypertens. 2008;26(7): 1427-34
Lüders S, Schrader J, Berger J, Unger T, Zidek W, Böhm M, Middeke M, Motz W, Lübcke C, Gansz A, Brokamp L, Schmieder RE, Trenkwalder P, Haller H, Dominiak P, PHARAO study group: (2008) The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure - a prospective, randomized, controlled prevention trial of the German Hypertension League. J Hypertens. 2008;26(7): 1487-1496
Veelken R, Schmieder RE: (2008) [Combination therapy: used too little and too late?] MMW Fortschr Med. 2008;150(24): 27-8, 30
Ritt M, Ott C, Delles C, Schneider MP, Schmieder RE: (2008) Impact of the endothelial nitric oxide synthase gene G894T polymorphism on renal endothelial function in patients with type 2 diabetes. Pharmacogenet Genomics. 2008;18(8): 699-707
Schrader J, Lüders S, Diener HC, Haller H, Schmieder RE, Wahle K, Smolka W, Jung C, Bestehorn K: (2008) [Effects of Long-Term Antihypertensive Therapy with Losartan on Blood Pressure and Cognitive Function in Patients with Essential Hypertension and Other Cerebrovascular Risk Factors (AWARE Observational Study).] Med Klin (Munich). 2008;103(7): 491-9
Kjeldsen SE, McInnes GT, Mancia G, Hua TA, Julius S, Weber MA, Coca A, Girerd X, Jamerson K, Larochelle P, Macdonald T, Schmieder RE, Anthony Schork M, Viskoper R, Widimsky J, Zanchetti A: (2008) Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: The VALUE trial. Blood Press. 2008;17(3): 170-7
Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsärinne K, Oto A, Parkhomenko A, Piegas LS, Svendsen TL, Teo KK, Yusuf S, ONTARGET investigators: (2008) Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet. 2008;372(9638): 547-53
Schmieder RE, Ruilope LM: (2008) Blood pressure control in patients with comorbidities. J Clin Hypertens (Greenwich). 2008;10(8): 624-31
Adamzik M, Frey UH, Bitzer K, Jakob H, Baba HA, Schmieder RE, Schneider MP, Heusch G, Peters J, Siffert W: (2008) A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men. Basic Res Cardiol. 2008;103(6): 598-610
Delles C, Raff U, Mimran A, Fauvel JP, Ruilope LM, Schmieder RE: (2008) Effects of telmisartan and ramipril on adiponectin and blood pressure in patients with type 2 diabetes. Am J Hypertens. 2008;21(12): 1330-6
Zimmerli LU, Schiffer E, Zürbig P, Good DM, Kellmann M, Mouls L, Pitt AR, Coon JJ, Schmieder RE, Peter K, Mischak H, Kolch W, Delles C, Dominiczak AF: (2008) Urinary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics. 2008;7(2): 290-8
Schmieder RE: (2008) Hypertensive retinopathy: a window to vascular remodeling in arterial hypertension. Hypertension. 2008;51(1): 43-4
Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD: (2008) Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2008;23(2): 573-9
Jacobi J, Maas R, Cordasic N, Koch K, Schmieder RE, Böger RH, Hilgers KF: (2008) Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice. Am J Physiol Heart Circ Physiol. 2008;294(2): H1058-66
Hohenstein B, Hugo CP, Hausknecht B, Boehmer KP, Riess RH, Schmieder RE: (2008) Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Nephrol Dial Transplant. 2008;23(4): 1346-54
Ott C, Schlaich MP, Schmidt BM, Titze SI, Schäufele T, Schmieder RE: (2008) Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemia. Atherosclerosis. 2008;196(2): 704-11
Schlaich MP, Oehmer S, Schneider MP, Delles C, Schmidt BM, Schmieder RE: (2007) Effects of nitric oxide synthase inhibition and l-arginine on renal haemodynamics in young patients at high cardiovascular risk. Atherosclerosis. 2007;192(1): 155-160
Pool JL, Schmieder RE, Azizi M, Aldigier JC, Januszewicz A, Zidek W, Chiang Y, Satlin A: (2007) Aliskiren, an orally effective Renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan. Am J Hypertens. 2007;20(1): 11-20
Zolk O, Jacobi J, Pahl A, Fromm MF, Schmieder RE: (2007) MDR1 genotype-dependent regulation of the aldosterone system in humans. Pharmacogenet Genomics. 2007;17(2): 137-44
Schmieder RE, Delles C, Mimran A, Fauvel JP, Ruilope LM: (2007) Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes. Diabetes Care. 2007;30(6): 1351-6
Schlaich MP, Schmieder RE: (2007) Contribution of endothelial nitric oxide to blood pressure in humans. Hypertension. 2007;49(5): e29; author reply e30
Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM: (2007) Renin-angiotensin system and cardiovascular risk. Lancet. 2007;369(9568): 1208-19
Schmieder RE, Schrader J, Zidek W, Tebbe U, Paar WD, Bramlage P, Pittrow D, Böhm M: (2007) Low-grade albuminuria and cardiovascular risk : What is the evidence? Clin Res Cardiol. 2007;96(5): 247-257
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A: (2007) 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6): 1105-87
Schmieder RE: (2007) The potential role of prorenin in diabetic nephropathy. J Hypertens. 2007;25(7): 1323-6
Schlaich MP, Delles C, Schmieder RE: (2007) Involvement of endothelial mechanisms in L-arginine-induced alterations of renal haemodynamics in humans. J Hypertens. 2007;25(7): 1515-6
Nussberger J, Gradman AH, Schmieder RE, Lins RL, Chiang Y, Prescott MF: (2007) Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension. Int J Clin Pract. 2007;61(9): 1461-8
Böhm M, Baumhäkel M, Probstfield JL, Schmieder R, Yusuf S, Zhao F, Koon T: (2007) Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telm Am Heart J. 2007;154(1): 94-101
Ruilope LM, Redon J, Schmieder R: (2007) Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme. Vasc Health Risk Manag. 2007;3(1): 1-9
Fellström B, Holdaas H, Jardine AG, Rose H, Schmieder R, Wilpshaar W, Zannad F, AURORA Study Group: (2007) Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study. Kidney Blood Press Res. 2007;30(5): 314-22
Ott C, Titze SI, Schwarz TK, Kreutz R, Hilgers KF, Schmidt BM, Schlaich MP, Schmieder RE: (2007) High sodium intake modulates left ventricular mass in patients with G expression of +1675 G/A angiotensin II receptor type 2 gene. J Hypertens. 2007;25(8): 1627-32
Schmieder RE: (2007) Untitled Herz. 2007;32(3): A15-A15
Authors/Task Force Members: , Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, ESC Committee for Practice Guidelines (CPG): , Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, ESH Scientific Council: , Kjeldsen SE, Erdine S, Narkiewicz K, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Cifkova R, Dominiczak A, Fagard R, Heagerty AM, Laurent S, Lindholm LH, Mancia G, Manolis A, Nilsson PM, Redon J, Schmieder RE, Struijker-Boudier HA, Viigimaa M, Document Reviewers: , Filippatos G, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clément D, Erdine S, Farsang C, Gaita D, Kiowski W, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Viigimaa M, Waeber B, Williams B, Zamorano JL: (2007) 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28(12): 1462-536
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Dalby Kristensen S, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Manolis A, Nilsson PM, Redon J, Viigimaa M, Linee Guida della Società Europea , di Ipertensione Arteriosa , Società Europea di Cardiologia: (2007) [Practice guidelines 2007 for the treatment of arterial hypertension] G Ital Cardiol (Rome). 2007;8(7): 389-479
Harazny JM, Ritt M, Baleanu D, Ott C, Heckmann J, Schlaich MP, Michelson G, Schmieder RE: (2007) Increased wall:lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event. Hypertension. 2007;50(4): 623-9
Ott C, Schmieder RE: (2007) [High blood pressure and changes in the ocular fundus] MMW Fortschr Med. 2007;149(27-28): 39-41
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Authors/Task Force Members: , Co-Chairperson (Italy) , Co-Chairperson (Belgium) , (UK) , (Czech Republic) , (Belgium) , (Italy) , (Italy) , (UK) , (Norway) , (France) , (Poland) , (Spain) , (Poland) , (Germany) , (Netherlands) , (Italy): (2007) 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007;25(9): 1751-1762
Ott C, Schwarz T, Hilgers KF, Kreutz R, Schlaich MP, Schmieder RE: (2007) Left-ventricular structure and function are influenced by angiotensinogen gene polymorphism (-20 a/c) in young male patients. Am J Hypertens. 2007;20(9): 974-80
Michelson G, Harazny J, Schmieder RE, Berendes R, Fiermann T, Wärntges S: (2007) Fourier analysis of the envelope of the ophthalmic artery blood flow velocity: age- and blood pressure related impact. Hypertension. 2007;50(5): 964-9
Mansia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, European Society of Hypertension , European Society of Cardiology: (2007) 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press. 2007;16(3): 135-232
Bramlage P, Thoenes M, Paar WD, Bramlage CP, Schmieder RE: (2007) [Albuminuria: an indicator of cardiovascular risk.] Med Klin (Munich). 2007;102(10): 833-43
Grupo de Trabajo para el Tratamiento de la Hipertensión Arterial de la Sociedad Europea , Sociedad Europea de Cardiología , Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosion E, Fagard R, Lindholm LH, Manolis A, Nilsson PM, Redon J, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Bertomeu V, Clément D, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'brien E, Ponikowski P, Ruschitzka F, Tamargo J, van Zwieten P, Viigimaa M, Waeber B, Williams B, Zamorano JL: (2007) [ESH/ESC 2007 Guidelines for the management of arterial hypertension] Rev Esp Cardiol. 2007;60(9): 968.e1-94
Silber S, Richartz BM, Goss F, Haerer W, Glowatzki M, Schmieder RE: (2007) [Care of hypertensive patients seen by cardiologists: results of the Snapshot Hypertension Registry] Dtsch Med Wochenschr. 2007;132(46): 2430-5
Schmieder RE: (2007) [Guidelines 2007 of the European Societies of Hypertension and of Cardiology: what has changed?] Dtsch Med Wochenschr. 2007;132(46): 2463-6
Hamann J, Neuner B, Kasper J, Vodermaier A, Loh A, Deinzer A, Heesen C, Kissling W, Busch R, Schmieder R, Spies C, Caspari C, Härter M: (2007) Participation preferences of patients with acute and chronic conditions. Health Expect. 2007;10(4): 358-63
Asmar R, García-Puig J, Gosse P, Karpov YA, De Leeuws PW, Magometschniggs D, Matos L, Schmieder R: (2007) Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy. Vasc Health Risk Manag. 2007;3(4): 371-80
Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM: (2007) Renin-angiotensin system and cardiovascular risk - Reply Lancet. 2007;370(9581): 24-25
Schmieder RE, Delles C, Mimran A, Fauvel JP, Ruilope LM: (2007) Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes (vol 30, pg 1351, 2007) Diabetes Care. 2007;30(9): 2421-2421
Werdan K, Pilz G, Bujdoso O, Fraunberger P, Neeser G, Schmieder RE, Viell B, Marget W, Seewald M, Walger P, Stuttmann R, Speichermann N, Peckelsen C, Kurowski V, Osterhues HH, Verner L, Neumann R, Müller-Werdan U, Score-Based Immunoglobulin Therapy of Sepsis (SBITS) Study Group: (2007) Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med. 2007;35(12): 2693-2701
Schmieder RE: (2007) New developments with nephroprotection Herz. 2007;32(5): A11-A11
Schmieder RE: (2007) Renin inhibitors: optimal strategy for renal protection. Curr Hypertens Rep. 2007;9(5): 415-21
Schmieder RE: (2006) Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum? J Hypertens. 2006;24 Suppl.(): S31-S35
Schmieder RE: (2006) Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum? J Hypertens Suppl. 2006;24(2): S31-5
Michelson G, Wärntges S, Harazny J, Oehmer S, Delles C, Schmieder RE: (2006) EFFECT OF NOS INHIBITION ON RETINAL ARTERIAL AND CAPILLARY CIRCULATION IN EARLY ARTERIAL HYPERTENSION. Retina. 2006;26(4): 437-444
Jacobi J, Porst M, Cordasic N, Namer B, Schmieder RE, Eckardt KU, Hilgers KF: (2006) Subtotal nephrectomy impairs ischemia-induced angiogenesis and hindlimb re-perfusion in rats. Kidney Int. 2006;69(11): 2013-21
Mayer AF, Schroeder C, Heusser K, Tank J, Diedrich A, Schmieder RE, Luft FC, Jordan J: (2006) Influences of norepinephrine transporter function on the distribution of sympathetic activity in humans. Hypertension. 2006;48(1): 120-6
Kjeldsen SE, Julius S, Mancia G, McInnes GT, Hua T, Weber MA, Coca A, Ekman S, Girerd X, Jamerson K, Larochelle P, Macdonald TM, Schmieder RE, Schork MA, Stolt P, Viskoper R, Widimsky J, Zanchetti A, for the VALUE Trial Investigators: (2006) Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial. J Hypertens. 2006;24(7): 1405-1412
Schaufele TG, Schlaich MP, Delles C, Klingbeil AU, Fleischmann EH, Schmieder RE: (2006) Impaired basal NO activity in patients with glomerular disease and the influence of oxidative stress. Kidney Int. 2006;70(6): 1177-81
Oehmer S, Harazny J, Delles C, Schwarz T, Handrock R, Michelson G, Schmieder RE: (2006) Valsartan and retinal endothelial function in elderly hypertensive patients. Blood Press. 2006;15(3): 185-91
Koppert W, Frötsch K, Huzurudin N, Böswald W, Griessinger N, Weisbach V, Schmieder RE, Schüttler J: (2006) The Effects of Paracetamol and Parecoxib on Kidney Function in Elderly Patients Undergoing Orthopedic Surgery. Anesth Analg. 2006;103(5): 1170-1176
Deedwania PC, Schmieder R: (2006) Angiotensin receptor blockers: Cardiovascular protection in the metabolic syndrome. J Renin Angiotensin Aldosterone Syst. 2006;7 Suppl 1(): S12-8
Deinzer A, Babel H, Veelken R, Kohnen R, Schmieder RE: (2006) [Shared decision-making in hypertension.] Dtsch Med Wochenschr. 2006;131(46): 2592-2596
Schmidt BM, Schmieder RE: (2006) [Established and new parameters of hypertensive target organ damage.] Dtsch Med Wochenschr. 2006;131(46 spezial): H20-H23
Schmieder RE, Schrader J, Zidek W, Tebbe U, Bramlage P, Paar WD, Böhm M: (2006) [Low grade albuminuria, microalbuminuria and proteinuria - accepted cardiovascular risk markers?] Dtsch Med Wochenschr. 2006;131(47): 2665-2671
Schmieder RE: (2006) Aliskiren: a clinical profile. J Renin Angiotensin Aldosterone Syst. 2006;7 Suppl 2(): S16-20
Schmidt BM, Sammer U, Fleischmann I, Schlaich M, Delles C, Schmieder RE: (2006) Rapid nongenomic effects of aldosterone on the renal vasculature in humans. Hypertension. 2006;47(4): 650-5
London G, Schmieder R, Calvo C, Asmar R: (2006) Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study. Am J Hypertens. 2006;19(1): 113-21
Stumpf C, John S, Jukic J, Yilmaz A, Raaz D, Schmieder RE, Daniel WG, Garlichs CD: (2005) Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension. J Hypertens. 2005;23(5): 995-1000
Riegel W, Hahn K, Kreutz R, Weber M, Zidek W, Schmieder R: (2005) [Multi-centre enquiry into the influence of the referral of patients with progressive kidney disease to nephrologists.] Dtsch Med Wochenschr. 2005;130(13): 792-6
Hutchison AJ, Maes B, Vanwalleghem J, Asmus G, Mohamed E, Schmieder R, Backs W, Jamar R, Vosskuhler A: (2005) Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonate. Nephron Clin Pract. 2005;100(1): c8-19
Schmieder RE: (2005) Optimizing therapeutic strategies to achieve renal and cardiovascular risk reduction in diabetic patients with angiotensin receptor blockers. J Hypertens. 2005;23(5): 905-11
Schmieder RE: (2005) Mechanisms for the Clinical Benefits of Angiotensin II Receptor Blockers. Am J Hypertens. 2005;18(5): 720-30
John S, Schneider MP, Delles C, Jacobi J, Schmieder RE: (2005) Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. Am Heart J. 2005;149(3): 473
Fellström B, Zannad F, Schmieder R, Holdaas H, Jardine A, Rose H, Wilpshaar W: (2005) Effect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study. Curr Control Trials Cardiovasc Med. 2005;6(1): 9
Schmieder RE: (2005) [In Process Citation] Krankenpfl J. 2005;43(1-3): 63
Schneider MP, Delles C, Schmidt BM, Oehmer S, Schwarz TK, Schmieder RE, John S: (2005) Superoxide scavenging effects of N-acetylcysteine and vitamin C in subjects with essential hypertension. Am J Hypertens. 2005;18(8): 1111-7
Schmieder RE, Krekler M: (2005) [Observational study of blood pressure control and microalbuminuria in type 2 diabetics on Irbesartan or Irbesartan/HCTZ] MMW Fortschr Med. 2005;147(31-32): 713
Schmieder RE, Klingbeil AU, Fleischmann EH, Veelken R, Delles C: (2005) Additional antiproteinuric effect of ultrahigh dose candesartan: a double-blind, randomized, prospective study. J Am Soc Nephrol. 2005;16(10): 3038-45
Fromm MF, Schmidt BM, Pahl A, Jacobi J, Schmieder RE: (2005) CYP3A5 genotype is associated with elevated blood pressure. Pharmacogenet Genomics. 2005;15(10): 737-41
Schmieder RE, Krekler M: (2005) [Observational study of blood pressure control and microalbuminuria in type 2 diabetics on irbesartan or irbesartan/HCTZ] MMW Fortschr Med. 2005;147 Suppl(): 97-101
Hutchison AJ, Maes B, Vanwalleghem J, Asmus G, Mohamed E, Schmieder R, Backs W, Jamar R, Vosskuhler A: (2005) Long-Term Efficacy and Tolerability of Lanthanum Carbonate: Results from a 3-Year Study. Nephron Clin Pract. 2005;102(2): c61-c71
Dahlof B, Gosse P, Guéret P, Dubourg O, De Simone G, Schmieder R, Karpov Y, García-Puig J, Matos L, De Leeuw PW, Degaute JP, Magometschnigg D: (2005) Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. J Hypertens. 2005;23(11): 2063-70
Schmidt BM, Schmieder RE: (2005) Cardiotrophin: its importance as a pathogenetic factor and as a measure of left ventricular hypertrophy. J Hypertens. 2005;23(12): 2151-3
Schmieder RE: (2005) The role of non-haemodynamic factors of the genesis of LVH. Nephrol Dial Transplant. 2005;20(12): 2610-2612
Schäufele T, Harazny J, Oehmer S, Delles C, Michelson G, Schmieder RE: (2005) Effects of erythropoietin on retinal capillary flow in humans J Hypertens. 2005;23 Suppl.(): 59-59
Veelken R, Hilgers KF, Porst M, Krause H, Hartner A, Schmieder RE: (2005) Effects of Sympathetic Nerves and Angiotensin II on Renal Sodium and Water Handling in Rats with Common Bile Duct Ligature. Am J Physiol Renal Physiol. 2005;288(6): F1267-75
Schaeufele T, Harazny J, Oehmer S, Delles C, Michelson G, Schmieder RE: (2005) Effects of erythropoietin on retinal capillary flow in normotensive and hypertensive subjects Nephrol Dial Transplant. 2005;20 Suppl.(): V195-V195
Schmieder RE, Delles CC, Mimran A, Fauvel JP, Ruilope L: (2005) Effects of telmisartan versus ramipril on endothelium function of the renal vasculature in type 2 diabetes Nephrol Dial Transplant. 2005;20 Suppl.(): V242-V242
Hilgers KF, Zeltner R, Porst M, Delles C, Hartner A, Schmieder RE, Schulze BD: (2005) The progression of autosomal dominant polycystic kidney disease is modified in patients with a promoter polymorphism of the alpha 8 integrin gene Nephrol Dial Transplant. 2005;20 Suppl.(): V245-V245
Schmieder RE, Klingbeil AU, Fleischmann EH, Delles C, Veelken R: (2005) Dose-response effect of angiotensin receptor blocker candesartan on proteinuria: A double blind, randomized study Nephrol Dial Transplant. 2005;20 Suppl.(): V69-V69
Nussberger J, Gradman AH, Schmieder RE, Lins RL, White WB, Prescott M, Chiang YT: (2005) Changes in plasma renin match the antihypertensive effects of aliskiren in patients with hypertension: Placebo/irbesartan-controlled trial with the orally active renin inhibitor aliskiren Am J Hypertens. 2005;18(5): 234A-234A
Schneider MP, Klingbeil AU, Delles C, Ludwig M, Kolloch RE, Krekler M, Stumpe KO, Schmieder RE: (2005) Effects of irbesartan versus atenolol on vascular stiffness and aortic blood pressure in essential hypertension J Hypertens. 2005;23 Suppl.(): S13-S13
Schmieder RE, Delles C, Mimran A, Fauvel JP, Ruilope L: (2005) Effects of telmisartain versus ramipril on endothelium function of the renal vasculature in type 2 diabetes J Hypertens. 2005;23 Suppl.(): S147-S147
Schmidt BMW, Kalizki T, Rastatter A, Schwarz TK, Schmieder RE: (2005) Aldosterone release during head up tilt is related to left ventricular diastolic function J Hypertens. 2005;23 Suppl.(): S167-S167
Schaufele TG, Delles C, Schmidt BMW, Fleischmann EH, Schmieder RE: (2005) Impact of vitamin C as an antioxidative agent on renal hemodynamics in normotensive and hypertensive subjects J Hypertens. 2005;23 Suppl.(): S178-S179
Brain NJR, Delles C, McClure JD, Lee WK, McBride MW, Schmieder RE, Dominiczak AF: (2005) Single locus and haploptype analyses of human glutathione-s-transferase type MU (GSTM) gene cluster suggest association of GSTM4 to indices of endothelial function and hypertension status J Hypertens. 2005;23 Suppl.(): S246-S247
Legendre C, Philipp T, Schmieder RE, Mourad G, Geiger H, Moulin B, Nisse-Durgeat S, Kiel G: (2005) The secret study - Study on evaluation of candesartan cilexetil after renal transplantation J Hypertens. 2005;23 Suppl.(): S3-S3
Schmieder RE, Deinzer AF, Kohnen R, Veelken R: (2005) Antihypertensive therapy - Is a shared decision making approach more effective? J Hypertens. 2005;23 Suppl.(): S318-S318
Fleischmann EH, Klingbeil AU, Delles C, Veelken R, Schmieder RE: (2005) Dose-response effect of angiotensin receptor blocker candesartan on proteinuria: A double blind, randomized study J Hypertens. 2005;23 Suppl.(): S328-S328
Schwarz TK, Schwab J, Schäufele T, Gottwik MG, Bar I, Schmieder RE: (2005) Does acute volume depletion influence the assessment of left ventricular structure, function and vascular compliance J Hypertens. 2005;23 Suppl.(): S9-S9
Gradman AH, Schmieder RE, Lins RL, Nussberger J, Chiang Y, Bedigian MP: (2005) Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients. Circulation. 2005;111(8): 1012-8
Schmieder RE: (2005) [In Process Citation] MMW Fortschr Med. 2005;147(3): 10
Schneider MP, Schmieder RE: (2005) Critical value of the electrocardiogram in LVH: From predictive index to therapeutic reassessment - Response Hypertension. 2005;45(2): E6-E7
Barlage S, Hauser IA, Elbracht R, Abletshauser C, Schmieder RE, Weidinger G, Lackner KJ, Rothe G, Schmitz G: (2005) Monitoring of peripheral blood cytotoxic T-cells under fluvastatin treatment in renal transplant recipients. J Biol Regul Homeost Agents. 2005;19(3-4): 159-68
Gosse P, Asmar R, Guéret P, Dubourg O, De Simone G, Schmieder R, Dahlof B: (2005) Does perindopril/indapamide combination have a blood pressure independent effect on left ventricular mass evolution? The picxel study J Hypertens. 2005;23 Suppl.(): S191-S192
Schmieder RE, Porst M, London G, Calvo C, Hilgers KF: (2005) Decrease of systolic blood pressure in mild-to-moderate hypertension: Are genetic polymophisms helpful? The X-CELLENT genetics substudy J Hypertens. 2005;23 Suppl.(): S364-S365
Asmar R, Karpov Y, Gosse P, García-Puig J, Matos L, De Leeuw PW, Schmieder R, Magometschnigg D, Dahlof B: (2005) Picxel: Perindopril/indapamide 24-hour ABPM efficacy in hypertensive patients with left ventricular hypertrophy J Hypertens. 2005;23 Suppl.(): S81-S81
Pahl A, Schmidt BMW, Fromm MF, Jacobi J, Schmieder RE: (2005) CYP3A5 genotype is associated with elevated blood pressure Pharmacogenet Genomics. 2005;61(9): 716-716
Delles C, Schmieder RE: (2004) Is the afferent arteriole the main location of nitric oxide action and synthesis in humans? Reply Nephrol Dial Transplant. 2004;19(11): 2925-2926
Heusser K, Vitkovsky J, Raasch W, Schmieder RE, Schobel HP: (2004) Re: Heusser et al: Elevation of sympathetic activity by eprosartan in young male subjects - In reply Am J Hypertens. 2004;17(3): 281-283
Schmidt BMW, Schmieder RE: (2004) Response: Rapid nongenomic effects of aldosterone on human forearm vasculature Hypertension. 2004;43(5): E30-E30
Gosse P, Schmieder R, Guéret P, De Simone G, Dubourg O, Karpov Y, Dahlof B: (2004) Low-dose Perindopril, indapamide and eccentric, concentric left ventricular hypertrophy in the PICXEL study Eur Heart J. 2004;25 Suppl.(): 208-208
Delles C, Michelson G, Harazny J, Oehmer S, Hilgers KF, Schmieder RE: (2004) Impaired endothelial function of the retinal vasculature in hypertensive patients. Stroke. 2004;35(6): 1289-93
Delles C, Klingbeil AU, Schneider MP, Handrock R, Schäufele T, Schmieder RE: (2004) The role of nitric oxide in the regulation of glomerular haemodynamics in humans. Nephrol Dial Transplant. 2004;19(6): 1392-7
Delles C, Schneider MP, Oehmer S, Fleischmann I, Fleischmann EF, Schmieder RE: (2004) Increased response of renal perfusion to the antioxidant vitamin C in type 2 diabetes. Nephrol Dial Transplant. 2004;19(10): 2513-8
Schneider MP, Klingbeil AU, Delles C, Ludwig M, Kolloch RE, Krekler M, Stumpe KO, Schmieder RE: (2004) Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project. Hypertension. 2004;44(1): 61-6
Delles C, Schmieder RE: (2004) Renal endothelial effects of antihypertensive therapy. Curr Opin Nephrol Hypertens. 2004;13(5): 489-93
Fleischmann EH, John S, Delles C, Schneider MP, Schmidt BM, Schmieder RE: (2004) The effect of statins on angiotensin II-induced hemodynamic changes in young, mildly hypercholesterolemic men. Am J Hypertens. 2004;17(12 Pt 1): 1120-6
Fleischmann EH, Friedrich A, Danzer E, Gallert K, Walter H, Schmieder RE: (2004) Intensive training of patients with hypertension is effective in modifying lifestyle risk factors. J Hum Hypertens. 2004;18(2): 127-31
Schmidt BM, Schmieder RE: (2004) Response: Rapid Nongenomic Effects of Aldosterone on Human Forearm Vasculature. Hypertension. 2004;():
Schneider MP, Schmieder RE: (2004) Response. Expert Opin Pharmacother. 2004;():
Deinzer A, Hegemann T, Veelken R, Schmieder RE: (2004) [A model project on shared decision-making in the treatment of arterial hypertension] MMW Fortschr Med. 2004;146(16): 48-50
Frank H, Heusser K, Höffken B, Huber P, Schmieder RE, Schobel HP: (2004) Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients. Kidney Int. 2004;66(2): 832-40
Schmieder RE: (2004) Telmisartan/hydrochlorothiazide combination therapy in the treatment of essential hypertension. Expert Opin Pharmacother. 2004;5(11): 2303-10
Kostis JB, Packer M, Black HR, Schmieder R, Henry D, Levy E: (2004) Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. Am J Hypertens. 2004;17(2): 103-11
Gosse P, De Simone G, Dubourg O, Guéret P, Schmieder R: (2004) Serial echocardiographic assessment of left ventricular mass: how blinded should readers be? J Hypertens. 2004;22(9): 1813-8
Gradman AH, Schmieder RE, Lins RL, Chiang YT, Bedigian MP: (2004) Aliskiren, a novel orally effective renin inhibitor, provides antihypertensive efficacy and placebo-like tolerability similar to an AT(1)-receptor blocker in hypertensive patients Am J Hypertens. 2004;17(5): 108A-108A
Oehmer S, Harazny J, Delles C, Schwarz T, Handrock R, Michelson G, Schmieder RE: (2004) The effect of Valsartan on the endothelial function of the retinal capillary bed in elderly hypertensive subjects Am J Hypertens. 2004;17(5): 62A-62A
Oehmer S, Schmidt BMW, Hilgers K, Schneider MP, Schmieder RE: (2004) Impaired stimulated no-activity by erythropoetin in hypertensive subjects Am J Hypertens. 2004;17(5): 73A-73A
Delles C, Schmieder RE: (2004) Effects of the angiotensin-1 receptor blocker valsartan compared with amlodipine on renal hemodynamics - Reply Am J Hypertens. 2004;17(7): 639-640
Stumpf C, John S, Jukic J, Yilmaz A, Raaz D, Schmieder RE, Daniel WG, Garlichs CD: (2004) Platelet P-selectin and plasma levels of circulating cytokines in young patients with mild essential hypertension Eur Heart J. 2004;25 Suppl.(): 108-109
Schmidt BMW, Schmieder RE: (2004) Rapid nongenomic aldosterone effects in the human forearm? Response Hypertension. 2004;43(1): E2-E2
Stumpf C, Jukic J, Yilmaz A, John S, Raaz D, Schmieder RE, Daniel WG, Garlichs CD: (2004) Platelet P-selectin and plasma levels of circulating cytokines in young patients with mild arterial hypertension J Am Coll Cardiol. 2004;43 Suppl.(5): 12A-12A
Schneider MP, Klingbeil AU, Hilgers KF, Ludwig M, Kolloch R, Stumpe KO, Schmieder RE: (2004) The G1675A gene polymorphism of the angiotensin II type 2-receptor gene influences cardiac structural response to antihypertensive therapy J Am Coll Cardiol. 2004;43 Suppl.(5): 511A-511A
Schmieder RE, Kjeldsen SE, Julius S, Ekman S, Hua T: (2004) Determinants of the time course of LVH-regression: The VALUE-trial J Hypertens. 2004;22 Suppl.(): S7-S7
Oehmer S, Harazny J, Delles C, Schwarz T, Handrock R, Michelson G, Schmieder RE: (2004) The effect of Valsartan on the endothelial function of the retinal capillary bed J Hypertens. 2004;22 Suppl.(): S143-S143
Stumpf C, John S, Jukic J, Yilmaz A, Raaz D, Schmieder RE, Daniel WG, Garlichs CD: (2004) Platelet P-selectin and plasma levels of circulating cytokines in young patients with mild essential hypertension J Hypertens. 2004;22 Suppl.(): S178-S178
Delles C, Lee WK, John S, Schmieder RE, Dominiczak AF: (2004) A single nucleotide polymorphism (SNP) in the human glutathione S-transferase mu type 4 gene (Gstm 4) is associated with impaired endothelial function and arterial hypertension J Hypertens. 2004;22 Suppl.(): S212-S212
Schmieder RE, Kjeldsen SE, Julius S, Ekman S, Hua T: (2004) Determinants of the new development of left ventricular hypertrophy on treated hypertensives: The VALUE-trial J Hypertens. 2004;22 Suppl.(): S277-S277
Schwarz TK, Schwab J, Schmidt BMW, Schneider MP, Bar I, Schmieder RE: (2004) Cardiac structural adaptation of the left and right ventricle in early stages of essential hypertension J Hypertens. 2004;22 Suppl.(): S277-S277
Schmidt BMW, Rastatter A, Agafonov T, Oehmer S, Delles C, Schneider MP, Schwarz TK, Schmieder RE: (2004) Rapid nongenomic effects of aldosterone in essential hypertension J Hypertens. 2004;22 Suppl.(): S300-S300
Oehmer S, Schmidt BMW, Schneider MP, Hilgers K, Schmieder RE: (2004) Impaired stimulated NO-activity by darbepoietin in hypertensive subjects J Hypertens. 2004;22 Suppl.(): S55-S55
Klingbeil AU, Fleischmann EH, Schneider MP, Delles C, Schmieder RE: (2004) Effects of ultra high dose candesartan (64mg) on proteinuria: Interim results of a double blind, randomized study J Hypertens. 2004;22 Suppl.(): S79-S80
Schmieder RE, Michelson G, Harazny J, Oehmer S, Hilgers KF, Delles C: (2003) Nitric oxide bioavailability in the retinal vasculature of hypertensive patients Circulation. 2003;108 Suppl.(17): 347-348
Mueller HJ, Schmieder RE, Zeltner R, Poliak R, Graf S, Schulze BD: (2003) Determinants for the, treatment in hypertensive patients with autosomal dominant polycystic kidney disease (ADPKD): Choice of drug versus blood pressure (BP) control. J Am Soc Nephrol. 2003;14 Suppl.(): 109A-109A
Schmidt BMW, Sammer U, Oehmer S, Delles C, Schneider MP, Fleischmann EH, Schmieder RE: (2003) Rapid nongenomic aldosterone effects on the renal perfusion J Am Soc Nephrol. 2003;14 Suppl.(): 146A-146A
Schmidt BMW, Rastatter A, Oehmer S, Schwarz T, Schneider MP, Delles C, Schmieder RE: (2003) Rapid nongenomic aldosterone effects - A pathophysiological factor in primary hypertension? J Am Soc Nephrol. 2003;14 Suppl.(): 514A-514A
Oehmer S, Schmidt BMW, Schneider MP, Hilgers K, Schmieder RE: (2003) Impaired stimulated NO-Activity by erythropoietin in hypertensive subjects. J Am Soc Nephrol. 2003;14 Suppl.(): 515A-515A
Fleischmann EH, Klingbeil AU, Schneider MP, Delles C, Schmieder RE: (2003) Effects of ultra high dose of candesartan (64 mg) on proteinuria: Interim results of a double-blind, randomized, Multicenter study. J Am Soc Nephrol. 2003;14 Suppl.(): 528A-528A
Delles C, Schneider MP, Oehmer S, Fleischmann I, Fleischmann EH, Schmieder RE: (2003) Evidence for increased oxidative stress in the renal vasculature of patients with type 2 diabetes. J Am Soc Nephrol. 2003;14 Suppl.(): 608A-608A
Delles C, Schneider MP, Oehmer S, Klingbeil AU, Schmieder RE: (2003) The importance of nitric oxide (NO) for the regulation of glomerular hemodynamics in humans. J Am Soc Nephrol. 2003;14 Suppl.(): 615A-615A
Schneider MP, Stumpe KO, Kolloch RE, Krekler M, Delles C, Klingbeil AU, Schmieder RE: (2003) Results on left ventricular structure in the Cardivascular Irbesartan Projekt (CVIP): An 18 month comparison between irbesartan and atenolol. J Am Soc Nephrol. 2003;14 Suppl.(): 673A-673A
Fleischmann EH, Bruns S, Baumgärtel M, Leidig M, Veelken R, Schmieder RE: (2003) Successful treatment of peritonitis in a patient using the Vasca Life Site port for peritoneal dialysis. J Am Soc Nephrol. 2003;14 Suppl.(): 863A-863A
Fleischmann EH, Schmidt BMW, Oehmer S, Schwarz T, Schmieder RE: (2003) Hyperemia following ischemia is mediated by nitric oxide. J Am Soc Nephrol. 2003;14 Suppl.(): 872A-872A
Zeltner R, Schmieder RE, Graf S, Delles C, Oehmer S, Schulze BD: (2003) Nitric oxide activity in the renal vasculature of patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2003;14 Suppl.(): 875A-875A
Schmidt BM, Schmieder RE: (2003) Aldosterone-induced cardiac damage: focus on blood pressure independent effects. Am J Hypertens. 2003;16(1): 80-6
Klingbeil AU, John S, Schneider MP, Jacobi J, Handrock R, Schmieder RE: (2003) Effect of AT1 receptor blockade on endothelial function in essential hypertension. Am J Hypertens. 2003;16(2): 123-8
Heusser K, Vitkovsky J, Raasch W, Schmieder RE, Schobel HP: (2003) Elevation of sympathetic activity by eprosartan in young male subjects. Am J Hypertens. 2003;16(8): 658-64
Delles C, Klingbeil AU, Schneider MP, Handrock R, Weidinger G, Schmieder RE: (2003) Direct comparison of the effects of valsartan and amlodipine on renal hemodynamics in human essential hypertension. Am J Hypertens. 2003;16(12): 1030-5
Delles C, Schmieder RE: (2003) [Endothelial function of the human renal vasculature] Dtsch Med Wochenschr. 2003;128(3): 92-6
Schmieder RE, Handrock R: (2003) [Control of systolic blood pressure in the VALUE trial after 12 months] Dtsch Med Wochenschr. 2003;128(10): 485-6
Delles C, Schmidt BM, Müller HJ, Oehmer S, Klingbeil AU, Schmieder RE: (2003) Functional relevance of aldosterone for the determination of left ventricular mass. Am J Cardiol. 2003;91(3): 297-301
Schneider MP, Delles C, Fleischmann E, Schmidt BM, John S, Schmieder RE: (2003) Effect of elevated triglyceride levels on endothelium-dependent vasodilation in patients with hypercholesterolemia. Am J Cardiol. 2003;91(4): 482-4
Frank H, Schobel HP, Vitkowsky J, Schmieder RE, Heusser K: (2003) Effects of angiotensin II receptor antagonism on the renal hemodynamic response to cardiovascular stress. Kidney Int. 2003;63(2): 617-23
Schneider MP, Hilgers KF, Huang Y, Delles C, John S, Oehmer S, Schmieder RE: (2003) The C242T p22phox polymorphism and endothelium-dependent vasodilation in subjects with hypercholesterolaemia. Clin Sci (Lond). 2003;105(1): 97-103
John S, Schmieder RE: (2003) Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia. Curr Hypertens Rep. 2003;5(3): 199-207
Delles C, Schneider MP, Oehmer S, Fleischmann EH, Schmieder RE: (2003) L-arginine-induced vasodilation of the renal vasculature is not altered in hypertensive patients with type 2 diabetes. Diabetes Care. 2003;26(6): 1836-40
Schmidt BM, Oehmer S, Delles C, Bratke R, Schneider MP, Klingbeil A, Fleischmann EH, Schmieder RE: (2003) Rapid nongenomic effects of aldosterone on human forearm vasculature. Hypertension. 2003;42(2): 156-60
Schmidt BM, Schmieder RE: (2003) Response. Hypertension. 2003;():
Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE: (2003) A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med. 2003;115(1): 41-6
Schneider MP, Klingbeil AU, Delles C, Schmidt BM, John S, Schmieder RE: (2003) Vitamin C augments the renal response to L-arginine in smokers. Nephrol Dial Transplant. 2003;18(8): 1512-7
Heusser K, Vitkovsky J, Schmieder RE, Schobel HP: (2003) AT1 antagonism by eprosartan lowers heart rate variability and baroreflex gain. Auton Neurosci. 2003;107(1): 45-51
Delles C, Schneider MP, Oehmer S, John S, Fleischmann I, Schmieder RE: (2003) Evidence for increased oxidative stress in the renal vasculature of patients with type 2 diabetes J Hypertens. 2003;21 Suppl.(): S105-S105
Handtrack C, Klanke B, Cordasic N, Schmieder RE, Veelken R, Hilgers KF: (2003) The angiotensinogen genotype affects hypertension in mice and predicts the hypotensive response to AT1 receptor antagonism J Hypertens. 2003;21 Suppl.(): S121-S121
Schmidt BMW, Oehmer S, Delles C, Schneider MP, Fleischmann EH, Schmieder RE: (2003) Proof of rapid vascular aldosterone effects J Hypertens. 2003;21 Suppl.(): S149-S150
Schneider MP, John S, Oehmer S, Schmidt BMW, Klingbeil AU, Schmieder RE: (2003) Disparate effects of vitamin C and N-acetylcysteine on vascular dysfunction in subjects with essential hypertension J Hypertens. 2003;21 Suppl.(): S155-S155
Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE: (2003) Reduction of left ventricular mass in essential hypertension: Final results by meta-analysis including all randomized double-blind studies until September 2002 J Hypertens. 2003;21 Suppl.(): S176-S176
Schmidt BMW, Sammer U, Oehmer S, Delles C, Fleischmann EH, Schmieder RE: (2003) Interaction of nitric oxide and rapid non-genomic effects of aldosterone on the renal perfusion J Hypertens. 2003;21 Suppl.(): S287-S287
Schneider MP, Stumpe KO, Ludwig M, Kolloch RE, Krekler M, Delles C, Klingbeil AU, Schmieder RE: (2003) Results on left ventricular structure in the Cardiovascular Irbesartan Project (CVIP): An 18 months comparison between irbesartan and atenolol J Hypertens. 2003;21 Suppl.(): S70-S71
Delles C, Schneider MP, Oehmer S, Schwarz T, Fleischmann I, Schmieder RE: (2003) Vitamin C increases renal plasma flow in patients with type 2 diabetes J Hypertens. 2003;21 Suppl.(): S86-S86
Zidek W, Düsing R, Haller H, Middeke M, Paul M, Schmieder R, Schrader J, German Society of Hypertension: (2003) [New recommendations of the German Hypertension League for the drug treatment of hypertension] Dtsch Med Wochenschr. 2003;128(47): 2468-9
Delles C, Harazny J, Oehmer S, Michelson G, Schmieder RE: (2003) Contribution of nitric oxide (NO) to retinal perfusion is reduced in hypertensive patients but can be restored by treatment with candesartan cilexitil J Hypertens. 2003;21 Suppl.(): S169-S169
Gosse P, Dubourg O, Guéret P, De Simone G, Schmieder R, De Leeuw PW, Degaute JP, García Puig J, Karpov Y, Magometschnigg D, Matos L, Amouyel P, Asmar R, Le Heuzey JY, Nieminen M, Dahlof B: (2002) Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design. J Hum Hypertens. 2002;16(9): 653-9
Schunkert H, Schmieder R: (2002) Are the benefits of antihypertensive therapy only due to blood pressure reduction? J Hypertens. 2002;20(10): 2095-6; author reply 2096
Schlaich MP, Klingbeil AU, Jacobi J, Delles C, Schneider MP, Schmidt BM, Schmieder RE: (2002) Altered aldosterone response to salt intake and angiotensin II infusion in young normotensive men with parental history of arterial hypertension. J Hypertens. 2002;20(1): 117-24
Hilgers KF, Schmieder RE: (2002) Association studies in cardiovascular medicine. J Hypertens. 2002;20(2): 173-6
Jacobi J, Schneider MP, John S, Schmieder RE: (2002) Impact of NO-synthase inhibition on renal hemodynamics in normotensive and hypertensive subjects. J Hypertens. 2002;20(3): 525-30
Veelken R, Schmieder RE: (2002) Neutral endopeptidase inhibition: the potential of a new therapeutic approach in cardiovascular disease evolves. J Hypertens. 2002;20(4): 599-603
Klingbeil AU, John S, Schneider MP, Jacobi J, Weidinger G, Schmieder RE: (2002) AT1-receptor blockade improves augmentation index: a double-blind, randomized, controlled study. J Hypertens. 2002;20(12): 2423-8
John S, Schmieder RE: (2002) [Are COX-2 inhibitors a risk factor for cardiovascular disease?] Dtsch Med Wochenschr. 2002;127(4): 156-9
Delles C, Jacobi J, Schlaich MP, John S, Schmieder RE: (2002) Assessment of endothelial function of the renal vasculature in human subjects. Am J Hypertens. 2002;15(1 Pt 1): 3-9
Delles C, Schneider MP, John S, Gekle M, Schmieder RE: (2002) Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension. Am J Hypertens. 2002;15(7 Pt 1): 590-3
Delles C, Jacobi J, John S, Fleischmann I, Schmieder RE: (2002) Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension. Kidney Int. 2002;61(4): 1462-8
Schmieder RE, Delles C: (2002) [Microalbuminuria. Test for this risk factor!] MMW Fortschr Med. 2002;144(15): 47-8
Schmieder RE, Schneider MP: (2002) [Left ventricular hypertrophy. Recent aspects of diagnosis and therapy] MMW Fortschr Med. 2002;144(42): 45-6
Fleischmann EH, Schlaich MP, Schmidt BM, Oehmer S, Schmieder RE: (2002) Hypercholesterolaemia and treatment with statins do not alter L-arginine-induced changes of renal haemodynamics. Nephrol Dial Transplant. 2002;17(10): 1758-65
Fleischmann EH, Schmieder RE: (2002) Are all antihypertensive drug classes equal in reducing left ventricular hypertrophy? Curr Cardiol Rep. 2002;4(6): 474-8
Delles C, Klingbeil AU, Schneider MP, Handrock R, Schmieder RE: (2002) Different effects of amlodipine and valsartan on renal haemodynamics in essential hypertension Eur Heart J. 2002;23 Suppl.(): 496-496
Schneider MP, Klingbeil AU, John S, Delles C, Schmidt B, Schmieder RE: (2002) Vitamin C augments the renal response to L-arginine in smokers J Hypertens. 2002;20 Suppl.(): S104-S104
Schmieder RE, Delles C, Müller HJ, Schneider MP, John S, Schulze B: (2002) Analysis of endothelial function in the human renal vasculature J Hypertens. 2002;20 Suppl.(): S109-S109
Fleischmann EH, John S, Delles C, Schneider MP, Schmieder RE: (2002) Effect of cholesterol lowering agents on angiotensin II-induced blood pressure increase J Hypertens. 2002;20 Suppl.(): S143-S143
John S, Delles C, Schneider M, Jacobi J, Schmieder RE: (2002) Statins rapidly improve endothelial function in mildly hypertensive and hypercholesterolemic patients J Hypertens. 2002;20 Suppl.(): S144-S144
Hilgers KF, Porst M, Klanke B, Veelken R, Schmieder RE: (2002) Effect of the ACE genotype on angiotensin II and renin levels in plasma and kidney tissue J Hypertens. 2002;20 Suppl.(): S16-S16
Klanke B, Fehm N, Pentz ES, Schmieder RE, Veelken R, Hilgers KF: (2002) The ACE genotype determines the formation of angiotensin II in resistance vessels J Hypertens. 2002;20 Suppl.(): S16-S16
Handtrack C, Klanke B, Cordasic N, Veelken R, Schmieder RE, Hilgers KF: (2002) Effect of the angiotensinogen genotype on experimental hypertension in mice J Hypertens. 2002;20 Suppl.(): S17-S17
Frank H, Heusser K, Schmieder RE, Vitkovsky J, Schobel HP: (2002) Effects of angiotensin II receptor antagonism on renal hemodynamics J Hypertens. 2002;20 Suppl.(): S221-S221
Schmidt BMW, Delles C, Klingbeil AU, Schneider MP, John S, Schmieder RE: (2002) Is basal nitric oxide (NO) bioavailability similarly impaired in the forearm and the renal vasculature? J Hypertens. 2002;20 Suppl.(): S393-S393
Delles C, Klingbeil AU, Schneider MP, Handrock R, Schmieder RE: (2002) Divergent effects of amlodipine and valsartan on renal hemodynamics in essential hypertension J Hypertens. 2002;20 Suppl.(): S50-S50
Klingbeil AU, Delles C, Schneider M, John S, Schmieder RE: (2002) ACE-inhibitors, AT(1) receptor antagonists and augmentation index: Is combination therapy superior to monotherapy? J Hypertens. 2002;20 Suppl.(): S75-S75
Garlichs CD, John S, Schmeisser A, Eskafi S, Stumpf C, Karl M, Goppelt-Struebe M, Schmieder R, Daniel WG: (2001) Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation. 2001;104(20): 2395-400
Schmieder RE, Erdmann J, Delles C, Jacobi J, Fleck E, Hilgers K, Regitz-Zagrosek V: (2001) Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans. J Am Coll Cardiol. 2001;37(1): 175-82
John S, Delles C, Jacobi J, Schlaich MP, Schneider M, Schmitz G, Schmieder RE: (2001) Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks. J Am Coll Cardiol. 2001;37(5): 1351-8
Delles C, Erdmann J, Jacobi J, Hilgers KF, Fleck E, Regitz-Zagrosek V, Schmieder RE: (2001) Aldosterone synthase (CYP11B2) -344 C/T polymorphism is associated with left ventricular structure in human arterial hypertension. J Am Coll Cardiol. 2001;37(3): 878-84
John S, Griesbach D, Baumgärtel M, Weihprecht H, Schmieder RE, Geiger H: (2001) Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial. Nephrol Dial Transplant. 2001;16(2): 320-7
Renders L, Mayer-Kadner I, Koch C, Schärffe S, Burkhardt K, Veelken R, Schmieder RE, Hauser IA: (2001) Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients. Nephrol Dial Transplant. 2001;16(1): 141-6
Zeltner R, Delles C, Schneider M, Siffert W, Schmieder RE: (2001) G-protein beta(3) subunit gene (GNB3) 825T allele is associated with enhanced renal perfusion in early hypertension. Hypertension. 2001;37(3): 882-6
Schneider MP, Klingbeil AU, Schlaich MP, Langenfeld MR, Veelken R, Schmieder RE: (2001) Impaired sodium excretion during mental stress in mild essential hypertension. Hypertension. 2001;37(3): 923-7
Hilgers KF, Veelken R, Muller DN, Köhler H, Hartner A, Botkin SR, Stumpf C, Schmieder RE, Gomez RA: (2001) Renin uptake by the endothelium mediates vascular angiotensin formation. Hypertension. 2001;38(2): 243-8
Hilgers KF, Delles C, Veelken R, Schmieder RE: (2001) Angiotensinogen gene core promoter variants and non-modulating hypertension. Hypertension. 2001;38(6): 1250-4
Messerli FH, Schmieder RE: (2001) Salt and hypertension: going to the heart of the matter. Arch Intern Med. 2001;161(4): 505-6
Delles C, Schmieder RE: (2001) The kidney in congestive heart failure: renal adverse event rate of treatment. J Cardiovasc Pharmacol. 2001;38(1): 99-107
Veelken R, Delles C, Hilgers KF, Schmieder RE: (2001) Outcome survey in unselected hypertensive patients with type 2 diabetes mellitus: effects of ACE inhibition. Am J Hypertens. 2001;14(7 Pt 1): 672-8
Schmieder RE, Klingbeil AU: (2001) [Systolic or diastolic blood pressure. Which value is more important?] MMW Fortschr Med. 2001;143(28-29): 37-8
John S, Schmieder RE: (2000) Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences. J Hypertens. 2000;18(4): 363-74
Schlaich M, Veelken R, Hilgers K, Schmieder RE: (2000) Relationship of renal histological damage to glomerular hypertension in patients with immunoglobulin A nephropathy. J Hypertens. 2000;18(9): 1341-3
Delles C, Erdmann J, Jacobi J, Fleck E, Regitz-Zagrosek V, Schmieder RE: (2000) Lack of association between polymorphisms of angiotensin II receptor genes and response to short-term angiotensin II infusion. J Hypertens. 2000;18(11): 1573-8
Schneider MP, Erdmann J, Delles C, Fleck E, Regitz-Zagrosek V, Schmieder RE: (2000) Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase. J Hypertens. 2000;18(12): 1767-73
John S, Jacobi J, Delles C, Schlaich MP, Alter O, Schmieder RE: (2000) Plasma soluble adhesion molecules and endothelium-dependent vasodilation in early human atherosclerosis. Clin Sci (Lond). 2000;98(5): 521-9
Schlaich MP, Jacobi J, John S, Delles C, Fleischmann I, Schmieder RE: (2000) Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature? Clin Sci (Lond). 2000;99(4): 293-302
Schlaich MP, Schobel HP, Hilgers K, Schmieder RE: (2000) Impact of aldosterone on left ventricular structure and function in young normotensive and mildly hypertensive subjects. Am J Cardiol. 2000;85(10): 1199-206
Schneider MP, Hilgers KF, Klingbeil AU, John S, Veelken R, Schmieder RE: (2000) Plasma endothelin is increased in early essential hypertension. Am J Hypertens. 2000;13(6 Pt 1): 579-85
Klingbeil AU, Jacobi J, Langenfeld MR, John S, Hilgers KF, Schmieder RE: (2000) Enhanced antinatriuresis in response to angiotensin II in essential hypertension. Am J Hypertens. 2000;13(9): 986-93
Klingbeil AU, Müller HJ, Delles C, Fleischmann E, Schmieder RE: (2000) Regression of left ventricular hypertrophy by AT1 receptor blockade in renal transplant recipients. Am J Hypertens. 2000;13(12): 1295-300
John S, Jacobi J, Schlaich MP, Delles C, Schmieder RE: (2000) Effects of oral contraceptives on vascular endothelium in premenopausal women. Am J Obstet Gynecol. 2000;183(1): 28-33
Fischer T, Schneider MP, Schobel HP, Heusser K, Langenfeld M, Schmieder RE: (2000) Vascular reactivity in patients with preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol. 2000;183(6): 1489-94
Danzer E, Gallert K, Henke J, Gustmann H, Walter H, Schmieder RE: (2000) [Nürnberg Prevention Survey. "Prevention yes--but only when no effort is required"] MMW Fortschr Med. 2000;142(33-34): 46
Jacobi J, Rockstroh J, John S, Schreiber M, Schlaich MP, Neumayer HH, Schmieder RE: (2000) Prospective analysis of the value of 24-hour ambulatory blood pressure on renal function after kidney transplantation. Transplantation. 2000;70(5): 819-27
Schmieder RE, Delles C, Messerli FH: (2000) Diuretic therapy and the risk for renal cell carcinoma. J Nephrol. 2000;13(5): 343-6
Schmieder RE, Messerli FH: (2000) Hypertension and the heart. J Hum Hypertens. 2000;14(10-11): 597-604
Schmieder RE: (2000) [Antihypertensive therapy in the year 2000: status] Dtsch Med Wochenschr. 2000;125(46): 1384
Danzer E, Gallert K, Friedrich A, Fleischmann EH, Walter H, Schmieder RE: (2000) [Results of an intensive training program for hypertension at the Institute for Preventive Medicine] Dtsch Med Wochenschr. 2000;125(46): 1385-9
Frank H, Schmieder RE, Vogt-Ladner G, Schobel HP, Neumayer HH: (2000) Determinants of left ventricular structure after kidney transplantation. Transplant Proc. 2000;32(8): 2801-6
Schlaich MP, John S, Jacobi J, Lackner KJ, Schmieder RE: (2000) Mildly elevated homocysteine concentrations impair endothelium dependent vasodilation in hypercholesterolemic patients. Atherosclerosis. 2000;153(2): 383-9
Schmieder RE: (1999) [Diuretic therapy and the risk of renal-cell carcinoma] Dtsch Med Wochenschr. 1999;124(14): 410-1
Jacobi J, Schlaich MP, Delles C, Schobel HP, Schmieder RE: (1999) Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure. Am J Hypertens. 1999;12(4 Pt 1): 418-22
Schmieder RE, Delles C: (1999) Renal cell carcinoma and diuretics--should one restrict the use of diuretics? Nephrol Dial Transplant. 1999;14(7): 1621-3
Klingbeil AU, Schmieder RE: (1999) Not all left ventricular hypertrophy is created equal. Nephrol Dial Transplant. 1999;14(12): 2803-5
Messerli FH, Nunez BD, Nunez M, Garavaglia G, Schmieder RE, Ventura HO: (1999) Diuretics for hypertension. JAMA. 1999;282(6): 523; author reply 525
Klingbeil AU, Schobel H, Langenfeld MR, Hilgers K, Schäufele T, Schmieder RE: (1999) Hyper-responsiveness to angiotensin II is related to cardiac structural adaptation in hypertensive subjects. J Hypertens. 1999;17(6): 825-33
Jacobi J, Hilgers KF, Schlaich MP, Siffert W, Schmieder RE: (1999) 825T allele of the G-protein beta3 subunit gene (GNB3) is associated with impaired left ventricular diastolic filling in essential hypertension. J Hypertens. 1999;17(10): 1457-62
John S, Delles C, Klingbeil AU, Jacobi J, Schlaich MP, Schmieder RE: (1999) Low-density lipoprotein-cholesterol determines vascular responsiveness to angiotensin II in normocholesterolaemic humans. J Hypertens. 1999;17(12 Pt 2): 1933-9
Hilgers KF, Langenfeld MR, Schlaich M, Veelken R, Schmieder RE: (1999) 1166 A/C polymorphism of the angiotensin II type 1 receptor gene and the response to short-term infusion of angiotensin II. Circulation. 1999;100(13): 1394-9
Schlaich MP, Klingbeil A, Hilgers K, Schobel HP, Schmieder RE: (1999) Relation between the renin-angiotensin-aldosterone system and left ventricular structure and function in young normotensive and mildly hypertensive subjects. Am Heart J. 1999;138(5 Pt 1): 810-7
John S, Drobnik W, Lackner K, Schmieder RE: (1999) Soluble thrombomodulin and endothelial dysfunction in early atherosclerosis. Lancet. 1999;354(9190): 1647
Hilgers KF, Bingener E, Stumpf C, Muller DN, Schmieder RE, Veelken R: (1998) Angiotensinases restrict locally generated angiotensin II to the blood vessel wall. Hypertension. 1998;31(1 Pt 2): 368-72
Schlaich MP, John S, Langenfeld MR, Lackner KJ, Schmitz G, Schmieder RE: (1998) Does lipoprotein(a) impair endothelial function? J Am Coll Cardiol. 1998;31(2): 359-65
Schlaich MP, Schobel HP, Langenfeld MR, Hilgers K, Schmieder RE: (1998) Inadequate suppression of angiotensin II modulates left ventricular structure in humans. Clin Nephrol. 1998;49(3): 153-9
Schmieder RE, Schlaich MP, Klingbeil AU, Martus P: (1998) Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996). Nephrol Dial Transplant. 1998;13(3): 564-9
Schmieder RE: (1998) [Association between medication with calcium antagonists and increased cardiovascular mortality is not established] Fortschr Med. 1998;116(8): 51-2
Langenfeld MR, Schobel H, Veelken R, Weihprecht H, Schmieder RE: (1998) Impact of dietary sodium intake on left ventricular diastolic filling in early essential hypertension. Eur Heart J. 1998;19(6): 951-8
Schobel HP, Handwerker HO, Schmieder RE, Heusser K, Dominiak P, Luft FC: (1998) Effects of naloxone on hemodynamic and sympathetic nerve responses to pain in normotensive vs. borderline hypertensive men. J Auton Nerv Syst. 1998;69(1): 49-55
John S, Schlaich M, Langenfeld M, Weihprecht H, Schmitz G, Weidinger G, Schmieder RE: (1998) Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study. Circulation. 1998;98(3): 211-6
Schobel HP, Heusser K, Schmieder RE, Veelken R, Fischer T, Luft FC: (1998) Evidence against elevated sympathetic vasoconstrictor activity in borderline hypertension. J Am Soc Nephrol. 1998;9(9): 1581-7
Schobel HP, Schmieder RE: (1998) Vasodilatory capacity of forearm resistance vessels is augmented in hypercholesterolemic patients after treatment with fluvastatin. Angiology. 1998;49(9): 743-8
Schlaich MP, Schmieder RE: (1998) Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach: focus on treatment by antihypertensive agents. Am J Hypertens. 1998;11(11 Pt 1): 1394-404
Jacobi J, Schmieder RE: (1998) Nephroprotection by antihypertensive therapy. Basic Res Cardiol. 1998;93 Suppl 2(): 109-19
Veelken R, Hilgers KF, Scrogin KE, Mann JF, Schmieder RE: (1998) Endogenous angiotensin II and the reflex response to stimulation of cardiopulmonary serotonin 5HT3 receptors. Br J Pharmacol. 1998;125(8): 1761-7
Schmieder RE, Langenfeld MR, Hilgers KF: (1997) Endogenous erythropoietin correlates with blood pressure in essential hypertension. Am J Kidney Dis. 1997;29(3): 376-82
Schmieder RE, Weihprecht H, Schobel H, John S, Weidinger G, Gatzka C, Veelken R: (1997) Is endothelial function of the radial artery altered in human essential hypertension? Am J Hypertens. 1997;10(3): 323-31
Rockstroh JK, Schmieder RE, Schlaich MP, Messerli FH: (1997) Renal and systemic hemodynamics in black and white hypertensive patients. Am J Hypertens. 1997;10(9 Pt 1): 971-8
Schmieder RE, Langenfeld MR, Gatzka CD, Weidinger G, Schobel HP: (1997) Impact of alpha- versus beta-blockers on hypertensive target organ damage: results of a double-blind, randomized, controlled clinical trial. Am J Hypertens. 1997;10(9 Pt 1): 985-91
Schmieder RE, Rockstroh JK, Gatzka CD, Rüddel H, Schächinger H: (1997) Discontinuation of antihypertensive therapy: prevalence of relapses and predictors of successful withdrawal in a hypertensive community. Cardiology. 1997;88(3): 277-84
Schmieder RE: (1997) Dietary salt intake and left ventricular hypertrophy. Nephrol Dial Transplant. 1997;12(2): 245-8
Langenfeld MR, Veelken R, Schobel HP, Friedrich A, Schmieder RE: (1997) Is endogenous erythropoietin a pathogenetic factor in the development of essential hypertension? Nephrol Dial Transplant. 1997;12(6): 1155-60
Rockstroh JK, Schobel HP, Vogt-Ladner G, Hauser I, Neumayer HH, Schmieder RE: (1997) Blood pressure independent effects of nitrendipine on cardiac structure in patients after renal transplantation. Nephrol Dial Transplant. 1997;12(7): 1441-7
Schmieder RE, Veelken R, Schobel H, Dominiak P, Mann JF, Luft FC: (1997) Glomerular hyperfiltration during sympathetic nervous system activation in early essential hypertension. J Am Soc Nephrol. 1997;8(6): 893-900
Schmieder RE, Rockstroh JK, Lüchters G, Hammerstein U, Messerli FH: (1997) Comparison of early target organ damage between blacks and whites with mild systemic arterial hypertension. Am J Cardiol. 1997;79(12): 1695-8
Messerli FH, Schmieder RE, Weir MR: (1997) Salt. A perpetrator of hypertensive target organ disease? Arch Intern Med. 1997;157(21): 2449-52
Schmieder RE, Schlaich MP: (1997) Comparison of therapeutic studies on regression of left ventricular hypertrophy. Adv Exp Med Biol. 1997;432(): 191-8
Schmieder RE, Martus P, Klingbeil A: (1996) Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA. 1996;275(19): 1507-13
Messerli FH, Schmieder RE: (1996) Dietary sodium and blood pressure. JAMA. 1996;276(18): 1469; author reply 1469-7
Schmieder RE: (1996) Glomerular hyperfiltration in essential hypertension: cause or consequence? Contrib Nephrol. 1996;119(): 91-7
Schmieder RE, Langenfeld MR, Friedrich A, Schobel HP, Gatzka CD, Weihprecht H: (1996) Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. Circulation. 1996;94(6): 1304-9
Veelken R, Glabasnia A, Stetter A, Hilgers KF, Mann JF, Schmieder RE: (1996) Epicardial bradykinin B2 receptors elicit a sympathoexcitatory reflex in rats. Hypertension. 1996;28(4): 615-21
Veelken R, Hilgers KF, Stetter A, Siebert HG, Schmieder RE, Mann JF: (1996) Nerve-mediated antidiuresis and antinatriuresis after air-jet stress is modulated by angiotensin II. Hypertension. 1996;28(5): 825-32
Schobel HP, Ringkamp M, Behrmann A, Forster C, Schmieder RE, Handwerker HO: (1996) Hemodynamic and sympathetic nerve responses to painful stimuli in normotensive and borderline hypertensive subjects. Pain. 1996;66(2-3): 117-24
Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE: (1996) Preeclampsia -- a state of sympathetic overactivity. N Engl J Med. 1996;335(20): 1480-5
Schobel HP, Langenfeld M, Gatzka C, Schmieder RE: (1996) Treatment and post-treatment effects of alpha- versus beta-receptor blockers on left ventricular structure and function in essential hypertension. Am Heart J. 1996;132(5): 1004-9
Schmieder RE, Schobel HP, Gatzka CE, Häuser W, Dominiak P, Mann JF, Luft FC: (1996) Effects of angiotensin converting enzyme inhibitor on renal haemodynamics during mental stress. J Hypertens. 1996;14(10): 1201-7
Veelken R, Schmieder RE: (1996) Overview of alpha 1-adrenoceptor antagonism and recent advances in hypertensive therapy. Am J Hypertens. 1996;9(11): 139S-149S
Veelken R, Hilgers KF, Ditting T, Fierlbeck W, Geiger H, Schmieder RE: (1996) Subthreshold stimulation of a serotonin 5-HT3 reflex attenuates cardiovascular reflexes. Am J Physiol. 1996;271(6 Pt 2): R1500-6
Langenfeld MR, Bräutigam M, Weidinger G, Assmann I, Krönig B, Schmieder RE: (1996) Antihypertensive efficacy and orthostatic tolerance of bunazosin vs nitrendipine: a multicentre double-blind randomized controlled study. J Hum Hypertens. 1996;10(12): 831-6
Gatzka CD, Schmieder RE: (1995) Improved classification of dippers by individualized analysis of ambulatory blood pressure profiles. Am J Hypertens. 1995;8(7): 666-71
Schmieder RE, Rockstroh JK, Aepfelbacher F, Schulze B, Messerli FH: (1995) Gender-specific cardiovascular adaptation due to circadian blood pressure variations in essential hypertension. Am J Hypertens. 1995;8(12 Pt 1): 1160-6
Beil AH, Schmieder RE: (1995) Salt intake as a determinant of cardiac hypertrophy. Blood Press Suppl. 1995;2(): 30-4
Schmieder RE, Schobel HP, Messerli FH: (1995) Central blood volume: a determinant of early cardiac adaptation in arterial hypertension? J Am Coll Cardiol. 1995;26(7): 1692-8
Schmieder RE, Messerli FH: (1995) [The compliance of the large elastic arteries after blood pressure-lowering therapy with a calcium antagonist] Dtsch Med Wochenschr. 1995;120(25-26): 907-11
Schmieder RE, Schobel HP: (1995) Is endothelial dysfunction reversible? Am J Cardiol. 1995;76(2): 117A-121A
Schmieder RE, Veelken R, Gatzka CD, Rüddel H, Schächinger H: (1995) Predictors for hypertensive nephropathy: results of a 6-year follow-up study in essential hypertension. J Hypertens. 1995;13(3): 357-65
Schobel HP, Schmieder RE, Hartmann S, Schächinger H, Luft FC: (1995) Effects of bromocriptine on cardiovascular regulation in healthy humans. Hypertension. 1995;25(5): 1075-82
Gatzka CD, Schobel HP, Klingbeil AU, Neumayer HH, Schmieder RE: (1995) Normalization of circadian blood pressure profiles after renal transplantation. Transplantation. 1995;59(9): 1270-4
Schmieder RE, Beil AH, Weihprecht H, Messerli FH: (1995) How should renal hemodynamic data be indexed in obesity? J Am Soc Nephrol. 1995;5(9): 1709-13
Langenfeld MR, Schmieder RE: (1995) Salt and left ventricular hypertrophy: what are the links? J Hum Hypertens. 1995;9(11): 909-16
Schobel HP, Schmieder RE, Hartmann S, Schächinger H, Gatzka CD: (1995) BROMOCRIPTINE LOWERS SYMPATHETIC ACTIVITY PERIPHERALLY BUT NOT CENTRALLY DURING BAROREFLEX PERTURBATION Nieren und Hochdruckkrankheiten. 1995;24(1): 23-25
Schmieder RE, Rockstroh JK: (1994) Obesity and hypertension. Curr Opin Nephrol Hypertens. 1994;3(5): 546-9
Schmieder RE, Gatzka C, Schobel H, Schächinger H, Weihprecht H: (1994) Renal hemodynamic response to stress is influenced by ACE-inhibitors. Clin Nephrol. 1994;42(6): 381-8
Schmieder RE: (1994) Nephroprotection by antihypertensive agents. J Cardiovasc Pharmacol. 1994;24 Suppl 2(): S55-64
Beil AH, Schmieder RE, Messerli FH: (1994) Salt intake, blood pressure, and cardiovascular structure. Cardiovasc Drugs Ther. 1994;8(3): 425-32
Schmieder RE, Rockstroh JK: (1994) Efficacy and tolerance of low-dose loop diuretics in hypertension. Cardiology. 1994;84 Suppl 2(): 36-42
Nunez BD, Lavie CJ, Messerli FH, Schmieder RE, Garavaglia GE, Nunez M: (1994) Comparison of diastolic left ventricular filling and cardiac dysrhythmias in hypertensive patients with and without isolated septal hypertrophy. Am J Cardiol. 1994;74(6): 585-9
Schmieder RE, Schächinger H, Messerli FH: (1994) Accelerated decline in renal perfusion with aging in essential hypertension. Hypertension. 1994;23(3): 351-7
Schmieder RE, Messerli FH: (1993) [Ventricular arrhythmia and sudden cardiac death: the significance of left ventricular hypertrophy as risk factor] Schweiz Med Wochenschr. 1993;123(4): 99-107
Werner MG, Schmieder RE: (1993) [Rational therapy of heart failure] Z Kardiol. 1993;82 Suppl 4(): 7-16
Schmieder RE, Gatzka C, Klingbeil A, Rüddel H, Schächinger H, Tenes-Reino S: (1993) Obese hypertensive patients are less effectively treated than lean hypertensives. J Hypertens Suppl. 1993;11(5): S348-9
Schobel HP, Schmieder RE, Gatzka CD, Messerli FH: (1993) A centripetal shift in intravascular volume triggers the onset of early cardiac adaptation in hypertension. J Hypertens Suppl. 1993;11(5): S94-5
Gatzka CD, Schmieder RE, Schobel HP, Klingbeil AU, Weihprecht H: (1993) Improved prediction of left ventricular mass from ambulatory blood pressure monitoring using average tension-time index. J Hypertens Suppl. 1993;11(5): S98-9
Schmieder RE, Rüddel H, Schächinger H, Bruns J, Schulte W: (1993) Renal hemodynamics and cardiovascular reactivity in the prehypertensive stage. Behav Med. 1993;19(1): 5-12
Grossman E, Messerli FH, Oren S, Soria F, Schmieder RE: (1993) Disparate cardiovascular response to stress tests during isradipine and fosinopril therapy. Am J Cardiol. 1993;72(7): 574-9
Schmieder RE, Gatzka C, Schächinger H, Schobel H, Rüddel H: (1993) Obesity as a determinant for response to antihypertensive treatment. BMJ. 1993;307(6903): 537-40
Schmieder RE, Messerli FH: (1993) Does obesity influence early target organ damage in hypertensive patients? Circulation. 1993;87(5): 1482-8
Schmieder RE, Messerli FH: (1992) Determinants of ventricular ectopy in hypertensive cardiac hypertrophy. Am Heart J. 1992;123(1): 89-95
Schmieder RE: (1992) Hypertensive heart disease--significance of left ventricular hypertrophy. J Cardiovasc Pharmacol. 1992;20 Suppl 6(): S50-5
Mann JF, Hilgers KF, Veelken R, Geiger H, Schmieder RE, Luft FC: (1992) Effect of antihypertensive therapy on the progression of non-diabetic renal disease. Clin Nephrol. 1992;38 Suppl 1(): S74-7
Schmieder RE, Rüddel H, Schächinger H, Schulte W: (1992) Impact of angiotensin converting enzyme inhibition on the haemodynamic profile during laboratory stress tests. J Hum Hypertens. 1992;6(3): 227-32
Schmieder RE: (1992) [Pathophysiology of left heart failure with reference to hemodynamic and neurohumoral changes] Acta Med Austriaca. 1992;19(3): 77-82
Gatzka CD, Schobel HP, Vogt-Ladner G, Neumayer HH, Schmieder RE: (1992) [Decreased blood pressure in sleep and left ventricular hypertrophy in patients with kidney transplants] Z Kardiol. 1992;81 Suppl 2(): 17-9
Rockstroh JK, Schmieder RE, Schächinger H, Messerli FH: (1992) Stress response pattern in obesity and systemic hypertension. Am J Cardiol. 1992;70(11): 1035-9
Schobel HP, Schmieder RE, Messerli FH: (1992) Risks versus benefits of withdrawing antihypertensive therapy. Drug Saf. 1992;7(6): 395-403
Schmieder RE, Messerli FH: (1992) Is the decrease in arterial pressure the sole factor for reduction of left ventricular hypertrophy? Am J Med. 1992;92(4B): 28S-34S
Schmieder RE, Rüddel H, Schlebusch H, Rockstroh J, Schächinger H, Schulte W: (1992) Impact of antihypertensive therapy with isradipine and metoprolol on early markers of hypertensive nephropathy. Am J Hypertens. 1992;5(5 Pt 1): 318-21
Schmieder RE, Rockstroh JK, Münch HG, Rüddel H, Schlebusch H: (1991) Elevated serum activity of N-acetyl-beta-glucosaminidase in essential hypertension: diagnostic value and reversal to normal values after antihypertensive therapy. Am J Kidney Dis. 1991;18(6): 638-48
Schmieder RE, Rockstroh JK, Messerli FH: (1991) Antihypertensive therapy. To stop or not to stop? JAMA. 1991;265(12): 1566-71
Schächinger H, Schmieder RE: (1991) [Importance of 24-hour blood pressure monitoring in detection of hypertension-induced end organ damage] Z Kardiol. 1991;80 Suppl 1(): 41-7
Schmieder RE, Messerli FH: (1990) Reversal of left ventricular hypertrophy: a desirable therapeutic goal? J Cardiovasc Pharmacol. 1990;16 Suppl 6(): S16-22
Schmieder RE, Rockstroh JK: (1990) When is discontinuation of antihypertensive therapy indicated? Cardiovasc Drugs Ther. 1990;4(6): 1487-94
Schmieder RE, Grube E, Rüddel H, Schächinger H, Schulte W: (1990) Relation of hemodynamic reaction during stress to left ventricular hypertrophy in essential hypertension. Am J Hypertens. 1990;3(4): 281-7
Schmieder RE: (1990) Risk reduction following regression of cardiac hypertrophy. Clin Exp Hypertens A. 1990;12(5): 903-16
Schmieder RE, Grube E, Impelmann V, Rüddel H, Schulte W: (1990) [Determinants for myocardial hypertrophy in mild essential hypertension. The effect of sodium chloride on left-ventricular hypertrophy] Z Kardiol. 1990;79(8): 557-64
Messerli FH, Schmieder RE: (1990) [Arterial hypertension, left ventricular hypertrophy and sudden cardiac death] Dtsch Med Wochenschr. 1990;115(44): 1682-7
Schmieder RE, Messerli FH, Garavaglia G, Nunez B: (1990) Glomerular hyperfiltration indicates early target organ damage in essential hypertension. JAMA. 1990;264(21): 2775-80
Lavie CJ, Schmieder RE, Messerli FH: (1988) Ambulatory blood pressure monitoring: practical considerations. Am Heart J. 1988;116(4): 1146-51
Rüddel H, Langewitz W, Schächinger H, Schmieder R, Schulte W: (1988) Hemodynamic response patterns to mental stress: diagnostic and therapeutic implications. Am Heart J. 1988;116(2 Pt 2): 617-27
Nunez BD, Messerli FH, Amodeo C, Garavaglia GE, Schmieder RE, Frohlich ED: (1987) Biventricular cardiac hypertrophy in essential hypertension. Am Heart J. 1987;114(4 Pt 1): 813-8
Messerli FH, Schmieder RE, Nunez BD: (1986) Heterogeneous pathophysiology of essential hypertension: implications for therapy. Am Heart J. 1986;112(4): 886-93

Schriftgröße anpassen

Prof. Dr. Roland Schmieder

Publikationsliste Prof. Dr. Roland Schmieder

Notfall

Notfallinformationen UKER

Patienten & Besucher

Ärzte & Zuweiser

Forschung

Lehre